ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State of Incorporation) |
(I.R.S. Employer Identification Number) | |
(Address of principal executive offices) |
(Zip Code) |
Title of Each Class |
Trading Symbol |
Name of Each Exchange on Which Registered | ||
☒ | Accelerated filer | ☐ | ||||
Non-accelerated filer | ☐ | Smaller Reporting Company | ||||
Emerging growth company |
Auditor Firm Id: |
Auditor Name: |
Auditor Location: |
Page |
||||||
PART I |
||||||
Item 1. |
1 | |||||
Item 1A. |
31 | |||||
Item 1B. |
71 | |||||
Item 1C. |
72 | |||||
Item 2. |
73 | |||||
Item 3. |
73 | |||||
Item 4. |
73 | |||||
PART II |
||||||
Item 5. |
74 | |||||
Item 6. |
79 | |||||
Item 7. |
79 | |||||
Item 7A. |
104 | |||||
Item 8. |
106 | |||||
Item 9. |
163 | |||||
Item 9A. |
163 | |||||
Item 9B. |
163 | |||||
Item 9C. |
163 | |||||
PART III |
||||||
Item 10. |
164 | |||||
Item 11. |
169 | |||||
Item 12. |
171 | |||||
Item 13. |
173 | |||||
Item 14. |
176 | |||||
PART IV |
||||||
Item 15. |
178 | |||||
Item 16. |
182 | |||||
183 |
Item 1. |
Business |
• | Middle-market companies continue to face increasing difficulty in accessing the capital markets. |
• | There is a large pool of uninvested private equity capital likely to seek additional capital to support their investments. |
• | The significant amount of debt maturing through 2025 should provide additional demand for capital. |
• | Investing in private middle-market debt provides an attractive risk reward profile. |
• Aerospace & Defense |
• Household & Personal Products | |
• Air Freight & Logistics |
• Industrial Conglomerates | |
• Airlines |
• Insurance | |
• Asset Management |
• Internet & Catalog Retail | |
• Automobiles |
• Internet Software & Services | |
• Auto Components |
• IT Services |
• Auto Parts & Equipment |
• Leisure Equipment & Products | |
• Biotechnology |
• Life Sciences Tools & Services | |
• Building Products |
• Machinery | |
• Capital Markets |
• Media | |
• Chemicals |
• Metals & Mining | |
• Commercial Services & Supplies |
• Multiline Retail | |
• Communications Equipment |
• Multi-Sector Holdings | |
• Construction & Engineering |
• Oil, Gas & Consumable Fuels | |
• Consumer Finance |
• Packaged Foods & Meats | |
• Containers & Packaging |
• Paper & Forest Products | |
• Distributors |
• Personal Products | |
• Diversified Consumer Services |
• Pharmaceuticals | |
• Diversified Financial Services |
• Professional Services | |
• Diversified Real Estate Activities |
• Research & Consulting Services | |
• Diversified Telecommunications Services |
• Road & Rail | |
• Education Services |
• Software | |
• Energy Equipment & Services |
• Specialty Retail | |
• Food Products |
• Textiles, Apparel & Luxury Goods | |
• Food & Staples Retailing |
• Thrifts & Mortgage Finance | |
• Footwear |
• Trading Companies & Distributors | |
• Health Care Equipment & Supplies |
• Transportation Infrastructure | |
• Health Care Facilities |
• Water Utilities | |
• Health Care Providers & Services |
• Wireless Telecommunications Services | |
• Health Care Technology |
||
• Hotels, Restaurants & Leisure |
Portfolio Company |
% of Total Assets |
|||
SLR Credit Solutions* |
11.3 | % | ||
Kingsbridge Holdings, LLC* |
9.4 | % | ||
SLR Equipment Finance* |
4.9 | % | ||
SLR Business Credit* |
3.6 | % | ||
Arcutis Biotherapeutics, Inc. |
2.7 | % | ||
Outset Medical, Inc. |
1.8 | % | ||
SLR Senior Lending Program LLC* |
1.7 | % | ||
Enhanced Capital Group, LLC |
1.7 | % | ||
BridgeBio Pharma, Inc. |
1.6 | % | ||
Vapotherm, Inc. |
1.5 | % |
* | Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. |
Industry |
% of Total Assets |
|||
Diversified Financial Services |
18.7 | % | ||
Multi-Sector Holdings |
14.8 | % | ||
Health Care Providers & Services |
11.2 | % | ||
Health Care Equipment & Supplies |
6.5 | % | ||
Pharmaceuticals |
4.9 | % | ||
Biotechnology |
3.1 | % | ||
Software |
3.0 | % | ||
Insurance |
2.5 | % | ||
Diversified Consumer Services |
1.9 | % | ||
Commercial Services & Supplies |
1.9 | % |
Portfolio Company |
% of Total Assets |
|||
SLR Credit Solutions* |
11.4 | % | ||
Kingsbridge Holdings, LLC* |
9.0 | % | ||
SLR Equipment Finance* |
5.0 | % | ||
SLR Business Credit* |
3.5 | % | ||
Arcutis Biotherapeutics, Inc. |
2.7 | % | ||
BridgeBio Pharma, Inc. |
1.6 | % | ||
Foundation Consumer Brands, LLC |
1.4 | % | ||
Enhanced Capital Group, LLC |
1.4 | % | ||
Outset Medical, Inc. |
1.4 | % | ||
Vapotherm, Inc. |
1.4 | % |
* | Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. |
Industry |
% of Total Assets |
|||
Diversified Financial Services |
18.2 | % | ||
Multi-Sector Holdings |
14.4 | % | ||
Health Care Providers & Services |
6.4 | % | ||
Health Care Equipment & Supplies |
5.4 | % | ||
Pharmaceuticals |
4.5 | % | ||
Software |
3.6 | % | ||
Insurance |
3.5 | % | ||
Biotechnology |
3.2 | % | ||
Diversified Consumer Services |
2.2 | % | ||
Media |
1.6 | % |
• | buy larger companies with strong business franchises; |
• | invest significant amounts of equity in their portfolio companies; |
• | value flexibility and creativity in structuring their transactions; |
• | possess longer track records over multiple investment funds; |
• | have a deeper management bench; |
• | have better ability to withstand downturns; and |
• | possess the ability to support portfolio companies with additional capital. |
• | review of historical and prospective financial information; |
• | review and valuation of assets; |
• | research relating to the company’s management, industry, markets, products and services and competitors; |
• | on-site visits; |
• | discussions with management, employees, customers or vendors of the potential portfolio company; |
• | review of senior loan documents; and |
• | background investigations. |
• | investment track record; |
• | industry experience; |
• | capacity and willingness to provide additional financial support to the company through additional capital contributions, if necessary; and |
• | reference checks. |
• | requiring a total return on our investments (including both interest and potential capital appreciation) that compensates us for credit risk; |
• | incorporating “put” rights and call protection into the investment structure; and |
• | negotiating covenants in connection with our investments that afford our portfolio companies as much flexibility in managing their businesses as possible, consistent with preservation of our capital. Such restrictions may include affirmative and negative covenants, default penalties, lien protection, change of control provisions and board rights, including either observation or participation rights. |
• | Assessment of success in adhering to each portfolio company’s business plan and compliance with covenants; |
• | Periodic and regular contact with portfolio company management and, if appropriate, the financial or strategic sponsor, to discuss financial position, requirements and accomplishments; |
• | Comparisons to other SLR invested portfolio companies in the industry, if any; |
• | Attendance at and participation in board meetings; and |
• | Review of monthly and quarterly financial statements and financial projections for portfolio companies. |
Investment Rating |
Summary Description | |
1 | Involves the least amount of risk in our portfolio, the portfolio company is performing above expectations, and the trends and risk factors are generally favorable (including a potential exit) | |
2 | Risk that is similar to the risk at the time of origination, the portfolio company is performing as expected, and the risk factors are neutral to favorable; all new investments are initially assessed a grade of 2 | |
3 | The portfolio company is performing below expectations, may be out of compliance with debt covenants, and requires procedures for closer monitoring | |
4 | The investment is performing well below expectations and is not anticipated to be repaid in full |
(1) | our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment; |
(2) | preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser; |
(3) | independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets; |
(4) | the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and |
(5) | the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee. |
• | pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended (the “1934 Act”), our Co-Chief Executive Officers and Chief Financial Officer must certify as to the accuracy of the financial statements contained in our periodic reports; |
• | pursuant to Item 307 of Regulation S-K, our periodic reports must disclose our conclusions about the effectiveness of our disclosure controls and procedures; |
• | pursuant to Rule 13a-15 of the 1934 Act, our management is required to prepare an annual report regarding its assessment of our internal control over financial reporting and to obtain an audit of the effectiveness of internal control over financial reporting performed by our independent registered public accounting firm; and |
• | pursuant to Item 308 of Regulation S-K and Rule 13a-15 of the 1934 Act, our periodic reports must disclose whether there were significant changes in our internal controls over financial reporting or in other factors that could significantly affect these controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. |
• | Information we receive from recordholders, whether we receive it orally, in writing or electronically. This includes recordholders’ communications to us concerning their investment; |
• | Information about recordholders’ transaction history with us; and |
• | Other general information that we may obtain about recordholders, such as demographic and contact information such as address. |
• | to our affiliates (such as SLR and our administrator) and their employees for everyday business purposes; |
• | to our service providers (such as our accountants, attorneys, custodians, transfer agent, underwriter and proxy solicitors) and their employees as is necessary to service recordholder accounts or otherwise provide the applicable service; |
• | to comply with court orders, subpoenas, lawful discovery requests, or other legal or regulatory requirements; or |
• | as allowed or required by applicable law or regulation. |
• | at all times during each taxable year, have in effect an election to be treated as a BDC under the 1940 Act; |
• | derive in each taxable year at least 90% of our gross income from (a) dividends, interest, payments with respect to certain securities loans, gains from the sale of stock or other securities or currencies, or other income derived with respect to our business of investing in such stock, securities or currencies and (b) net income derived from an interest in a “qualified publicly traded partnership;” and |
• | diversify our holdings so that at the end of each quarter of the taxable year: |
• | at least 50% of the value of our assets consists of cash, cash equivalents, U.S. government securities, securities of other RICs, and other securities if such other securities of any one issuer do not represent more than 5% of the value of our assets or more than 10% of the outstanding voting securities of the issuer; and |
• | no more than 25% of the value of our assets is invested in (i) the securities, other than U.S. government securities or securities of other RICs, of one issuer, (ii) the securities of two or more issuers that are controlled, as determined under applicable tax rules, by us and that are engaged in the same or similar or related trades or businesses or (iii) the securities of one or more “qualified publicly traded partnerships.” |
• | no performance-based incentive fee in any calendar quarter in which our pre-incentive fee net investment income does not exceed the hurdle of 1.75%; |
• | 100% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle but is less than 2.1875% in any calendar quarter (8.75% annualized). We refer to this portion of our pre-incentive fee net investment income (which exceeds the hurdle but is less than 2.1875%) as the “catch-up.” The “catch-up” is meant to provide our investment adviser with 20% of our pre-incentive fee net investment income as if a hurdle did not apply if this net investment income exceeds 2.1875% in any calendar quarter; and |
• | 20% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.1875% in any calendar quarter (8.75% annualized) is payable to SLR Capital Partners (once the hurdle is reached and the catch-up is achieved, 20% of all pre-incentive fee investment income thereafter is allocated to SLR Capital Partners). |
(*) | The hypothetical amount of pre-incentive fee net investment income shown is based on a percentage of total net assets. |
(1) |
Represents 7% annualized hurdle rate. |
(2) |
Represents 1.50% annualized management fee. |
(3) |
Excludes organizational and offering expenses. |
(4) |
The “catch-up” provision is intended to provide our investment adviser with an incentive fee of 20% on all of our pre-incentive fee net investment income as if a hurdle rate did not apply when our net investment income exceeds 2.1875% in any calendar quarter. |
• | Year 1: $20 million investment made in Company A (“Investment A”), and $30 million investment made in Company B (“Investment B”) |
• | Year 2: Investment A sold for $50 million and fair market value (“FMV”) of Investment B was determined to be $32 million |
• | Year 3: FMV of Investment B determined to be $25 million |
• | Year 4: Investment B sold for $31 million |
• | Year 1: None |
• | Year 2: Capital gains incentive fee of $6 million ($30 million realized capital gains on the sale of Investment A multiplied by 20%) |
• | Year 3: None |
• | Year 4: Capital gains incentive fee of $200,000 |
• | Year 1: $20 million investment made in Company A (“Investment A”), $30 million investment made in Company B (“Investment B”) and $25 million investment made in Company C (“Investment C”) |
• | Year 2: Investment A sold for $50 million, FMV of Investment B determined to be $25 million and FMV of Investment C determined to be $25 million |
• | Year 3: FMV of Investment B determined to be $27 million and Investment C sold for $30 million |
• | Year 4: FMV of Investment B determined to be $24 million |
• | Year 5: Investment B sold for $20 million |
• | Year 1: None |
• | Year 2: $5 million capital gains incentive fee |
• | Year 3: $1.4 million capital gains incentive fee (1) |
• | Year 4: None |
• | Year 5: None |
(1) |
As illustrated in Year 3 of Alternative 2 above, if the Company were to be wound up on a date other than December 31 of any year, the Company may have paid aggregate capital gain incentive fees that are more than the amount of such fees that would be payable if the Company had been wound up on December 31 of such year. |
• | the cost of our organization and public offerings; |
• | the cost of calculating our net asset value, including the cost of any third-party valuation services; |
• | the cost of effecting sales and repurchases of our shares and other securities; |
• | interest payable on debt, if any, to finance our investments; |
• | fees payable to third parties relating to, or associated with, making investments, including fees and expenses associated with performing due diligence reviews of prospective investments and advisory fees; |
• | transfer agent and custodial fees; |
• | fees and expenses associated with marketing efforts; |
• | federal and state registration fees, any stock exchange listing fees; |
• | federal, state and local taxes; |
• | independent directors’ fees and expenses; |
• | brokerage commissions; |
• | fidelity bond, directors and officers errors and omissions liability insurance and other insurance premiums; |
• | direct costs and expenses of administration, including printing, mailing, long distance telephone and staff; |
• | fees and expenses associated with independent audits and outside legal costs; |
• | costs associated with our reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws; and |
• | all other expenses incurred by either SLR Capital Management or us in connection with administering our business, including payments under the Administration Agreement that will be based upon our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the costs of compensation and related expenses of our chief compliance officer and our chief financial officer and their respective staffs. |
• | We operate in a highly competitive market for investment opportunities. |
• | Our investments are very risky and highly speculative. |
• | The lack of liquidity in our investments may make it difficult for us to dispose of our investments at a favorable price, which may adversely affect our ability to meet our investment objectives. |
• | Our portfolio may be concentrated in a limited number of portfolio companies and industries, which will subject us to a risk of significant loss if any of these companies performs poorly or defaults on its obligations under any of its debt instruments or if there is a downturn in a particular industry. |
• | Economic sanction laws in the United States and other jurisdictions may prohibit us and our affiliates from transacting with certain countries, individuals and companies. |
• | If we cannot obtain additional capital because of either regulatory or market price constraints, we could be forced to curtail or cease our new lending and investment activities, our net asset value could decrease and our level of distributions and liquidity could be affected adversely. |
• | We may suffer a loss if a portfolio company defaults on a loan and the underlying collateral is not sufficient. |
• | Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity. |
• | We may be exposed to higher risks with respect to our investments that include original issue discount or PIK interest. |
• | Our shares may trade at a substantial discount from net asset value and may continue to do so over the long term. |
• | Our common stock price may be volatile and may decrease substantially. |
• | Our business and operation could be negatively affected if we become subject to any securities litigation or stockholder activism, which could cause us to incur significant expense, hinder execution of investment strategy and impact our stock price. |
• | If the current period of capital market disruption and instability continues for an extended period of time, there is a risk that investors in our equity securities may not receive distributions consistent with historical levels or at all or that our distributions may not grow over time and a portion of our distributions may be a return of capital. |
• | Due to disruptions in the economy, we may reduce or defer our dividends and choose to incur U.S. federal excise tax in order to preserve cash and maintain flexibility. |
• | We may choose to pay distributions in our own common stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive. |
• | Sales of substantial amounts of our common stock in the public market may have an adverse effect on the market price of our common stock. |
• | The net asset value per share of our common stock may be diluted if we issue or sell shares of our common stock at prices below the then current net asset value per share of our common stock or securities to subscribe for or convertible into shares of our common stock. |
• | To the extent we use debt or preferred stock to finance our investments, changes in interest rates will affect our cost of capital and net investment income. |
• | Our stock repurchase program could affect the price of our common stock and increase volatility and may be suspended or terminated at any time, which may result in a decrease in the trading price of our common stock. |
• | We are dependent upon SLR Capital Partners’ key personnel for our future success. |
• | Our business model depends to a significant extent upon strong referral relationships with financial sponsors, and the inability of the senior investment professionals of our Investment Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business. |
• | Our financial condition and results of operations will depend on SLR Capital Partners’ ability to manage our future growth effectively by identifying, investing in and monitoring companies that meet our investment criteria. |
• | We may need to raise additional capital to grow because we must distribute most of our income. |
• | Any failure on our part to maintain our status as a BDC would reduce our operating flexibility and we may be limited in our investment choices as a BDC. |
• | Regulations governing our operation as a BDC affect our ability to, and the way in which we will, raise additional capital. As a BDC, the necessity of raising additional capital may expose us to risks, including the typical risks associated with leverage. |
• | We have and will continue to borrow money, which would magnify the potential for loss on amounts invested and may increase the risk of investing in us. |
• | It is likely that the terms of any current or future long-term or revolving credit or warehouse facility we may enter into in the future could constrain our ability to grow our business. |
• | There will be uncertainty as to the value of our portfolio investments, which may impact our net asset value. |
• | There are significant potential conflicts of interest, including SLR Capital Partners’ management of other investment funds such as SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC, which could impact our investment returns, and an investment in SLR Investment Corp. is not an investment in SCP Private Credit Income BDC LLC, SLR HC BDC LLC, or SLR Private Credit BDC II LLC. |
• | We may be obligated to pay our Investment Adviser incentive compensation even if we incur a loss. |
• | Our incentive fee may induce SLR Capital Partners to pursue speculative investments. |
• | We may become subject to corporate-level U.S. federal income tax if we are unable to qualify and maintain our qualification for tax treatment as a regulated investment company under Subchapter M of the Code. |
• | The failure in cyber security systems, as well as the occurrence of events unanticipated in our disaster recovery systems and management continuity planning could impair our ability to conduct business effectively. |
• | Our business is subject to increasingly complex corporate governance, public disclosure and accounting requirements that could adversely affect our business and financial results. |
Item 1A. |
Risk Factors. |
• | these companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees we may have obtained in connection with our investment; |
• | they typically have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as general economic downturns; |
• | they are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us; |
• | they generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence, and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position. In addition, our executive officers, directors and our Investment Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies; and |
• | they may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness upon maturity. |
• | The interest payments deferred on a PIK loan are subject to the risk that the borrower may default when the deferred payments are due in cash at the maturity of the loan; |
• | The interest rates on PIK loans are higher to reflect the time-value of money on deferred interest payments and the higher credit risk of borrowers who may need to defer interest payments; |
• | PIK instruments may have unreliable valuations because the accruals require judgments about ultimate collectability of the deferred payments and the value of the associated collateral; |
• | An election to defer PIK income payments by adding them to principal increases our gross assets and, thus, increases future base fees to the Investment Adviser and, because income payments will then be |
payable on a larger principal amount, the PIK election also increases the Investment Adviser’s future income incentive fees at a compounding rate; |
• | Market prices of original issue discount instruments are more volatile because they are affected to a greater extent by interest rate changes than instruments that pay interest periodically in cash; |
• | The deferral of interest on a PIK loan increases its loan-to-value |
• | Original issue discount creates the risk of non-refundable cash payments to the Investment Adviser based on non-cash accruals that may never be realized. |
• | price and volume fluctuations in the overall stock market from time to time; |
• | investor demand for our shares; |
• | significant volatility in the market price and trading volume of securities of BDCs or other companies in our sector, which are not necessarily related to the operating performance of these companies; |
• | exclusion of our common stock from certain market indices, such as the Russell 2000 Financial Services Index, which could reduce the ability of certain investment funds to own our common stock and put short-term selling pressure on our common stock; |
• | changes in regulatory policies or tax guidelines with respect to RICs or BDCs; |
• | failure to qualify as a RIC, or the loss of RIC tax treatment; |
• | any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts; |
• | changes, or perceived changes, in the value of our portfolio investments; |
• | departures of SLR Capital Partners’ key personnel; |
• | operating performance of companies comparable to us; |
• | changes in the prevailing interest rates; |
• | loss of a major funding source; or |
• | general economic conditions and trends and other external factors. |
Assumed total return (net of interest expense) |
||||||||||||||||||||
(10)% |
(5)% |
0% |
5% |
10% |
||||||||||||||||
Corresponding return to stockholder(1) |
( |
)% | ( |
)% | ( |
)% | % | % |
(1) | Assumes $2.5 billion in total assets (inclusive of temporary cash assets of $332 million) and $1.2 billion in total debt outstanding, which reflects our total assets and total debt outstanding as of December 31, 2023, and a cost of funds of 5.88%. Excludes non-leverage related expenses. |
• | The Annual Distribution Requirement for a RIC will be satisfied if we distribute to our stockholders on an annual basis at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Because we may use debt financing, we are subject to certain asset coverage ratio requirements under the 1940 Act and financial covenants under loan and credit agreements that could, under certain circumstances, restrict us from making distributions necessary to satisfy the Annual Distribution Requirement. If we are unable to obtain cash from other sources, we could fail to qualify for RIC tax treatment and become subject to corporate-level U.S federal income tax. |
• | The income source requirement will be satisfied if we obtain at least 90% of our income for each year from certain passive investments, including interest, dividends, gains from the sale of stock or securities, or similar sources. |
• | The asset diversification requirement will be satisfied if we meet certain asset diversification requirements at the end of each quarter of our taxable year. Failure to meet those requirements may result in our having to dispose of certain investments quickly in order to prevent the loss of RIC tax treatment. Because most of our investments will be relatively illiquid, any such dispositions could be made at disadvantageous prices and could result in substantial losses. |
• | sudden electrical or telecommunications outages; |
• | natural disasters such as earthquakes, tornadoes and hurricanes; |
• | events arising from local or larger scale political or social matters, including terrorist acts; and |
• | cyber-attacks. |
Item 1B. |
Unresolved Staff Comments |
Item 1C. |
Cybersecurity |
Item 2. |
Properties |
Item 3. |
Legal Proceedings |
Item 4. |
Mine Safety Disclosures |
Item 5. |
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities |
Price Range |
Premium or (Discount) of High Closing |
Premium or (Discount) of Low Closing Price to |
Declared |
|||||||||||||||||||||
NAV (1) |
High |
Low |
Price to NAV (2) |
NAV (2) |
Distributions (3) |
|||||||||||||||||||
Fiscal 2023 |
||||||||||||||||||||||||
Fourth Quarter |
$ | $ | $ | ( |
)% | ( |
)% | $ | 0.41 | |||||||||||||||
Third Quarter |
( |
) | ( |
) | 0.41 | |||||||||||||||||||
Second Quarter |
( |
) | ( |
) | 0.41 | |||||||||||||||||||
First Quarter |
( |
) | ( |
) | 0.41 | |||||||||||||||||||
Fiscal 2022 |
||||||||||||||||||||||||
Fourth Quarter |
$ | $ | $ | ( |
)% | ( |
)% | $ | 0.41 | |||||||||||||||
Third Quarter |
( |
) | ( |
) | 0.41 | |||||||||||||||||||
Second Quarter |
( |
) | ( |
) | 0.41 | |||||||||||||||||||
First Quarter |
( |
) | ( |
) | 0.41 |
(1) |
NAV per share is determined as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low sales prices. The net asset values shown are based on outstanding shares at the end of each period. |
(2) |
Calculated as of the respective high or low closing price divided by NAV and subtracting 1. |
(3) |
Represents the cash distribution for the specified quarter. |
Stockholder transaction expenses: |
||||
Sales load (as a percentage of offering price) |
% (1) | |||
Offering expenses (as a percentage of offering price) |
% (2) | |||
Dividend reinvestment plan expenses |
% (3) | |||
Total stockholder transaction expenses (as a percentage of offering price) |
% (2) | |||
Annual expenses (as a percentage of net assets attributable to common stock) (4) : |
||||
Base management fee |
% (5) | |||
Incentive fees payable under the Advisory Agreement (up to 20%) |
% (6) | |||
Interest payments on borrowed funds |
% (7) | |||
Acquired fund fees and expenses |
% (8) | |||
Other expenses (estimated) |
% (9) | |||
Total annual expenses |
% |
(1) |
In the event that the shares of common stock are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load and the “Example” will be updated accordingly. |
(2) |
The prospectus supplement corresponding to each offering will disclose the applicable offering expenses and total stockholder transaction expenses. |
(3) |
The expenses of the dividend reinvestment plan are included in “other expenses.” |
(4) |
Annual Expenses are presented in this manner because common stockholders will bear all costs of running the Company. |
(5) |
Our 1.50% base management fee under the Advisory Agreement (giving effect to the Letter Agreement) is based on our gross assets, which is defined as all the assets of SLRC, excluding temporary assets, including those acquired using borrowings for investment purposes, and assumes our gross assets remain consistent with gross assets for the fiscal year ended December 31, 2023. The base management fee is reduced to 1.00% on gross assets that exceed 200% of total net assets as of the immediately preceding quarter. |
(6) |
Assumes that annual incentive fees earned by our investment adviser, SLR Capital Partners, remain consistent with the incentive fees earned by SLR Capital Partners for the fiscal year ended December 31, 2023. The incentive fee consists of two parts: |
• | no incentive fee is payable to our investment adviser in any calendar quarter in which our Pre-Incentive Fee Net Investment Income does not exceed the Hurdle of 1.75%; |
• | 100% of our Pre-Incentive Fee Net Investment Income with respect to that portion of such Pre-Incentive Fee Net Investment Income, if any, that exceeds the Hurdle but is less than 2.1875% in any calendar quarter (8.75% annualized) is payable to our investment adviser. We refer to this portion of our Pre-Incentive Fee Net Investment Income (which exceeds the Hurdle but is less than 2.1875%) as the “catch-up.” The “catch-up” is meant to provide our investment adviser with 20% of our |
Pre-Incentive Fee Net Investment Income, as if a Hurdle did not apply when our Pre-Incentive Fee Net Investment Income exceeds 2.1875% in any calendar quarter; and |
• | 20% of the amount of our Pre-Incentive Fee Net Investment Income, if any, that exceeds 2.1875% in any calendar quarter (8.75% annualized) is payable to our investment adviser (once the Hurdle is reached and the catch-up is achieved, 20% of all Pre-Incentive Fee Investment Income thereafter is allocated to our investment adviser). |
(7) |
We have historically and will in the future borrow funds from time to time to make investments to the extent we determine that the economic situation is conducive to doing so. The costs associated with our outstanding borrowings are indirectly borne by our investors. For purposes of this section, we have computed interest expense using the average consolidated balance outstanding for borrowings during the fiscal year ended December 31, 2023. We used SOFR or a similar base rate on December 31, 2023 and the interest rate on the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes and the 2024 Unsecured Notes on December 31, 2023. We have also included, as applicable, the estimated market discount or amortization of fees incurred in establishing the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes and the 2024 Unsecured Notes as of December 31, 2023. Additionally, we included the estimated cost of commitment fees for unused balances on the Credit Facility and the SPV Credit Facility. As of December 31, 2023, we had $507.0 million outstanding under the Credit Facility, $206.3 million outstanding under the SPV Credit Facility and $135 million, $50 million, $75 million, $125 million and $85 million outstanding under the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes and the 2024 Unsecured Notes, respectively. We may also issue preferred stock, subject to our compliance with applicable requirements under the 1940 Act, although we have no immediate intention to do so. |
(8) |
The holders of shares of our common stock indirectly bear the expenses of our investment in SLR Senior Lending Program LLC (“SSLP”). No management fee is charged on our investments in SSLP in connection with the administrative services provided to SSLP. Future expenses for SSLP may be substantially higher or lower because certain expenses may fluctuate over time. |
(9) |
“Other expenses” are based on estimated amounts for the current fiscal year, which considers the amounts incurred for the fiscal year ended December 31, 2023 and include our overhead expenses, including payments under our Administration Agreement based on our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement. |
1 Year |
3 Years |
5 Years |
10 Years |
|||||||||||||
You would pay the following expenses on a $1,000 investment, assuming a 5% annual return |
$ | $ | $ | $ |
1 Year |
3 Years |
5 Years |
10 Years |
|||||||||||||
You would pay the following expenses on a $1,000 investment, assuming a 5% annual return |
$ | $ | $ | $ |
Item 6. |
Reserved |
Item 7. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
• | our future operating results, including our ability to achieve objectives; |
• | our business prospects and the prospects of our portfolio companies; |
• | the impact of investments that we expect to make; |
• | our contractual arrangements and relationships with third parties; |
• | the dependence of our future success on the general economy and its impact on the industries in which we invest; |
• | the impact of any protracted decline in the liquidity of credit markets on our business; |
• | the ability of our portfolio companies to achieve their objectives; |
• | the valuation of our investments in portfolio companies, particularly those having no liquid trading market; |
• | market conditions and our ability to access alternative debt markets and additional debt and equity capital; |
• | our expected financings and investments; |
• | the adequacy of our cash resources and working capital; |
• | the timing of cash flows, if any, from the operations of our portfolio companies; |
• | the ability of the Investment Adviser to locate suitable investments for us and to monitor and administer our investments; |
• | the ability of the Investment Adviser to attract and retain highly talented professionals; |
• | the ability of the Investment Adviser to adequately allocate investment opportunities among the Company and its other advisory clients; |
• | any conflicts of interest posed by the structure of the management fee and incentive fee to be paid to the Investment Adviser; |
• | changes in political, economic or industry conditions, relations between the United States, Russia, Ukraine and other nations, the interest rate environment, certain regional bank failures or conditions affecting the financial and capital markets; |
• | the escalating conflict in the Middle East; |
• | changes in the general economy, slowing economy, rising inflation, risk of recession and risks in respect of a failure to increase the U.S. debt ceiling; and |
• | our ability to anticipate and identify evolving market expectations with respect to environmental, social and governance matters, including the environmental impacts of our portfolio companies’ supply chains and operations. |
• | an economic downturn could impair our portfolio companies’ ability to continue to operate, which could lead to the loss of some or all of our investments in such portfolio companies; |
• | a contraction of available credit and/or an inability to access the equity markets could impair our lending and investment activities; |
• | interest rate volatility could adversely affect our results, particularly because we use leverage as part of our investment strategy; |
• | currency fluctuations could adversely affect the results of our investments in foreign companies, particularly to the extent that we receive payments denominated in foreign currency rather than U.S. dollars; and |
• | the risks, uncertainties and other factors we identify in Item 1A. — Risk Factors contained in this Annual Report on Form 10-K for the year ended December 31, 2023 and in our other filings with the SEC. |
• | the cost of our organization and public offerings; |
• | the cost of calculating our net asset value, including the cost of any third-party valuation services; |
• | the cost of effecting sales and repurchases of our shares and other securities; |
• | interest payable on debt, if any, to finance our investments; |
• | fees payable to third parties relating to, or associated with, making investments, including fees and expenses associated with performing due diligence reviews of prospective investments and advisory fees; |
• | transfer agent and custodial fees; |
• | fees and expenses associated with marketing efforts; |
• | federal and state registration fees, any stock exchange listing fees; |
• | federal, state and local taxes; |
• | independent directors’ fees and expenses; |
• | brokerage commissions; |
• | fidelity bond, directors and officers errors and omissions liability insurance and other insurance premiums; |
• | direct costs and expenses of administration, including printing, mailing, long distance telephone and staff; |
• | fees and expenses associated with independent audits and outside legal costs; |
• | costs associated with our reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws; and |
• | all other expenses incurred by either SLR Capital Management or us in connection with administering our business, including payments under the Administration Agreement that will be based upon our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the costs of compensation and related expenses of our chief compliance officer and our chief financial officer and their respective staffs. |
* |
We have included SLR Credit Solutions, SLR Equipment Finance, SLR Healthcare ABL, SLR Business Credit and Kingsbridge Holdings, LLC within our income producing investment portfolio. |
Description |
Industry |
Spread Above Index (1) |
Floor |
Interest Rate (2) |
Maturity Date |
Par Amount |
Cost |
Fair Value (3) |
||||||||||||||||||||||
Aegis Toxicology Sciences Corporation (4) |
Health Care Providers & Services | S+550 | 1.00 | % | 11.13 | % | 5/9/25 | $ | 2,947 | $ | 2,947 | $ | 2,947 | |||||||||||||||||
Alkeme Intermediary Holdings, LLC (4) |
Insurance | S+650 | 1.00 | % | 11.96 | % | 10/28/26 | 3,017 | 2,934 | 3,017 | ||||||||||||||||||||
All States Ag Parts, LLC (4) |
Trading Companies & Distributors | S+600 | 1.00 | % | 11.61 | % | 9/1/26 | 2,133 | 2,133 | 2,133 | ||||||||||||||||||||
Apex Service Partners, LLC |
Diversified Consumer Services | S+700 | 1.00 | % | 11.87 | % | 10/24/30 | 4,905 | 4,784 | 4,783 | ||||||||||||||||||||
Atria Wealth Solutions, Inc. (4) |
Diversified Financial Services | S+650 | 1.00 | % | 11.97 | % | 5/31/24 | 2,468 | 2,468 | 2,468 | ||||||||||||||||||||
BayMark Health Services, Inc. (4) |
Health Care Providers & Services | S+500 | 1.00 | % | 10.61 | % | 6/11/27 | 4,033 | 4,033 | 4,033 | ||||||||||||||||||||
CC SAG Holdings Corp. (4) |
Diversified Consumer Services | S+575 | 0.75 | % | 11.22 | % | 6/29/28 | 8,969 | 8,969 | 8,969 | ||||||||||||||||||||
CVAUSA Management, LLC (4) |
Health Care Providers & Services | S+650 | 1.00 | % | 11.74 | % | 5/22/29 | 5,412 | 5,251 | 5,412 | ||||||||||||||||||||
ENS Holdings III Corp. & ES Opco USA LLC (4) |
Trading Companies & Distributors | S+475 | 1.00 | % | 10.20 | % | 12/31/25 | 1,086 | 1,086 | 1,086 | ||||||||||||||||||||
Erie Construction Mid-west, LLC |
Building Products | S+475 | 1.00 | % | 10.20 | % | 7/30/27 | 8,457 | 8,457 | 8,457 | ||||||||||||||||||||
Fertility (ITC) Investment Holdco, LLC (4) |
Health Care Providers & Services | S+650 | 1.00 | % | 11.97 | % | 1/3/29 | 5,955 | 5,791 | 5,955 | ||||||||||||||||||||
Foundation Consumer Brands, LLC (4) |
Personal Products | S+625 | 1.00 | % | 11.79 | % | 2/12/27 | 8,641 | 8,641 | 8,641 | ||||||||||||||||||||
GSM Acquisition Corp. (4) |
Leisure Equipment & Products | S+500 | 1.00 | % | 10.47 | % | 11/16/26 | 8,541 | 8,541 | 8,541 | ||||||||||||||||||||
Higginbotham Insurance Agency, Inc. (4) |
Insurance | S+550 | 1.00 | % | 10.96 | % | 11/25/28 | 7,573 | 7,573 | 7,573 | ||||||||||||||||||||
High Street Buyer, Inc. |
Insurance | S+575 | 0.75 | % | 11.25 | % | 4/16/28 | 7,604 | 7,604 | 7,604 | ||||||||||||||||||||
iCIMS, Inc. (4) |
Software | S+725 | 0.75 | % | 12.62 | % | 8/18/28 | 3,089 | 3,066 | 3,089 | ||||||||||||||||||||
Kaseya, Inc. (4) |
Software | S+600 | 0.75 | % | 11.38 | % | 6/23/29 | 9,058 | 9,058 | 9,058 | ||||||||||||||||||||
Kid Distro Holdings, LLC (4) |
Software | S+550 | 1.00 | % | 11.00 | % | 10/1/27 | 8,939 | 8,939 | 8,939 | ||||||||||||||||||||
Maxor Acquisition, Inc. (4) |
Health Care Providers & Services | S+675 | 1.00 | % | 12.48 | % | 3/1/29 | 6,120 | 5,940 | 6,120 | ||||||||||||||||||||
ONS MSO, LLC (4) |
Health Care Providers & Services | S+625 | 1.00 | % | 11.62 | % | 7/8/26 | 5,922 | 5,784 | 5,922 | ||||||||||||||||||||
Pinnacle Treatment Centers, Inc. (4) |
Health Care Providers & Services | S+650 | 1.00 | % | 11.95 | % | 1/2/26 | 6,951 | 6,951 | 6,951 | ||||||||||||||||||||
Plastics Management, LLC (4) |
Health Care Providers & Services | S+500 | 1.00 | % | 10.45 | % | 8/18/27 | 5,637 | 5,471 | 5,637 | ||||||||||||||||||||
RQM+ Corp. (4) |
Life Sciences Tools & Services | S+575 | 1.00 | % | 11.36 | % | 8/12/26 | 5,955 | 5,955 | 5,955 | ||||||||||||||||||||
RxSense Holdings LLC (4) |
Diversified Consumer Services | S+500 | 1.00 | % | 10.48 | % | 3/13/26 | 8,968 | 8,968 | 8,968 | ||||||||||||||||||||
SunMed Group Holdings, LLC (4) |
Health Care Equipment & Supplies | S+550 | 0.75 | % | 10.96 | % | 6/16/28 | 8,948 | 8,948 | 8,948 | ||||||||||||||||||||
The Townsend Company, LLC (4) |
Commercial Services & Supplies | S+625 | 1.00 | % | 11.61 | % | 8/15/29 | 3,642 | 3,555 | 3,642 | ||||||||||||||||||||
Tilley Distribution, Inc. (4) |
Trading Companies & Distributors | S+600 | 1.00 | % | 11.50 | % | 12/31/26 | 5,850 | 5,850 | 5,850 | ||||||||||||||||||||
Ultimate Baked Goods Midco LLC (4) |
Packaged Foods & Meats | S+625 | 1.00 | % | 11.71 | % | 8/13/27 | 8,954 | 8,954 | 8,865 | ||||||||||||||||||||
United Digestive MSO Parent, LLC (4) |
Health Care Providers & Services | S+675 | 1.00 | % | 12.25 | % | 3/30/29 | 3,411 | 3,311 | 3,411 | ||||||||||||||||||||
Urology Management Holdings, Inc. (4) |
Health Care Providers & Services | S+650 | 1.00 | % | 11.93 | % | 6/15/26 | 3,179 | 3,102 | 3,155 | ||||||||||||||||||||
Vessco Midco Holdings, LLC (4) |
Water Utilities | S+450 | 1.00 | % | 9.96 | % | 11/2/26 | 4,304 | 4,304 | 4,304 | ||||||||||||||||||||
West-NR Parent, Inc.(4) |
Insurance | S+625 | 1.00 | % | 11.70 | % | 12/27/27 | 6,822 | 6,691 | 6,822 | ||||||||||||||||||||
$ | 186,059 | $ | 187,255 | |||||||||||||||||||||||||||
(1) | Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor. |
(2) | Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2023. |
(3) | Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. |
(4) | The Company also holds this security on its Consolidated Statements of Assets and Liabilities. |
Description |
Industry |
Spread Above Index (1) |
Floor |
Interest Rate (2) |
Maturity Date |
Par Amount |
Cost |
Fair Value (3) |
||||||||||||||||||||||
Atria Wealth Solutions, Inc. (4) |
Diversified Financial Services | S+600 | 1.00 | % | 10.84 | % | 2/29/24 | $ | 2,494 | $ | 2,494 | $ | 2,494 | |||||||||||||||||
BayMark Health Services, Inc. (4) |
Health Care Providers & Services | L+500 | 1.00 | % | 9.73 | % | 6/11/27 | 2,992 | 2,992 | 2,992 | ||||||||||||||||||||
ENS Holdings III Corp. & ES Opco USA LLC (4) |
Trading Companies & Distributors | L+475 | 1.00 | % | 9.43 | % | 12/31/25 | 1,097 | 1,097 | 1,097 | ||||||||||||||||||||
Foundation Consumer Brands, LLC (4) |
Personal Products | L+550 | 1.00 | % | 10.15 | % | 2/12/27 | 2,963 | 2,963 | 2,963 | ||||||||||||||||||||
High Street Buyer, Inc. (4) |
Insurance | L+600 | 0.75 | % | 10.73 | % | 4/16/28 | 2,494 | 2,494 | 2,494 | ||||||||||||||||||||
Ivy Fertility Services, LLC (4) |
Health Care Providers & Services | L+625 | 1.00 | % | 10.39 | % | 2/25/26 | 3,000 | 3,000 | 3,030 | ||||||||||||||||||||
Kid Distro Holdings, LLC (4) |
Software | L+575 | 1.00 | % | 10.48 | % | 10/1/27 | 2,992 | 2,992 | 2,992 | ||||||||||||||||||||
$ | 18,032 | $ | 18,062 | |||||||||||||||||||||||||||
(1) | Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor. |
(2) | Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022. |
(3) | Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. |
(4) | The Company also holds this security on its Consolidated Statements of Assets and Liabilities. |
December 31, 2023 |
December 31, 2022 |
|||||||
Selected Balance Sheet Information for SSLP (in thousands): |
||||||||
Investments at fair value (cost $186,059 and $18,032, respectively) |
$ | 187,255 | $ | 18,062 | ||||
Cash and other assets. |
8,613 | 1,043 | ||||||
Total assets |
$ | 195,868 | $ | 19,105 | ||||
Debt outstanding ($106,900 and $0 face amounts, respectively, reported net of unamortized debt issuance costs of $1,697 and $0, respectively) |
$ | 105,203 | $ | — | ||||
Distributions payable |
1,900 | — | ||||||
Interest payable and other credit facility related expenses |
551 | 165 | ||||||
Accrued expenses and other payables |
416 | 89 | ||||||
Total liabilities |
$ | 108,070 | $ | 254 | ||||
Members’ equity |
$ | 87,798 | $ | 18,851 | ||||
Total liabilities and members’ equity |
$ | 195,868 | $ | 19,105 | ||||
Year ended December 31, 2023 |
For the Period December 1, 2022 (commencement of operations) through December 31, 2022 |
|||||||
Selected Income Statement Information for SSLP (in thousands): |
||||||||
Interest income |
$ | 10,209 | $ | 152 | ||||
Service fees* |
$ | 224 | $ | 4 | ||||
Interest and other credit facility expenses |
6,517 | 166 | ||||||
Organizational costs |
— | 73 | ||||||
Other general and administrative expenses |
195 | 88 | ||||||
Total expenses |
$ | 6,936 | $ | 331 | ||||
Net investment income (loss). |
$ | 3,273 | $ | (179 | ) | |||
Realized gain on investments |
30 | — | ||||||
Net change in unrealized gain on investments |
1,166 | 30 | ||||||
Net realized and unrealized gain on investments |
1,196 | 30 | ||||||
Net income (loss). |
$ | 4,469 | $ | (149 | ) | |||
* | Service fees are included within the Company’s Consolidated Statements of Operations as other income. |
Total |
Less than 1 Year |
1-3 Years |
3-5 Years |
More Than 5 Years |
||||||||||||||||
Revolving credit facilities (1) |
$ | 613.3 | $ | — | $ | 613.3 | $ | — | $ | — | ||||||||||
Unsecured senior notes |
470.0 | 125.0 | 160.0 | 185.0 | — | |||||||||||||||
Term loans |
100.0 | — | 100.0 | — | — |
(1) | As of December 31, 2023, we had a total of $246.8 million of unused borrowing capacity under our revolving credit facilities, subject to borrowing base limits. |
Class and Year |
Total Amount Outstanding(1) |
Asset Coverage Per Unit(2) |
Involuntary Liquidating Preference Per Unit(3) |
Average Market Value Per Unit(4) |
||||||||||||
Credit Facility |
||||||||||||||||
Fiscal 2023 |
$ | $ | N/A | |||||||||||||
Fiscal 2022 |
N/A | |||||||||||||||
Fiscal 2021 |
N/A | |||||||||||||||
Fiscal 2020 |
N/A | |||||||||||||||
Fiscal 2019 |
N/A | |||||||||||||||
Fiscal 2018 |
N/A | |||||||||||||||
Fiscal 2017 |
N/A | |||||||||||||||
Fiscal 2016 |
N/A | |||||||||||||||
Fiscal 2015 |
N/A | |||||||||||||||
Fiscal 2014 |
N/A | |||||||||||||||
Fiscal 2013 |
N/A | |||||||||||||||
SPV Credit Facility |
||||||||||||||||
Fiscal 2023 |
N/A | |||||||||||||||
Fiscal 2022 |
N/A | |||||||||||||||
2022 Unsecured Notes |
||||||||||||||||
Fiscal 2022 |
N/A | |||||||||||||||
Fiscal 2021 |
N/A | |||||||||||||||
Fiscal 2020 |
N/A | |||||||||||||||
Fiscal 2019 |
N/A | |||||||||||||||
Fiscal 2018 |
N/A | |||||||||||||||
Fiscal 2017 |
N/A | |||||||||||||||
Fiscal 2016 |
N/A |
Class and Year |
Total Amount Outstanding(1) |
Asset Coverage Per Unit(2) |
Involuntary Liquidating Preference Per Unit(3) |
Average Market Value Per Unit(4) |
||||||||||||
2022 Tranche C Notes |
||||||||||||||||
Fiscal 2022 |
N/A | |||||||||||||||
Fiscal 2021 |
N/A | |||||||||||||||
Fiscal 2020 |
N/A | |||||||||||||||
Fiscal 2019 |
N/A | |||||||||||||||
Fiscal 2018 |
N/A | |||||||||||||||
Fiscal 2017 |
N/A | |||||||||||||||
2023 Unsecured Notes |
||||||||||||||||
Fiscal 2023 |
N/A | |||||||||||||||
Fiscal 2022 |
N/A | |||||||||||||||
Fiscal 2021 |
N/A | |||||||||||||||
Fiscal 2020 |
N/A | |||||||||||||||
Fiscal 2019 |
N/A | |||||||||||||||
Fiscal 2018 |
N/A | |||||||||||||||
Fiscal 2017 |
N/A | |||||||||||||||
2024 Unsecured Notes |
||||||||||||||||
Fiscal 2023 |
N/A | |||||||||||||||
Fiscal 2022 |
N/A | |||||||||||||||
Fiscal 2021 |
N/A | |||||||||||||||
Fiscal 2020 |
N/A | |||||||||||||||
Fiscal 2019 |
N/A | |||||||||||||||
2025 Unsecured Notes |
||||||||||||||||
Fiscal 2023 |
N/A | |||||||||||||||
Fiscal 2022 |
N/A | |||||||||||||||
2026 Unsecured Notes |
||||||||||||||||
Fiscal 2023 |
N/A | |||||||||||||||
Fiscal 2022 |
N/A | |||||||||||||||
Fiscal 2021 |
N/A | |||||||||||||||
Fiscal 2020 |
N/A | |||||||||||||||
Fiscal 2019 |
N/A | |||||||||||||||
2027 Unsecured Notes |
||||||||||||||||
Fiscal 2023 |
N/A | |||||||||||||||
Fiscal 2022 |
N/A | |||||||||||||||
Fiscal 2021 |
N/A | |||||||||||||||
2027 Series F Unsecured Notes |
||||||||||||||||
Fiscal 2023 |
N/A | |||||||||||||||
Fiscal 2022 |
N/A | |||||||||||||||
2042 Unsecured Notes |
||||||||||||||||
Fiscal 2017 |
N/A | |||||||||||||||
Fiscal 2016 |
$ | |||||||||||||||
Fiscal 2015 |
||||||||||||||||
Fiscal 2014 |
||||||||||||||||
Fiscal 2013 |
||||||||||||||||
Senior Secured Notes |
||||||||||||||||
Fiscal 2017 |
N/A | |||||||||||||||
Fiscal 2016 |
N/A | |||||||||||||||
Fiscal 2015 |
N/A | |||||||||||||||
Fiscal 2014 |
N/A | |||||||||||||||
Fiscal 2013 |
N/A |
Class and Year |
Total Amount Outstanding(1) |
Asset Coverage Per Unit(2) |
Involuntary Liquidating Preference Per Unit(3) |
Average Market Value Per Unit(4) |
||||||||||||
Term Loans |
||||||||||||||||
Fiscal 2023 |
N/A | |||||||||||||||
Fiscal 2022 |
N/A | |||||||||||||||
Fiscal 2021 |
N/A | |||||||||||||||
Fiscal 2020 |
N/A | |||||||||||||||
Fiscal 2019 |
N/A | |||||||||||||||
Fiscal 2018 |
N/A | |||||||||||||||
Fiscal 2017 |
N/A | |||||||||||||||
Fiscal 2016 |
N/A | |||||||||||||||
Fiscal 2015 |
N/A | |||||||||||||||
Fiscal 2014 |
N/A | |||||||||||||||
Fiscal 2013 |
N/A | |||||||||||||||
NEFPASS Facility |
||||||||||||||||
Fiscal 2021 |
N/A | |||||||||||||||
Fiscal 2020 |
N/A | |||||||||||||||
Fiscal 2019 |
N/A | |||||||||||||||
Fiscal 2018 |
N/A | |||||||||||||||
SSLP Facility |
||||||||||||||||
Fiscal 2019 |
N/A | |||||||||||||||
Fiscal 2018 |
N/A | |||||||||||||||
Total Senior Securities |
||||||||||||||||
Fiscal 2023 |
$ | $ | N/A | |||||||||||||
Fiscal 2022 |
N/A | |||||||||||||||
Fiscal 2021 |
N/A | |||||||||||||||
Fiscal 2020 |
N/A | |||||||||||||||
Fiscal 2019 |
N/A | |||||||||||||||
Fiscal 2018 |
N/A | |||||||||||||||
Fiscal 2017 |
N/A | |||||||||||||||
Fiscal 2016 |
N/A | |||||||||||||||
Fiscal 2015 |
N/A | |||||||||||||||
Fiscal 2014 |
N/A | |||||||||||||||
Fiscal 2013 |
N/A |
(1) | Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented. |
(2) | The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of December 31, 2023, asset coverage was 183.4%. |
(3) | The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. |
(4) | Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively. |
Year ended December 31, 2018 |
Year ended December 31, 2017 |
Year ended December 31, 2016 |
Year ended December 31, 2015 |
Year ended December 31, 2014 |
||||||||||||||||
Per Share Data: (a) |
||||||||||||||||||||
Net asset value, beginning of year |
$ | 21.81 | $ | 21.74 | $ | 20.79 | $ | 22.05 | $ | 22.50 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income |
1.77 | 1.62 | 1.68 | 1.52 | 1.56 | |||||||||||||||
Net realized and unrealized gain (loss) |
(0.19 | ) | 0.05 | 0.84 | (1.18 | ) | (0.43 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase in net assets resulting from operations |
1.58 | 1.67 | 2.52 | 0.34 | 1.13 | |||||||||||||||
Distributions to stockholders (see note 8a): |
— | |||||||||||||||||||
From net investment income |
— | (1.60 | ) | (1.60 | ) | (1.60 | ) | (1.55 | ) | |||||||||||
From net realized gains |
— | — | — | — | ||||||||||||||||
From return of capital |
(1.64 | ) | — | — | — | (0.05 | ) | |||||||||||||
Anti-dilution |
— | — | 0.03 | — | 0.02 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net asset value, end of year |
$ | 21.75 | $ | 21.81 | $ | 21.74 | $ | 20.79 | $ | 22.05 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Per share market value, end of year |
$ | 19.19 | $ | 20.21 | $ | 20.82 | $ | 16.43 | $ | 18.01 | ||||||||||
Total Return(b) |
2.77 | % | 4.47 | % | 37.49 | % | (0.29 | )% | (13.58 | )% | ||||||||||
Net assets, end of year |
$ | 919,171 | $ | 921,605 | $ | 918,507 | $ | 882,698 | $ | 936,568 | ||||||||||
Shares outstanding, end of year |
42,260,826 | 42,260,826 | 42,248,525 | 42,464,762 | 42,465,162 | |||||||||||||||
Ratios to average net assets: |
||||||||||||||||||||
Net investment income |
8.10 | % | 7.43 | % | 7.91 | % | 6.94 | % | 6.93 | % | ||||||||||
Operating expenses |
5.83 | % | 5.80 | % | 6.25 | % | 3.84 | %* | 4.24 | % | ||||||||||
Interest and other credit facility expenses** |
2.67 | % | 2.35 | % | 2.73 | % | 1.68 | % | 1.50 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total expenses |
8.50 | % | 8.15 | % | 8.98 | % | 5.52 | %* | 5.74 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Average debt outstanding |
$ | 508,445 | $ | 414,264 | $ | 495,795 | $ | 262,341 | $ | 225,000 | ||||||||||
Portfolio turnover ratio |
39.3 | % | 24.9 | % | 31.0 | % | 13.0 | % | 53.7 | % |
(a) | Calculated using the average shares outstanding method. |
(b) | Total return is based on the change in market price per share during the year and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. Total return does not include a sales load. |
* | The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of a voluntary incentive fee waiver (see note 3). For the year ended December 31, 2015, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.02% and 5.70%, respectively, without the voluntary incentive fee waiver. |
** | Ratios shown without the non-recurring costs associated with the amendments and establishment of the Credit Facility and 2022 Unsecured Notes would be 2.67%, 2.29%, 2.39%, 1.68% and 1.50%, respectively for the years shown. |
December 31, 2023 |
December 31, 2022 |
|||||||
(in millions) |
||||||||
SLR Credit Solutions* |
$ |
44.3 |
$ |
44.3 |
||||
Orthopedic Care Partners Management, LLC |
20.8 |
1.6 |
||||||
Southern Orthodontic Partners Management, LLC |
17.9 |
1.9 |
||||||
Ardelyx, Inc. |
15.9 |
7.8 |
||||||
CVAUSA Management, LLC |
10.2 |
— |
||||||
BDG Media, Inc. |
10.1 |
3.5 |
||||||
iCIMS, Inc. |
9.8 |
11.4 |
||||||
Retina Midco, Inc. |
9.4 |
— |
||||||
Alkeme Intermediate Holdings, LLC |
8.5 |
— |
||||||
SPAR Marketing Force, Inc. |
8.3 |
1.3 |
||||||
SLR Senior Lending Program LLC* |
7.1 |
40.5 |
||||||
Copper River Seafoods, Inc. |
7.1 |
3.6 |
||||||
Legacy Service Partners, LLC |
5.4 |
— |
||||||
Peter C. Foy & Associates Insurance Services, LLC |
5.1 |
1.1 |
||||||
West-NR Parent, Inc. |
5.0 |
— |
||||||
Luxury Asset Capital, LLC |
4.5 |
7.5 |
||||||
One Touch Direct, LLC |
4.1 |
3.1 |
||||||
DeepIntent, Inc. |
3.9 |
3.1 |
||||||
United Digestive MSO Parent, LLC |
3.9 |
— |
||||||
Kaseya, Inc. |
3.8 |
3.9 |
||||||
The Townsend Company, LLC |
3.3 |
— |
||||||
Vertos Medical, Inc. |
3.3 |
— |
||||||
AMF Levered II, LLC |
3.2 |
— |
||||||
Foundation Consumer Brands, LLC |
3.0 |
3.0 |
||||||
UVP Management, LLC. |
2.9 |
— |
||||||
Kid Distro Holdings, LLC |
2.7 |
2.7 |
||||||
Erie Construction Mid-west, LLC |
2.4 |
1.3 |
||||||
Ultimate Baked Goods Midco LLC |
2.4 |
1.6 |
||||||
Basic Fun, Inc |
2.1 |
2.7 |
||||||
SLR Equipment Finance* |
2.1 |
1.0 |
||||||
Bayside Opco, LLC |
2.1 |
— |
||||||
SunMed Group Holdings, LLC |
1.6 |
0.8 |
||||||
Urology Management Holdings, Inc. |
1.5 |
— |
||||||
SLR Healthcare ABL* |
1.4 |
1.4 |
||||||
RxSense Holdings LLC |
1.3 |
1.3 |
||||||
Tilley Distribution, Inc. |
1.2 |
0.5 |
||||||
SCP Eye Care, LLC |
1.0 |
2.8 |
||||||
GSM Acquisition Corp. |
0.9 |
0.8 |
||||||
Medrina, LLC |
0.8 |
— |
||||||
Pinnacle Treatment Centers, Inc. |
0.6 |
1.7 |
||||||
High Street Buyer, Inc. |
0.6 |
0.3 |
December 31, 2023 |
December 31, 2022 |
|||||||
(in millions) |
||||||||
ENS Holdings III Corp, LLC |
0.6 | 0.1 | ||||||
CC SAG Holdings Corp. (Spectrum Automotive) |
0.5 | 20.7 | ||||||
Crewline Buyer, Inc. |
0.5 | — | ||||||
Exactcare Parent, Inc. |
0.4 | — | ||||||
WCI-BXC Purchaser, LLC |
0.3 | — | ||||||
All States Ag Parts, LLC |
0.3 | 0.1 | ||||||
Vessco Midco Holdings, LLC |
0.3 | 3.9 | ||||||
TAUC Management, LLC |
0.3 | 0.3 | ||||||
Outset Medical, Inc. |
— | 35.1 | ||||||
Apeel Technology, Inc. |
— | 32.8 | ||||||
Human Interest, Inc. |
— | 20.1 | ||||||
Glooko, Inc. |
— | 17.9 | ||||||
World Insurance Associates, LLC |
— | 17.1 | ||||||
Spectrum Pharmaceuticals, Inc. |
— | 8.8 | ||||||
Arcutis Biotherapeutics, Inc. |
— | 8.4 | ||||||
Atria Wealth Solutions, Inc. |
— | 8.2 | ||||||
Accession Risk Management Group, Inc. |
— | 7.5 | ||||||
Cerapedics, Inc. |
— | 6.7 | ||||||
Maurices, Incorporated |
— | 4.3 | ||||||
Meditrina, Inc. |
— | 3.4 | ||||||
Plastics Management, LLC |
— | 2.4 | ||||||
Pediatric Home Respiratory Services, LLC |
— | 1.8 | ||||||
Ivy Fertility Services, LLC |
— | 1.6 | ||||||
Composite Technology Acquisition Corp. |
— | 1.5 | ||||||
NAC Holdings Corporation |
— | 1.5 | ||||||
Montefiore Nyack Hospital |
— | 1.0 | ||||||
Enverus Holdings, Inc. |
— | 1.0 | ||||||
American Teleconferencing Services, Ltd. |
— | 1.1 | ||||||
BayMark Health Services, Inc. |
— | 0.4 | ||||||
Total Commitments |
$ | 248.7 | $ | 364.2 | ||||
* | The Company controls the funding of these commitments and may cancel them at its discretion |
Date Declared |
Record Date |
Payment Date |
Amount |
|||||||||
Fiscal 2024 |
||||||||||||
February 27, 2024 |
March 14, 2024 | March 28, 2024 | $ | 0.41 | ||||||||
Total 2024 |
$ | 0.41 | ||||||||||
Fiscal 2023 |
||||||||||||
November 7, 2023 |
December 14, 2023 | December 28, 2023 | $ | 0.41 | ||||||||
September 5, 2023 |
September 20, 2023 | September 28, 2023 | 0.136667 | |||||||||
August 8, 2023 |
August 18, 2023 | August 30, 2023 | 0.136667 | |||||||||
July 5, 2023 |
July 20, 2023 | August 1, 2023 | 0.136667 | |||||||||
June 1, 2023 |
June 20, 2023 | June 29, 2023 | 0.136667 | |||||||||
May 10, 2023 |
May 24, 2023 | June 1, 2023 | 0.136667 | |||||||||
April 4, 2023 |
April 20, 2023 | May 2, 2023 | 0.136667 | |||||||||
February 28, 2023 |
March 23, 2023 | April 4, 2023 | 0.136667 | |||||||||
February 2, 2023 |
February 16, 2023 | March 1, 2023 | 0.136667 | |||||||||
January 10, 2023. |
January 26, 2023 | February 2, 2023 | 0.136667 | |||||||||
Total 2023 |
$ | 1.64 | ||||||||||
Fiscal 2022 |
||||||||||||
December 6, 2022 |
December 22, 2022 | January 5, 2023 | $ | 0.136667 | ||||||||
November 2, 2022 |
November 17, 2022 | December 1, 2022 | 0.136667 | |||||||||
October 5, 2022 |
October 20, 2022 | November 2, 2022 | 0.136667 | |||||||||
September 2, 2022 |
September 20, 2022 | October 4, 2022 | 0.136667 | |||||||||
August 2, 2022 |
August 18, 2022 | September 1, 2022 | 0.136667 | |||||||||
July 6, 2022 |
July 21, 2022 | August 2, 2022 | 0.136667 | |||||||||
June 3, 2022 |
June 23, 2022 | July 5, 2022 | 0.136667 | |||||||||
May 3, 2022 |
May 19, 2022 | June 2, 2022 | 0.136667 | |||||||||
April 4, 2022 |
April 21, 2022 | May 3, 2022 | 0.136667 | |||||||||
March 1, 2022 |
March 18, 2022 | April 1, 2022 | 0.41 | |||||||||
Total 2022 |
$ | 1.64 | ||||||||||
• | We have entered into the Advisory Agreement with the Investment Adviser. Mr. Gross, our Chairman, Co-Chief Executive Officer and President, and Mr. Spohler, our Co-Chief Executive Officer, Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, the Investment Adviser. In addition, Mr. Kajee, our Chief Financial Officer and Treasurer, serves as the Chief Financial Officer for the Investment Adviser and Mr. Talarico, our Chief Compliance Officer and Secretary, serves as Partner, General Counsel and Chief Compliance Officer for the Investment Adviser. |
• | The Administrator provides us with the office facilities and administrative services necessary to conduct day-to-day |
• | We have entered into a license agreement with the Investment Adviser, pursuant to which the Investment Adviser has granted us a non-exclusive, royalty-free license to use the licensed marks “SOLAR” and “SLR”. |
Item 7A. |
Quantitative and Qualitative Disclosure About Market Risk |
Increase (Decrease) in SOFR |
(1.00 | %) | 1.00 | % | ||||
Increase (Decrease) in Net Investment Income Per Share Per Year |
$ | (0.06 | ) | $ | 0.06 |
Item 8. |
Financial Statements and Supplementary Data |
Page |
||||
107 | ||||
108 | ||||
111 | ||||
112 | ||||
113 | ||||
114 | ||||
115 | ||||
136 |
December 31, 2023 |
December 31, 2022 |
|||||||
Assets |
||||||||
Investments at fair value: |
||||||||
Companies less than 5% owned (cost: $ |
$ | $ | ||||||
Companies 5% to 25% owned (cost: $ |
||||||||
Companies more than 25% owned (cost: $ |
||||||||
Cash |
||||||||
Cash equivalents (cost: $ |
||||||||
Dividends receivable |
||||||||
Interest receivable |
||||||||
Receivable for investments sold |
||||||||
Prepaid expenses and other assets |
||||||||
|
|
|
|
|||||
Total assets |
$ | $ | ||||||
|
|
|
|
|||||
Liabilities |
||||||||
Debt ($ |
$ | $ | ||||||
Payable for investments and cash equivalents purchased |
||||||||
Distributions payable |
||||||||
Management fee payable (see note 3) |
||||||||
Performance-based incentive fee payable (see note 3) |
||||||||
Interest payable (see note 7) |
||||||||
Administrative services payable (see note 3) |
||||||||
Other liabilities and accrued expenses |
||||||||
|
|
|
|
|||||
Total liabilities |
$ | $ | ||||||
|
|
|
|
|||||
Commitments and contingencies (see note 15) |
||||||||
Net Assets |
||||||||
Common stock, par value $ |
$ | $ | ||||||
Paid-in capital in excess of par (see note 2f) |
||||||||
Accumulated distributable net loss (see note 2f) |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total net assets |
$ | $ | ||||||
|
|
|
|
|||||
Net Asset Value Per Share |
$ | $ | ||||||
|
|
|
|
Year ended December 31, |
||||||||||||
2023 |
2022 |
2021 |
||||||||||
INVESTMENT INCOME: |
||||||||||||
Interest: |
||||||||||||
Companies less than 5% owned |
$ | $ | $ | |||||||||
Companies 5% to 25% owned |
||||||||||||
Companies more than 25% owned |
||||||||||||
Dividends: |
||||||||||||
Companies less than 5% owned |
||||||||||||
Companies more than 25% owned |
||||||||||||
Other income: |
||||||||||||
Companies less than 5% owned |
||||||||||||
Companies 5% to 25% owned |
||||||||||||
Companies more than 25% owned |
||||||||||||
|
|
|
|
|
|
|||||||
Total investment income |
||||||||||||
|
|
|
|
|
|
|||||||
EXPENSES: |
||||||||||||
Management fees (see note 3) |
||||||||||||
Performance-based incentive fees (see note 3) |
||||||||||||
Interest and other credit facility expenses (see note 7) |
||||||||||||
Administrative services expense (see note 3) |
||||||||||||
Other general and administrative expenses |
||||||||||||
|
|
|
|
|
|
|||||||
Total expenses |
||||||||||||
|
|
|
|
|
|
|||||||
Performance-based incentive fees waived (see note 3) |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net expenses |
||||||||||||
|
|
|
|
|
|
|||||||
Net investment income |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND CASH EQUIVALENTS: |
||||||||||||
Net realized gain (loss) on investments and cash equivalents: |
||||||||||||
Companies less than 5% owned |
$ | ( |
) | $ | ( |
) | $ | |||||
Companies more than 25% owned |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Net realized gain (loss) on investments and cash equivalents |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net change in unrealized gain (loss) on investments: |
||||||||||||
Companies less than 5% owned |
( |
) | ( |
) | ||||||||
Companies 5% to 25% owned |
( |
) | ||||||||||
Companies more than 25% owned |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net change in unrealized gain (loss) on investments |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net realized and unrealized loss on investments and cash equivalents |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
EARNINGS PER SHARE (see note 5) |
$ | $ | $ | |||||||||
|
|
|
|
|
|
Year ended December 31, |
||||||||||||
2023 |
2022 |
2021 |
||||||||||
Increase (decrease) in net assets resulting from operations: |
||||||||||||
Net investment income |
$ | $ | $ | |||||||||
Net realized gain (loss) |
( |
) | ( |
) | ||||||||
Net change in unrealized gain (loss) |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net increase in net assets resulting from operations |
||||||||||||
|
|
|
|
|
|
|||||||
Distributions to stockholders (see note 8a): |
||||||||||||
From distributable earnings |
( |
) | ( |
) | ( |
) | ||||||
From return of capital |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net distributions to stockholders |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Capital transactions (see note 16): |
||||||||||||
Issuance of common stock |
||||||||||||
Repurchases of common stock |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net increase (decrease) in net assets resulting from capital transactions |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total increase (decrease) in net assets |
( |
) | ( |
) | ||||||||
Net assets at beginning of year |
||||||||||||
|
|
|
|
|
|
|||||||
Net assets at end of year |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Capital share activity (see note 16): |
||||||||||||
Issuance of common stock |
||||||||||||
Repurchases of common stock |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net increase (decrease) from capital share activity |
( |
) | ||||||||||
|
|
|
|
|
|
Year ended December 31, |
||||||||||||
2023 |
2022 |
2021 |
||||||||||
Cash Flows from Operating Activities: |
||||||||||||
Net increase in net assets resulting from operations |
$ | $ | $ | |||||||||
Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by (used in) operating activities: |
||||||||||||
Net realized (gain) loss on investments and cash equivalents |
( |
) | ||||||||||
Net change in unrealized (gain) loss on investments |
( |
) | ||||||||||
Deferred financing costs/market discount |
||||||||||||
(Increase) decrease in operating assets: |
||||||||||||
Purchase of investments |
( |
) | ( |
) | ( |
) | ||||||
Proceeds from disposition of investments |
||||||||||||
Net accretion of discount on investments |
( |
) | ( |
) | ( |
) | ||||||
Capitalization of payment-in-kind |
( |
) | ( |
) | ( |
) | ||||||
Collections of payment-in-kind |
||||||||||||
Receivable for investments sold |
( |
) | ( |
) | ||||||||
Interest receivable |
( |
) | ( |
) | ( |
) | ||||||
Dividends receivable |
( |
) | ( |
) | ( |
) | ||||||
Prepaid expenses and other assets |
( |
) | ||||||||||
Cash and other net assets acquired in Mergers |
||||||||||||
Increase (decrease) in operating liabilities: |
||||||||||||
Payable for investments and cash equivalents purchased |
( |
) | ( |
) | ||||||||
Management fee payable |
||||||||||||
Performance-based incentive fee payable |
||||||||||||
Administrative services expense payable |
( |
) | ||||||||||
Interest payable |
( |
) | ||||||||||
Other liabilities and accrued expenses |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Net Cash Provided by (Used in) Operating Activities |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Cash Flows from Financing Activities: |
||||||||||||
Cash distributions paid |
( |
) | ( |
) | ( |
) | ||||||
Proceeds from unsecured borrowings |
||||||||||||
Repayment of unsecured borrowings |
( |
) | ( |
) | ||||||||
Proceeds from secured borrowings |
||||||||||||
Repayments of secured borrowings |
( |
) | ( |
) | ( |
) | ||||||
Repurchase of common stock |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net Cash Provided by (Used in) Financing Activities |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |
( |
) | ( |
) | ||||||||
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR |
||||||||||||
|
|
|
|
|
|
|||||||
CASH AND CASH EQUIVALENTS AT END OF YEAR |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Supplemental disclosure of cash flow information: |
||||||||||||
Cash paid for interest |
$ | $ | $ | |||||||||
Issuance of shares in connection with the Mergers (1) |
||||||||||||
|
|
|
|
|
|
(1) | On April 1, 2022, in connection with the Mergers (as defined in Note 1 “Organization”), the Company acquired net assets of $ |
Description |
Industry |
Spread Above Index (7) |
Floor |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||||||||||||||
Senior Secured Loans — |
| |||||||||||||||||||||||||||||||||
First Lien Bank Debt/Senior Secured Loans |
||||||||||||||||||||||||||||||||||
Accession Risk Management Group, Inc. (f/k/a RSC Acquisition, Inc.) |
S+ |
% | % | $ | $ | $ | ||||||||||||||||||||||||||||
Aegis Toxicology Sciences Corporation(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Alkeme Intermediary Holdings, LLC |
S+ |
% | % | |||||||||||||||||||||||||||||||
All States Ag Parts, LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Atria Wealth Solutions, Inc.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Basic Fun, Inc.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
BayMark Health Services, Inc.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Bayside Opco, LLC(27) |
S+ |
(11) |
% | % | ||||||||||||||||||||||||||||||
Bayside Parent, LLC(27) |
S+ |
(11) |
% | % | ||||||||||||||||||||||||||||||
BDG Media, Inc. |
P+ |
% | % | |||||||||||||||||||||||||||||||
CC SAG Holdings Corp. (Spectrum Automotive)(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Copper River Seafoods, Inc. |
P+ |
% | ||||||||||||||||||||||||||||||||
Crewline Buyer, Inc. |
S+ |
% | % | |||||||||||||||||||||||||||||||
CVAUSA Management, LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
DeepIntent, Inc. |
P+ |
% | ||||||||||||||||||||||||||||||||
Enhanced Permanent Capital, LLC(3) |
S+ |
% | % | |||||||||||||||||||||||||||||||
ENS Holdings III Corp. & ES Opco USA LLC (Bluefin)(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Exactcare Parent, Inc. |
S+ |
% | % | |||||||||||||||||||||||||||||||
Fertility (ITC) Investment Holdco, LLC |
S+ |
% | % | |||||||||||||||||||||||||||||||
Foundation Consumer Brands, LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
GSM Acquisition Corp. |
S+ |
% | % |
Description |
Industry |
Spread Above Index (7) |
Floor |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||||||||||||||
Senior Secured Loans (continued) |
|
|||||||||||||||||||||||||||||||||
Higginbotham Insurance Agency, Inc.(16) |
S+ |
% | % | $ | $ | $ | ||||||||||||||||||||||||||||
Human Interest Inc |
S+ |
% | % | |||||||||||||||||||||||||||||||
iCIMS, Inc. |
S+ |
% | % (26) |
|||||||||||||||||||||||||||||||
Kaseya, Inc.(16) |
S+ |
% | % (14) |
|||||||||||||||||||||||||||||||
Kid Distro Holdings, LLC (Distro Kid)(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Kingsbridge Holdings, LLC(2) . |
S+ |
% | % | |||||||||||||||||||||||||||||||
Logix Holding Company, LLC(16) |
P+ |
% | % | |||||||||||||||||||||||||||||||
Luxury Asset Capital, LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Maxor Acquisition, Inc.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Medrina, LLC |
S+ |
% | % | |||||||||||||||||||||||||||||||
NSPC Intermediate Corp. (National Spine) |
S+ |
% | % | |||||||||||||||||||||||||||||||
One Touch Direct, LLC. |
P+ |
% | ||||||||||||||||||||||||||||||||
ONS MSO, LLC |
S+ |
% | % | |||||||||||||||||||||||||||||||
Orthopedic Care Partners Management, LLC |
S+ |
% | % | |||||||||||||||||||||||||||||||
Peter C. Foy & Associates Insurance Services, LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Pinnacle Treatment Centers, Inc.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Plastics Management, LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Retina Midco, Inc.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
RQM+ Corp.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
RxSense Holdings LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
SCP Eye Care, LLC |
S+ |
% | % | |||||||||||||||||||||||||||||||
SHO Holding I Corporation (Shoes for Crews)(16) |
S+ |
% | % |
Description |
Industry |
Spread Above Index (7) |
Floor |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||||||||||||||
Senior Secured Loans (continued) |
|
|||||||||||||||||||||||||||||||||
Southern Orthodontic Partners Management, LLC(16) |
S+ |
% | % | $ | $ | $ | ||||||||||||||||||||||||||||
SPAR Marketing Force, Inc |
P+ |
% | ||||||||||||||||||||||||||||||||
Stryten Resources LLC |
S+ |
% | % | |||||||||||||||||||||||||||||||
SunMed Group Holdings, LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
TAUC Management, LLC(16) |
P+ |
% | % | |||||||||||||||||||||||||||||||
The Townsend Company, LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Tilley Distribution, Inc.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Ultimate Baked Goods Midco LLC (Rise Baking)(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
United Digestive MSO Parent, LLC |
S+ |
% | % | |||||||||||||||||||||||||||||||
Urology Management Holdings, Inc |
S+ |
% | % | |||||||||||||||||||||||||||||||
UVP Management, LLC |
S+ |
% | % | |||||||||||||||||||||||||||||||
Vessco Midco Holdings, LLC |
P+ |
% | % | |||||||||||||||||||||||||||||||
WCI-BXC Purchaser, LLC |
S+ |
% | % | |||||||||||||||||||||||||||||||
West-NR Parent, Inc.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||
Total First Lien Bank Debt/Senior Secured Loans |
|
$ | $ | |||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||
Second Lien Asset-Based Senior Secured Loans |
||||||||||||||||||||||||||||||||||
AMF Levered II, LLC |
S+ |
% | % | $ | $ | |||||||||||||||||||||||||||||
FGI Worldwide LLC |
S+ |
% | % | |||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||
$ | $ | |||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||
Second Lien Bank Debt/Senior Secured Loans |
||||||||||||||||||||||||||||||||||
RD Holdco, Inc.** (2) |
S+ |
(11) |
% | $ | $ | |||||||||||||||||||||||||||||
|
|
|
|
Description |
Industry |
Spread Above Index (7) |
Floor |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||||||||||||||
Senior Secured Loans (continued) |
|
|||||||||||||||||||||||||||||||||
First Lien Life Science Senior Secured Loans |
||||||||||||||||||||||||||||||||||
Alimera Sciences, Inc.(16) |
S+ |
% | % | $ | $ | $ | ||||||||||||||||||||||||||||
Arcutis Biotherapeutics, Inc.(3) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Ardelyx, Inc.(3) |
S+ |
% | % | |||||||||||||||||||||||||||||||
BridgeBio Pharma, Inc.(3) |
% (22) |
|||||||||||||||||||||||||||||||||
Cerapedics, Inc. |
S+ |
% | % | |||||||||||||||||||||||||||||||
Glooko, Inc.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Meditrina, Inc. |
S+ |
% | % | |||||||||||||||||||||||||||||||
Neuronetics, Inc.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
OmniGuide Holdings, Inc. (13) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Outset Medical, Inc.(3)(16) |
S+ |
% | % | |||||||||||||||||||||||||||||||
Vapotherm, Inc. |
S+ |
% | % (24) |
|||||||||||||||||||||||||||||||
Vertos Medical, Inc. |
S+ |
% | % | |||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||
Total First Lien Life Science Senior Secured Loans |
|
$ | $ | |||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||
Total Senior Secured Loans |
|
$ |
$ |
|||||||||||||||||||||||||||||||
|
|
|
|
Description |
Industry |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||||||
Equipment Financing — |
||||||||||||||||||||||||
A&A Crane and Rigging, LLC (10) |
$ | $ | $ | |||||||||||||||||||||
Aero Operating LLC (10) |
||||||||||||||||||||||||
AFG Dallas III, LLC (10) |
||||||||||||||||||||||||
Air Methods Corporation (10) |
||||||||||||||||||||||||
AmeraMex International, Inc. (10) |
||||||||||||||||||||||||
Bazzini, LLC (10) |
||||||||||||||||||||||||
Boart Longyear Company (10) |
||||||||||||||||||||||||
Bowman Energy Solutions, LLC (10) |
||||||||||||||||||||||||
C-Port/Stone LLC (10) |
Description |
Industry |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||||||
Equipment Financing (continued) |
||||||||||||||||||||||||
Capital City Jet Center, Inc. (10) |
$ | $ | $ | |||||||||||||||||||||
Carolina’s Contracting, LLC (10) |
||||||||||||||||||||||||
CKD Holdings, Inc. (10) |
||||||||||||||||||||||||
Clubcorp Holdings, Inc. (10) |
||||||||||||||||||||||||
Complete Equipment Rentals, LLC (10) |
||||||||||||||||||||||||
Dongwon Autopart Technology Inc. (10) |
||||||||||||||||||||||||
Double S Industrial Contractors, Inc. (10) |
||||||||||||||||||||||||
Drillers Choice, Inc. (10) |
||||||||||||||||||||||||
Energy Drilling Services, LLC (10) |
||||||||||||||||||||||||
Environmental Protection & Improvement Company, LLC (10) |
||||||||||||||||||||||||
Equipment Operating Leases, LLC (2)(12) |
||||||||||||||||||||||||
Extreme Steel Crane & Rigging, LLC (10) |
||||||||||||||||||||||||
First American Commercial Bancorp, Inc. (10) |
||||||||||||||||||||||||
First National Capital, LLC (10) |
||||||||||||||||||||||||
Georgia Jet, Inc. (10) |
||||||||||||||||||||||||
GMT Corporation (10) |
||||||||||||||||||||||||
Hawkeye Contracting Company, LLC (10) |
||||||||||||||||||||||||
HTI Logistics Corporation (10) |
||||||||||||||||||||||||
International Automotive Components Group, North America, Inc. (10) |
||||||||||||||||||||||||
Kool Pak, LLC (10) |
||||||||||||||||||||||||
Loc Performance Products, LLC (10) |
||||||||||||||||||||||||
Loyer Capital LLC (2)(12) |
||||||||||||||||||||||||
Lux Credit Consultants, LLC (10) |
||||||||||||||||||||||||
Lux Vending, LLC (10) |
Description |
Industry |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||||||
Equipment Financing (continued) |
||||||||||||||||||||||||
Miranda Logistics Enterprise, Inc. (10) |
$ | $ | $ | |||||||||||||||||||||
Mountain Air Helicopters, Inc. (10) |
||||||||||||||||||||||||
Nimble Crane LLC (10) |
||||||||||||||||||||||||
No Limit Construction Services, LLC (10) |
||||||||||||||||||||||||
Ozzies, Inc. (10) |
||||||||||||||||||||||||
PCX Aerostructures LLC (10) |
||||||||||||||||||||||||
Rane Light Metal Castings Inc. (10) |
||||||||||||||||||||||||
Rango, Inc. (10) |
||||||||||||||||||||||||
Rayzor’s Edge LLC (10) |
||||||||||||||||||||||||
RH Land Construction, LLC & Harbor Dredging LA, Inc. (10) |
||||||||||||||||||||||||
Royal Express Inc. (10) |
||||||||||||||||||||||||
Rotten Rock Hardscaping & Tree Service (10) |
||||||||||||||||||||||||
Rutt Services, LLC (10) |
||||||||||||||||||||||||
Signet Marine Corporation (10) |
||||||||||||||||||||||||
SLR Equipment Finance(2) |
||||||||||||||||||||||||
Smiley Lifting Solutions, LLC(10) |
||||||||||||||||||||||||
ST Coaches, LLC (10) |
||||||||||||||||||||||||
Star Coaches Inc. (10) |
||||||||||||||||||||||||
Superior Transportation, Inc. (10) |
||||||||||||||||||||||||
The Smedley Company & Smedley Services, Inc. (10).. |
||||||||||||||||||||||||
Trinity Equipment, Inc. (10) |
||||||||||||||||||||||||
Trinity Equipment Rentals, Inc. (10) |
||||||||||||||||||||||||
U.S. Crane & Rigging, LLC (10) |
||||||||||||||||||||||||
Up Trucking Services, LLC (10) |
Description |
Industry |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||||||||
Equipment Financing (continued) |
|
|||||||||||||||||||||||||
Waste Pro of Florida, Inc. & Waste Pro USA, Inc. (10) |
$ | $ | $ | |||||||||||||||||||||||
Wind River Environmental, LLC (10) |
||||||||||||||||||||||||||
Womble Company, Inc. (10) |
||||||||||||||||||||||||||
Worldwide Flight Services, Inc. (10) |
||||||||||||||||||||||||||
Zamborelli Enterprises Pacific Souther n Foundation (10) |
||||||||||||||||||||||||||
Shares/Units |
||||||||||||||||||||||||||
SLR Equipment Finance Equity Interests (2)(9)(17)* |
||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||
Total Equipment Financing |
|
$ |
$ |
|||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||
Par Amount |
||||||||||||||||||||||||||
Preferred Equity – |
|
|||||||||||||||||||||||||
SOINT, LLC (2)(3)(4) |
(11) |
— | $ | $ | ||||||||||||||||||||||
|
|
|
|
Description |
Industry |
Acquisition Date |
Shares/ Units |
Cost |
Fair Value |
|||||||||||||
Common Equity/Equity Interests/Warrants— |
||||||||||||||||||
Assertio Holdings, Inc. (8)* |
$ | $ | ||||||||||||||||
aTyr Pharma, Inc. Warrants * |
||||||||||||||||||
Bayside Parent, LLC (27)* |
||||||||||||||||||
CardioFocus, Inc. Warrants * |
||||||||||||||||||
Centrexion Therapeutics, Inc. Warrants * |
||||||||||||||||||
Conventus Orthopaedics, Inc. Warrants * |
||||||||||||||||||
Delphinus Medical Technologies, Inc. Warrants * |
||||||||||||||||||
Essence Group Holdings Corporation (Lumeris) Warrants * |
||||||||||||||||||
KBH Topco LLC (Kingsbridge) (2)(5)(18). |
||||||||||||||||||
Meditrina, Inc. Warrants * |
||||||||||||||||||
NSPC Holdings, LLC (National Spine) * |
||||||||||||||||||
RD Holdco, Inc. (Rug Doctor) (2)* |
||||||||||||||||||
RD Holdco, Inc. (Rug Doctor) Class B (2)* |
||||||||||||||||||
Senseonics Holdings, Inc. (3)(8)* |
||||||||||||||||||
SLR-AMI Topco Blocker, LLC (15)(27)* |
||||||||||||||||||
SLR Business Credit (2)(3)(19) |
||||||||||||||||||
SLR Credit Solutions (2)(3)(20) |
Description |
Industry |
Acquisition Date |
Shares/ Units |
Cost |
Fair Value |
|||||||||||||
Common Equity/Equity Interests/Warrants (continued) |
||||||||||||||||||
SLR Healthcare ABL (2)(3)(21) |
$ | $ | ||||||||||||||||
SLR Senior Lending Program LLC (2)(3)(25) |
||||||||||||||||||
SLR Healthcare ABL (2)(3)(21) |
||||||||||||||||||
Vapotherm, Inc. Warrants* |
||||||||||||||||||
Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics) |
||||||||||||||||||
Vertos Medical, Inc. Warrants* |
||||||||||||||||||
|
|
|
|
|||||||||||||||
Total Common Equity/Equity Interests/Warrants |
|
$ |
$ |
|||||||||||||||
|
|
|
|
|||||||||||||||
Total Investments (6) — |
$ |
$ |
||||||||||||||||
|
|
|
|
Description |
Industry |
Acquisition Date |
Maturity Date |
Par Amount |
||||||||||||||||||||
Cash Equivalents — |
|
|||||||||||||||||||||||
U.S. Treasury Bill |
$ | $ | $ | |||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||
Total Investments & Cash Equivalents — |
|
$ |
$ |
|||||||||||||||||||||
Liabilities in Excess of Other Assets — ( %) |
|
( |
) | |||||||||||||||||||||
|
|
|||||||||||||||||||||||
Net Assets — |
|
$ |
||||||||||||||||||||||
|
|
(1) | Floating rate debt investments typically bear interest at a rate determined by reference to the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2023. |
(2) | Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than |
Name of Issuer |
Fair Value at December 31, 2022 |
Gross Additions |
Gross Reductions |
Realized Loss |
Change in Unrealized Gain (Loss) |
Fair Value at December 31, 2023 |
Interest/ Dividend/ Other Income |
|||||||||||||||||||||
Equipment Operating Leases, LLC |
$ | $ | $ | ( |
) | $ | $ | $ | $ | |||||||||||||||||||
Kingsbridge Holdings, LLC |
( |
) | ||||||||||||||||||||||||||
KBH Topco, LLC (Kingsbridge) |
( |
) | ||||||||||||||||||||||||||
Loyer Capital LLC |
||||||||||||||||||||||||||||
RD Holdco, Inc. (Rug Doctor, common equity) |
||||||||||||||||||||||||||||
RD Holdco, Inc. (Rug Doctor, class B).. |
||||||||||||||||||||||||||||
RD Holdco, Inc. (Rug Doctor, warrants).. |
( |
) | ||||||||||||||||||||||||||
RD Holdco, Inc. (debt) |
||||||||||||||||||||||||||||
SLR Business Credit |
Name of Issuer |
Fair Value at December 31, 2022 |
Gross Additions |
Gross Reductions |
Realized Loss |
Change in Unrealized Gain (Loss) |
Fair Value at December 31, 2023 |
Interest/ Dividend/ Other Income |
|||||||||||||||||||||
SLR Credit Solutions |
( |
) | ||||||||||||||||||||||||||
SLR Equipment Finance (equity) |
||||||||||||||||||||||||||||
SLR Equipment Finance (debt) |
( |
) | ||||||||||||||||||||||||||
SLR Healthcare ABL |
||||||||||||||||||||||||||||
SLR Senior Lending Program LLC |
||||||||||||||||||||||||||||
SOINT, LLC |
( |
) | ||||||||||||||||||||||||||
$ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | $ | ||||||||||||||||
(3) | Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2023, on a fair value basis, non-qualifying assets in the portfolio represented |
(4) | The Company’s investment in SOINT, LLC includes a one dollar investment in common shares. |
(5) | Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation. |
(6) | Aggregate net unrealized appreciation for U.S. federal income tax purposes is $ |
(7) | Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR or PRIME rate. These instruments are often subject to a SOFR or PRIME rate floor. |
(8) | Denotes a Level 1 investment. |
(9) | SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary. |
(10) | Indicates an investment that is wholly held by the Company through NEFPASS LLC. |
(11) | Interest is paid in kind (“PIK”). |
(12) | Denotes a subsidiary of SLR Equipment Finance. |
(13) | OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers. |
(14) | Kaseya, Inc. may elect to defer up to |
(15) | Through this entity and other intermediate entities, the Company owns approximately |
(16) | Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company. |
(17) | See note 11 to the consolidated financial statements. |
(18) | See note 12 to the consolidated financial statements. |
(19) | See note 14 to the consolidated financial statements. |
(20) | See note 10 to the consolidated financial statements. |
(21) | See note 13 to the consolidated financial statements. |
(22) | BridgeBio Pharma, Inc. may elect to defer up to |
(23) | The Company became an Affiliated Person to Bayside Opco, LLC and Bayside Parent, LLC on May 31, 2023 and to Amerimark Intermediate Holdings, LLC and SLR- AMI Topco Blocker, LLC on June 16, 2023. |
(24) | Vapotherm, Inc. may elect to defer up to |
(25) | See note 18 to the consolidated financial statements. |
(26) | iCIMS, Inc. may elect to defer up to |
(27) | Denotes investments in which we are an “Affiliated Person” but do not exercise a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2023 (beginning with the date at which the Company became an Affiliated Person) in these affiliated investments are as follows: |
Name of Issuer |
Fair Value at Date of Affiliation(23) |
Gross Additions |
Gross Reductions |
Realized Gain (Loss) |
Change in Unrealized Gain (Loss) |
Fair Value at December 31, 2023 |
Interest Income |
|||||||||||||||||||||
Oldco AI, LLC (f/k/a AmeriMark) |
$ | $ | $ | ( |
) | $ | |
$ | $ | $ | ||||||||||||||||||
Oldco AI, LLC (f/k/a AmeriMark) |
( |
) a |
||||||||||||||||||||||||||
Bayside Opco, LLC |
( |
) | ||||||||||||||||||||||||||
Bayside Opco, LLC |
||||||||||||||||||||||||||||
Bayside Parent, LLC (loan) |
||||||||||||||||||||||||||||
Bayside Parent, LLC (equity) |
( |
) | ||||||||||||||||||||||||||
SLR-AMI Topco Blocker, LLC |
a |
( |
) | |||||||||||||||||||||||||
$ |
$ |
$( |
$ |
$( |
$ |
$ |
||||||||||||||||||||||
a |
Includes contribution of basis from Oldco AI, LLC to SLR-AMI Topco Blocker, LLC. |
* | Non-income producing security. |
** | Investment is on non-accrual status. |
Industry Classification |
Percentage of Total Investments (at fair value) as of December 31, 2023 |
|||
Diversified Financial Services (includes SLR Credit Solutions, SLR Business Credit and SLR Healthcare ABL) |
% | |||
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC) |
% | |||
Health Care Providers & Services |
% | |||
Health Care Equipment & Supplies |
% | |||
Pharmaceuticals |
% | |||
Biotechnology |
% | |||
Software |
% | |||
Insurance |
% | |||
Diversified Consumer Services |
% | |||
Commercial Services & Supplies |
% | |||
Asset Management |
% | |||
Capital Markets |
% | |||
Media |
% | |||
Thrifts & Mortgage Finance |
% | |||
Personal Products |
% | |||
Packaged Foods & Meats |
% | |||
Auto Parts & Equipment |
% | |||
Road & Rail |
% | |||
Life Sciences Tools & Services |
% | |||
Internet Software & Services |
% | |||
Internet & Catalog Retail |
% | |||
Transportation Infrastructure |
% | |||
Communications Equipment |
% | |||
Health Care Technology |
% | |||
Trading Companies & Distributors |
% | |||
Hotels, Restaurants & Leisure . |
% | |||
Aerospace & Defense |
% | |||
Oil, Gas & Consumable Fuels. |
% | |||
Footwear |
% | |||
Auto Components |
% | |||
IT Services |
% | |||
Food Products |
% | |||
Machinery |
% | |||
Airlines |
% | |||
Distributors |
% | |||
Metals & Mining |
% | |||
Leisure Equipment & Products |
% | |||
Specialty Retail |
% | |||
Food & Staples Retailing |
% | |||
Construction & Engineering |
% | |||
Consumer Finance |
% | |||
Energy Equipment & Services |
% | |||
Water Utilities |
% | |||
|
|
|||
Total Investments |
% | |||
|
|
Description |
Industry |
Spread Above Index (7) |
Floor |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||||||||
Senior Secured Loans — |
||||||||||||||||||||||||||||
First Lien Bank Debt/Senior Secured Loans |
||||||||||||||||||||||||||||
Aegis Toxicology Sciences Corporation(16) |
L+ |
% | % | $ | $ | $ | ||||||||||||||||||||||
All State Ag Parts, LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||
American Teleconferencing Services, Ltd.** |
L+ |
% | ||||||||||||||||||||||||||
American Teleconferencing Services, Ltd.** |
L+ |
% | ||||||||||||||||||||||||||
AmeriMark Intermediate Holdings, LLC(14) |
L+ |
% | % | |||||||||||||||||||||||||
Apex Services Partners, LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||
Atria Wealth Solutions, Inc.(16) |
S+ |
% | % | |||||||||||||||||||||||||
Basic Fun, Inc.(16) |
L+ |
% | % | |||||||||||||||||||||||||
BayMark Health Services, Inc.(16) |
L+ |
% | % | |||||||||||||||||||||||||
BDG Media, Inc |
L+ |
% | % | |||||||||||||||||||||||||
CC SAG Holdings Corp. (Spectrum Automotive)(16) |
L+ |
% | % | |||||||||||||||||||||||||
Composite Technology Acquisition Corp.(16) |
L+ |
% | % | |||||||||||||||||||||||||
Copper River Seafoods, Inc. |
P+ |
% | ||||||||||||||||||||||||||
DeepIntent, Inc |
P+ |
% | ||||||||||||||||||||||||||
Enhanced Permanent Capital, LLC(3) |
L+ |
% | % | |||||||||||||||||||||||||
ENS Holdings III Corp. & ES Opco USA LLC (Bluefin)(16).. |
S+ |
% | % | |||||||||||||||||||||||||
Enverus Holdings, Inc. (fka Drilling Info Holdings)(16) |
L+ |
% | ||||||||||||||||||||||||||
Erie Construction Mid-west, LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||
Foundation Consumer Brands, LLC(16) |
L+ |
% | % | |||||||||||||||||||||||||
GSM Acquisition Corp.(16) |
S+ |
% | % | |||||||||||||||||||||||||
Higginbotham Insurance Agency, Inc.(16) |
L+ |
% | % | |||||||||||||||||||||||||
High Street Buyer, Inc.(16) |
L+ |
% | % |
Description |
Industry |
Spread Above Index (7) |
Floor |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||||||||||||
Senior Secured Loans (continued) |
||||||||||||||||||||||||||||||||
Human Interest Inc |
S+ |
% | % | $ | $ | $ | ||||||||||||||||||||||||||
iCIMS, Inc. |
S+ |
% | % (26) |
|||||||||||||||||||||||||||||
Ivy Fertility Services, LLC |
L+ |
% | % | |||||||||||||||||||||||||||||
Kaseya, Inc.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||
Kid Distro Holdings, LLC (Distro Kid)(16) |
L+ |
% | % | |||||||||||||||||||||||||||||
Kingsbridge Holdings, LLC(2) |
L+ |
% | % | |||||||||||||||||||||||||||||
KORE Wireless Group, Inc.(16) |
S+ |
% | ||||||||||||||||||||||||||||||
Logix Holding Company, LLC(16) |
L+ |
% | % | |||||||||||||||||||||||||||||
Luxury Asset Capital, LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||||||
Maurices, Incorporated(16) |
S+ |
% | % | |||||||||||||||||||||||||||||
Montefiore Nyack Hospital |
L+ |
% | ||||||||||||||||||||||||||||||
NAC Holdings Corporation (Jaguar)(16) |
S+ |
% | % | |||||||||||||||||||||||||||||
National Spine and Pain Centers, LLC |
L+ |
% | % | |||||||||||||||||||||||||||||
One Touch Direct, LLC |
P+ |
% | ||||||||||||||||||||||||||||||
Orthopedic Care Partners Management, LLC |
S+ |
% | % | |||||||||||||||||||||||||||||
Pediatric Home Respiratory Services, LLC |
S+ |
% | % | |||||||||||||||||||||||||||||
Peter C. Foy & Associates Insurance Services, LLC |
S+ |
% | % | |||||||||||||||||||||||||||||
PhyNet Dermatology LLC |
S+ (15) |
% | % | |||||||||||||||||||||||||||||
Pinnacle Treatment Centers, Inc.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||
Plastics Management, LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||||||
PPT Management Holdings, LLC(16) |
L+ (11) |
% | % | |||||||||||||||||||||||||||||
RQM+ Corp.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||
RSC Acquisition, Inc.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||
RxSense Holdings LLC(16) |
L+ |
% | % |
Description |
Industry |
Spread Above Index (7) |
Floor |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||||||||||||
Senior Secured Loans (continued) |
||||||||||||||||||||||||||||||||
SCP Eye Care, LLC |
S+ |
% | % | $ | $ | $ | ||||||||||||||||||||||||||
SHO Holding I Corporation (Shoes for Crews)(16) |
L+ |
% | % | |||||||||||||||||||||||||||||
Southern Orthodontic Partners Management, LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||||||
SPAR Marketing Force, Inc |
P+ |
% | ||||||||||||||||||||||||||||||
Stryten Resources LLC |
S+ |
% | % | |||||||||||||||||||||||||||||
SunMed Group Holdings, LLC(16) |
L+ |
% | % | |||||||||||||||||||||||||||||
TAUC Management, LLC(16) |
L+ |
% | % | |||||||||||||||||||||||||||||
Tilley Distribution, Inc.(16) |
S+ |
% | % | |||||||||||||||||||||||||||||
Ultimate Baked Goods Midco LLC (Rise Baking)(16) |
L+ |
% | % | |||||||||||||||||||||||||||||
Vessco Midco Holdings, LLC(16) |
L+ |
% | % | |||||||||||||||||||||||||||||
World Insurance Associates, LLC(16) |
S+ |
% | % | |||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||
Total First Lien Bank Debt/Senior Secured Loans |
|
$ | $ | |||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||
Second Lien Asset-Based Senior Secured Loans |
||||||||||||||||||||||||||||||||
ACRES Commercial Mortgage, LLC |
S+ |
% | % | $ | $ | |||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||
Second Lien Bank Debt/Senior Secured Loans |
||||||||||||||||||||||||||||||||
RD Holdco, Inc.** (2) |
S+ (11) |
% | $ | $ | ||||||||||||||||||||||||||||
|
|
|
|
Description |
Industry |
Spread Above Index (7) |
Floor |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||||||||||||
Senior Secured Loans (continued) |
||||||||||||||||||||||||||||||||
First Lien Life Science Senior Secured Loans |
||||||||||||||||||||||||||||||||
Alimera Sciences, Inc.(16) |
L+ |
% | % | $ | $ | $ | ||||||||||||||||||||||||||
Apeel Technology, Inc. |
S+ |
% | ||||||||||||||||||||||||||||||
Arcutis Biotherapeutics, Inc.(3) |
L+ |
% | ||||||||||||||||||||||||||||||
Ardelyx, Inc.(3) |
L+ |
% | ||||||||||||||||||||||||||||||
BridgeBio Pharma, Inc.(3) |
(22) |
|||||||||||||||||||||||||||||||
Centrexion Therapeutics, Inc. |
L+ |
% | ||||||||||||||||||||||||||||||
Cerapedics, Inc. |
S+ |
% | ||||||||||||||||||||||||||||||
Glooko, Inc.(16) |
L+ |
% | ||||||||||||||||||||||||||||||
Meditrina, Inc. |
S+ |
% | ||||||||||||||||||||||||||||||
Neuronetics, Inc.(16) |
L+ |
% | ||||||||||||||||||||||||||||||
OmniGuide Holdings, Inc. (13). |
L+ |
% | (23) |
|||||||||||||||||||||||||||||
Outset Medical, Inc.(3) |
S+ |
% | ||||||||||||||||||||||||||||||
Spectrum Pharmaceuticals, Inc.(16) |
S+ |
% | ||||||||||||||||||||||||||||||
Vapotherm, Inc. |
S+ |
% | (24) |
|||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||
Total First Lien Life Science Senior Secured Loans |
|
$ | $ | |||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||
Total Senior Secured Loans |
|
$ | $ | |||||||||||||||||||||||||||||
|
|
|
|
Description |
Industry |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||
Equipment Financing — |
||||||||||||||||||||
Aero Operating LLC (10) |
$ | $ | $ | |||||||||||||||||
AFG Dallas III, LLC (10) |
||||||||||||||||||||
Air Methods Corporation (10) |
Description |
Industry |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||
Equipment Financing (continued) |
||||||||||||||||||||
AmeraMex International, Inc. (10) |
$ | $ | $ | |||||||||||||||||
Bazzini, LLC (10) |
||||||||||||||||||||
Boart Longyear Company (10) |
||||||||||||||||||||
Bowman Energy Solutions, LLC (10) |
||||||||||||||||||||
C-Port/Stone LLC (10) |
||||||||||||||||||||
Capital City Jet Center, Inc. (10) |
||||||||||||||||||||
Champion Air, LLC (10) |
||||||||||||||||||||
CKD Holdings, Inc. (10) |
||||||||||||||||||||
Clubcorp Holdings, Inc. (10) |
||||||||||||||||||||
Dongwon Autopart Technology Inc. (10) |
||||||||||||||||||||
Drillers Choice, Inc. (10) |
||||||||||||||||||||
EasyPak, LLC (10) |
||||||||||||||||||||
Energy Drilling Services, LLC (10) |
||||||||||||||||||||
Environmental Protection & Improvement Company, LLC (10) |
||||||||||||||||||||
Equipment Operating Leases, LLC (2)(12) |
||||||||||||||||||||
First American Commercial Bancorp, Inc. (10) |
||||||||||||||||||||
First National Capital, LLC. (10) |
||||||||||||||||||||
Freightsol LLC (10) |
||||||||||||||||||||
Garda CL Technical Services, Inc. (10) |
||||||||||||||||||||
Georgia Jet, Inc. (10) |
||||||||||||||||||||
GMT Corporation (10) |
||||||||||||||||||||
Hawkeye Contracting Company, LLC (10) |
||||||||||||||||||||
HTI Logistics Corporation. (10) |
||||||||||||||||||||
International Automotive Components Group, North America, Inc. (10) |
||||||||||||||||||||
Kool Pak, LLC (10) |
||||||||||||||||||||
Loc Performance Products, LLC (10) |
||||||||||||||||||||
Loyer Capital LLC (2)(12) |
||||||||||||||||||||
Lux Credit Consultants, LLC (10) |
Description |
Industry |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||
Equipment Financing (continued) |
||||||||||||||||||||
Lux Vending, LLC (10) |
$ | $ | $ | |||||||||||||||||
Mountain Air Helicopters, Inc. (10) |
||||||||||||||||||||
Ozzies, Inc. (10) |
||||||||||||||||||||
PCX Aerostructures LLC (10) |
||||||||||||||||||||
Rane Light Metal Castings Inc. (10) |
||||||||||||||||||||
Rango, Inc. (10) |
||||||||||||||||||||
Royal Coach Lines, Inc.(10) |
||||||||||||||||||||
Royal Express Inc. (10) |
||||||||||||||||||||
Rotten Rock Hardscaping & Tree Service (10) |
||||||||||||||||||||
Signet Marine Corporation (10) |
||||||||||||||||||||
SLR Equipment Finance(2) |
||||||||||||||||||||
Smiley Lifting Solutions, LLC(10) |
||||||||||||||||||||
ST Coaches, LLC (10) |
||||||||||||||||||||
Star Coaches Inc. (10) |
||||||||||||||||||||
Superior Transportation, Inc. (10) |
||||||||||||||||||||
The Smedley Company & Smedley Services, Inc. (10).. |
||||||||||||||||||||
Trinity Equipment Rentals, Inc. (10) |
||||||||||||||||||||
U.S. Crane & Rigging, LLC (10) |
||||||||||||||||||||
Up Trucking Services, LLC (10) |
||||||||||||||||||||
Wind River Environmental, LLC (10) |
||||||||||||||||||||
Womble Company, Inc. (10) |
||||||||||||||||||||
Worldwide Flight Services, Inc. (10) |
||||||||||||||||||||
Zamborelli Enterprises Pacific Souther n Foundation (10) |
||||||||||||||||||||
Shares/Units |
||||||||||||||||||||
SLR Equipment Finance Equity Interests (2)(9)(17)* |
||||||||||||||||||||
|
|
|
|
|||||||||||||||||
Total Equipment Financing |
$ |
$ |
||||||||||||||||||
|
|
|
|
Description |
Industry |
Interest Rate (1) |
Acquisition Date |
Maturity Date |
Par Amount |
Cost |
Fair Value |
|||||||||||||
Preferred Equity – |
||||||||||||||||||||
SOINT, LLC (2)(3)(4) |
(11) |
$ | $ | |||||||||||||||||
|
|
|
|
Description |
Industry |
Acquisition Date |
Shares/ Units |
Cost |
Fair Value |
|||||||||||||||||
Common Equity/Equity Interests/Warrants— |
| |||||||||||||||||||||
aTyr Pharma, Inc. Warrants * |
$ | $ | ||||||||||||||||||||
CardioFocus, Inc. Warrants * |
||||||||||||||||||||||
Centrexion Therapeutics, Inc. Warrants * |
||||||||||||||||||||||
Conventus Orthopaedics, Inc. Warrants * |
||||||||||||||||||||||
Delphinus Medical Technologies, Inc. Warrants * |
||||||||||||||||||||||
Essence Group Holdings Corporation (Lumeris) Warrants * |
||||||||||||||||||||||
KBH Topco LLC (Kingsbridge) (2)(5)(18). |
||||||||||||||||||||||
Meditrina, Inc. Warrants * |
||||||||||||||||||||||
RD Holdco, Inc. (Rug Doctor) (2)* |
||||||||||||||||||||||
RD Holdco, Inc. (Rug Doctor) Class B (2)* |
||||||||||||||||||||||
RD Holdco, Inc. (Rug Doctor) Warrants (2)* |
||||||||||||||||||||||
Senseonics Holdings, Inc. (3)(8)* |
||||||||||||||||||||||
SLR Business Credit (2)(3)(19) |
||||||||||||||||||||||
SLR Credit Solutions (2)(3)(20) |
||||||||||||||||||||||
SLR Healthcare ABL (2)(3)(21) |
||||||||||||||||||||||
SLR Senior Lending Program LLC (2)(3)(25) |
||||||||||||||||||||||
Spectrum Pharmaceuticals, Inc. Warrants * |
||||||||||||||||||||||
Vapotherm, Inc. Warrants* |
||||||||||||||||||||||
Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics) |
||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||
Total Common Equity/Equity Interests/Warrants |
|
$ | $ | |||||||||||||||||||
|
|
|
|
|||||||||||||||||||
Total Investments (6) — |
|
$ |
$ |
|||||||||||||||||||
|
|
|
|
Description |
Industry |
Acquisition Date |
Maturity Date |
Par Amount |
||||||||||||||||||||
Cash Equivalents — |
|
|||||||||||||||||||||||
U.S. Treasury Bill |
$ | $ | $ | |||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||
Total Investments & Cash Equivalents — |
|
$ |
$ |
|||||||||||||||||||||
Liabilities in Excess of Other Assets — ( |
|
( |
) | |||||||||||||||||||||
|
|
|||||||||||||||||||||||
Net Assets — |
|
$ |
||||||||||||||||||||||
|
|
(1) | Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the |
prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2022. |
(2) | Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than |
Name of Issuer |
Fair Value at December 31, 2021 |
Gross Additions |
Gross Reductions |
Realized Gain (Loss) |
Change in Unrealized Gain (Loss) |
Interest/ Dividend Income |
Fair Value at December 31, 2022 |
|||||||||||||||||||||
Equipment Operating Leases, LLC |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Kingsbridge Holdings, LLC |
( |
) | ||||||||||||||||||||||||||
KBH Topco, LLC (Kingsbridge) |
||||||||||||||||||||||||||||
Loyer Capital LLC |
||||||||||||||||||||||||||||
RD Holdco, Inc. (Rug Doctor, common equity) |
||||||||||||||||||||||||||||
RD Holdco, Inc. (Rug Doctor, class B).. |
( |
) | ||||||||||||||||||||||||||
RD Holdco, Inc. (Rug Doctor, warrants).. |
||||||||||||||||||||||||||||
RD Holdco, Inc. (debt) |
( |
) | ( |
) | ||||||||||||||||||||||||
SLR Business Credit |
||||||||||||||||||||||||||||
SLR Credit Solutions |
( |
) | ||||||||||||||||||||||||||
SLR Equipment Finance (equity) |
( |
) | ||||||||||||||||||||||||||
SLR Equipment Finance (debt) |
||||||||||||||||||||||||||||
SLR Healthcare ABL |
||||||||||||||||||||||||||||
SLR Senior Lending Program LLC |
( |
) | ||||||||||||||||||||||||||
SOAGG LLC |
( |
) | ||||||||||||||||||||||||||
SOINT, LLC |
( |
) | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | $ | $ | $ | $ | ( |
) | $ | $ | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3) | Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis, non-qualifying assets in the portfolio represented |
(4) | The Company’s investment in SOINT, LLC includes a one dollar investment in common shares. |
(5) | Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation. |
(6) | Aggregate net unrealized appreciation for U.S. federal income tax purposes is $ |
are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated. |
(7) | Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor. |
(8) | Denotes a Level 1 investment. |
(9) | SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary. |
(10) | Indicates an investment that is wholly held by the Company through NEFPASS LLC. |
(11) | Interest is paid in kind (“PIK”). |
(12) | Denotes a subsidiary of SLR Equipment Finance. |
(13) | OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers. |
(14) | AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Amerimark may elect to defer up to |
(15) | Spread is |
(16) | Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company. |
(17) | See note 11 to the consolidated financial statements. |
(18) | See note 12 to the consolidated financial statements. |
(19) | See note 14 to the consolidated financial statements. |
(20) | See note 10 to the consolidated financial statements. |
(21) | See note 13 to the consolidated financial statements. |
(22) | BridgeBio Pharma, Inc. may elect to defer up to |
(23) | OmniGuide Holdings, Inc. may elect to defer up to |
(24) | Vapotherm, Inc. may elect to defer up to |
(25) | See note 18 to the consolidated financial statements. |
(26) | iCIMS, Inc. may elect to defer up to |
* | Non-income producing security. |
** | Investment is on non-accrual status. |
Industry Classification |
Percentage of Total Investments (at fair value) as of December 31, 2022 |
|||
Diversified Financial Services (includes SLR Credit Solutions, SLR Business Credit and SLR Healthcare ABL) |
% | |||
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC) |
% | |||
Health Care Providers & Services |
% | |||
Health Care Equipment & Supplies |
% | |||
Pharmaceuticals |
% | |||
Software |
% | |||
Insurance |
% | |||
Biotechnology |
% | |||
Diversified Consumer Services |
% | |||
Media |
% | |||
Road & Rail |
% | |||
Personal Products |
% | |||
Capital Markets |
% | |||
Thrifts & Mortgage Finance |
% | |||
Life Sciences Tools & Services |
% | |||
Auto Parts & Equipment |
% | |||
Packaged Foods & Meats |
% | |||
Wireless Telecommunication Services |
% | |||
Commercial Services & Supplies |
% | |||
Internet & Catalog Retail |
% | |||
Internet Software & Services |
% | |||
Building Products |
% | |||
Trading Companies & Distributors |
% | |||
Health Care Technology |
% | |||
Transportation Infrastructure |
% | |||
Communications Equipment |
% | |||
IT Services |
% | |||
Leisure Equipment & Products |
% | |||
Specialty Retail |
% | |||
Asset Management |
% | |||
Food Products |
% | |||
Auto Components |
% | |||
Airlines |
% | |||
Hotels, Restaurants & Leisure . |
% | |||
Oil, Gas & Consumable Fuels |
% | |||
Aerospace & Defense |
% | |||
Machinery |
% | |||
Footwear |
% | |||
Metals & Mining |
% | |||
Food & Staples Retailing |
% | |||
Water Utilities |
% | |||
Consumer Finance |
% | |||
Construction & Engineering |
% | |||
Energy Equipment & Services |
% | |||
Containers & Packaging |
% | |||
|
|
|||
Total Investments |
% | |||
|
|
(a) | Investment transactions are accounted for on the trade date. |
(b) | Under procedures established by the board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than mid-market pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of |
(1) | our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment; |
(2) | preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser; |
(3) | independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets; |
(4) | the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and |
(5) | the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee. |
(c) | Gains or losses on investments are calculated by using the specific identification method. |
(d) | The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market |
discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other non-recurring fee income as well as a management fee and other fee income for services rendered, if any, are recorded as other income when earned. |
(e) | The Company intends to comply with the applicable provisions of the Code pertaining to RICs to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a |
(f) | Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP; accordingly, at December 31, 2023, $ paid-in capital in excess of par. Total earnings and net asset value are not affected. |
(g) | Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually. |
(h) | In accordance with Regulation S-X and ASC Topic 810—Consolidation |
(i) | The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company. |
(j) | In accordance with ASC 835-30, the Company reports origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method. |
(k) | The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are marked-to-market |
exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled. |
(l) | The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC 946-20-25. |
(m) | Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when principal or interest cash payments are past due non-accrual investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment. |
(n) | The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents. |
Year ended December 31, 2023 |
Year ended December 31, 2022 |
Year ended December 31, 2021 |
||||||||||
Earnings per share (basic & diluted) |
||||||||||||
Numerator—net increase in net assets resulting from operations: |
$ | $ | $ | |||||||||
Denominator—weighted average shares: |
||||||||||||
Earnings per share: |
$ | $ | $ |
a) | Quoted prices for similar assets or liabilities in active markets; |
b) | Quoted prices for identical or similar assets or liabilities in non-active markets; |
c) | Pricing models whose inputs are observable for substantially the full term of the asset or liability; and |
d) | Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability. |
Level 1 |
Level 2 |
Level 3 |
Measured at Net Asset Value* |
Total |
||||||||||||||||
Assets: |
||||||||||||||||||||
Senior Secured Loans |
$ | $ | $ | $ | $ | |||||||||||||||
Equipment Financing |
||||||||||||||||||||
Preferred Equity |
||||||||||||||||||||
Common Equity/Equity Interests/Warrants |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Investments |
$ | $ | $ | $ | $ | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
Level 1 |
Level 2 |
Level 3 |
Measured at Net Asset Value* |
Total |
||||||||||||||||
Assets: |
||||||||||||||||||||
Senior Secured Loans |
$ | $ | $ | $ | $ | |||||||||||||||
Equipment Financing |
||||||||||||||||||||
Preferred Equity |
||||||||||||||||||||
Common Equity/Equity Interests/Warrants |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Investments |
$ | $ | $ | $ | $ | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
* | In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 18 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members. |
Senior Secured Loans |
Equipment Financing |
Preferred Equity |
Common Equity/ Equity Interests/ Warrants |
Total |
||||||||||||||||
Fair value, December 31, 2022 |
$ | $ | $ | $ | $ | |||||||||||||||
Total gains or losses included in earnings: |
||||||||||||||||||||
Net realized loss |
( |
) | ( |
) | ( |
) | ||||||||||||||
Net change in unrealized gain (loss) |
( |
) | ( |
) | ||||||||||||||||
Purchase of investment securities * |
||||||||||||||||||||
Proceeds from dispositions of investment securities |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Transfers in/out of Level 3 |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Fair value, December 31, 2023 |
$ | $ | $ | $ | $ | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period: |
||||||||||||||||||||
Net change in unrealized gain (loss) |
$ | $ | $ | ( |
) | $ | ( |
) | $ | |||||||||||
|
|
|
|
|
|
|
|
|
|
* |
Includes PIK capitalization and accretion of discount. |
Senior Secured Loans |
Equipment Financing |
Preferred Equity |
Common Equity/ Equity Interests/ Warrants |
Total |
||||||||||||||||
Fair value, December 31, 2021 |
$ | $ | $ | $ | $ | |||||||||||||||
Total gains or losses included in earnings: |
||||||||||||||||||||
Net realized gain (loss) |
( |
) | ( |
) | ||||||||||||||||
change in unrealized loss |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||
Purchase of investment securities(1) (2) |
||||||||||||||||||||
Proceeds from dispositions of investment securities |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||
Transfers in/out of Level 3 |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Fair value, December 31, 2022 |
$ | $ | $ | $ | $ | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period: |
||||||||||||||||||||
change in unrealized loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | |||||
|
|
|
|
|
|
|
|
|
|
(1) |
Includes positions acquired from SUNS as a result of the Mergers. |
(2) |
Includes PIK capitalization and accretion of discount. |
2022 Unsecured Notes |
For the year ended December 31, 2022 |
|||
Beginning fair value |
$ | |||
Net realized (gain) loss |
||||
Net change in unrealized (gain) loss |
||||
Borrowings |
||||
Repayments |
( |
) | ||
Transfers in/out of Level 3 |
||||
|
|
|||
Ending fair value |
$ | |||
|
|
Asset or Liability |
Fair Value at December 31, 2023 |
Principal Valuation Technique/Methodology |
Unobservable Input |
Range (Weighted Average) | ||||||||||
Senior Secured Loans |
Asset | $ | ||||||||||||
$ | N/A | |||||||||||||
Equipment Financing |
Asset | $ | ||||||||||||
$ | (1) |
|||||||||||||
Preferred Equity |
Asset | $ | ||||||||||||
Common Equity/Equity Interests/Warrants |
Asset | $ | (2) |
|||||||||||
$ |
(1) | Includes $ |
(2) | Includes $ |
Asset or Liability |
Fair Value at December 31, 2022 |
Principal Valuation Technique/Methodology |
Unobservable Input |
Range (Weighted Average) | ||||||||||||||
Senior Secured Loans |
Asset | $ | ||||||||||||||||
$ | (1) |
|||||||||||||||||
Equipment Financing |
Asset | $ | ||||||||||||||||
$ | (2) |
|||||||||||||||||
Preferred Equity |
Asset | $ | ||||||||||||||||
Common Equity/Equity Interests/Warrants |
Asset | $ | (3) |
|||||||||||||||
$ |
(1) | Investments are valued using a sum-of-the |
(2) | Includes $ |
(3) | Includes $ |
December 31, 2023 |
December 31, 2022 |
|||||||||||||||
Facility |
Face Amount |
Carrying Value |
Face Amount |
Carrying Value |
||||||||||||
Credit Facility |
$ | $ | (1) |
$ | $ | (1) | ||||||||||
SPV Credit Facility |
(2) |
(2) | ||||||||||||||
2023 Unsecured Notes |
(3) | |||||||||||||||
2024 Unsecured Notes |
(4) |
(4) | ||||||||||||||
2025 Unsecured Notes |
(5) |
(5) | ||||||||||||||
2026 Unsecured Notes |
(6) |
(6) | ||||||||||||||
2027 Unsecured Notes |
(7) |
(7) | ||||||||||||||
2027 Series F Unsecured Notes |
(8) |
(8) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | $ | $ | $ | |||||||||||||
|
|
|
|
|
|
|
|
(1) | Carrying Value equals the Face Amount net of unamortized debt issuance costs of $ |
(2) | Carrying Value equals the Face Amount net of unamortized market discount of $ |
(3) | Carrying Value equals the Face Amount net of unamortized debt issuance costs of $ |
(4) | Carrying Value equals the Face Amount net of unamortized debt issuance costs of $ |
(5) | Carrying Value equals the Face Amount net of unamortized market discount of $ |
(6) | Carrying Value equals the Face Amount net of unamortized debt issuance costs of $ |
(7) | Carrying Value equals the Face Amount net of unamortized debt issuance costs of $ |
(8) | Carrying Value equals the Face Amount net of unamortized debt issuance costs of $ |
2023 |
2022 |
2021 |
||||||||||||||||||||||
Ordinary income |
$ | % | $ | % | $ | % | ||||||||||||||||||
Capital gains |
% | % | % | |||||||||||||||||||||
Return of capital |
% | % | % | |||||||||||||||||||||
Distributions recognized in subsequent year |
% | % | % | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total distributions |
$ | % | $ | % | $ | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
2022 |
2021 |
||||||||||
Undistributed ordinary income |
$ | $ | $ | |||||||||
Undistributed long-term net capital gains |
||||||||||||
|
|
|
|
|
|
|||||||
Total undistributed net earnings |
||||||||||||
Post-October capital losses |
||||||||||||
Capital loss carryforward |
( |
) 2 |
( |
) 2 |
( |
) | ||||||
Other book/tax temporary differences |
( |
) | ||||||||||
Net unrealized appreciation |
||||||||||||
|
|
|
|
|
|
|||||||
Total tax accumulated loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
(1) | Tax information for the fiscal years ended December 31, 2023, 2022 and 2021 are/were estimates and are not final until the Company files its tax returns, typically in September or October each year. |
(2) | Includes capital loss carryforward acquired from the Mergers which is subject to limitations under IRC Sections 381-384. |
Year ended December 31, 2023 |
Year ended December 31, 2022 |
Year ended December 31, 2021 |
Year ended December 31, 2020 |
Year ended December 31, 2019 |
||||||||||||||||
Per Share Data: (a) |
||||||||||||||||||||
Net asset value, beginning of year |
$ | $ | $ | $ | $ | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income |
||||||||||||||||||||
Net realized and unrealized loss |
( |
) | ( |
)* | ( |
) | ( |
) | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase in net assets resulting from operations |
||||||||||||||||||||
Issuance of common stock in connection with the Mergers |
( |
) | ||||||||||||||||||
Anti-dilution |
||||||||||||||||||||
Distributions to stockholders (see note 8a): |
||||||||||||||||||||
From distributable earnings |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||
From return of capital |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net asset value, end of year |
$ | $ | $ | $ | $ | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Per share market value, end of year |
$ | $ | $ | $ | $ | |||||||||||||||
Total Return(b) |
% | ( |
%) | % | ( |
%) | % | |||||||||||||
Net assets, end of year |
$ | $ | $ | $ | $ | |||||||||||||||
Shares outstanding, end of year |
||||||||||||||||||||
Ratios to average net assets: |
||||||||||||||||||||
Net investment income |
% | % | % | % | % | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Operating expenses |
%** | %** | % | % | % | |||||||||||||||
Interest and other credit facility expenses |
% | % | % | % | % | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total expenses |
%** | %** | % | % | % | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Average debt outstanding |
$ | $ | $ | $ | $ | |||||||||||||||
Portfolio turnover ratio |
% | % | % | % | % |
(a) | Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Mergers, which reflects the actual amount per share for the applicable period. |
(b) | Total return is based on the change in market price per share during the year and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. Total return does not include a sales load. |
* | The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Mergers. |
** | The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the years ended December 31, 2023 and December 31, 2022, the ratios of operating expenses to average net assets would be |
December 31, 2023 |
December 31, 2022 |
|||||||
SLR Credit Solutions* |
$ | $ | ||||||
Orthopedic Care Partners Management, LLC |
||||||||
Southern Orthodontic Partners Management, LLC |
||||||||
Ardelyx, Inc. |
||||||||
CVAUSA Management, LLC |
||||||||
BDG Media, Inc. |
||||||||
iCIMS, Inc. |
||||||||
Retina Midco, Inc. |
||||||||
Alkeme Intermediate Holdings, LLC |
||||||||
SPAR Marketing Force, Inc. |
||||||||
SLR Senior Lending Program LLC* |
||||||||
Copper River Seafoods, Inc. |
||||||||
Legacy Service Partners, LLC |
||||||||
Peter C. Foy & Associates Insurance Services, LLC |
||||||||
West-NR Parent, Inc. |
||||||||
Luxury Asset Capital, LLC |
||||||||
One Touch Direct, LLC |
||||||||
DeepIntent, Inc. |
||||||||
United Digestive MSO Parent, LLC |
||||||||
Kaseya, Inc. |
||||||||
The Townsend Company, LLC |
||||||||
Vertos Medical, Inc. |
||||||||
AMF Levered II, LLC |
||||||||
Foundation Consumer Brands, LLC |
||||||||
UVP Management, LLC |
||||||||
Kid Distro Holdings, LLC |
||||||||
Erie Construction Mid-west, LLC |
||||||||
Ultimate Baked Goods Midco LLC |
||||||||
Basic Fun, Inc. |
||||||||
SLR Equipment Finance * |
||||||||
Bayside Opco, LLC |
||||||||
SunMed Group Holdings, LLC |
||||||||
Urology Management Holdings, Inc. |
||||||||
SLR Healthcare ABL* |
||||||||
RxSense Holdings LLC |
||||||||
Tilley Distribution, Inc. |
||||||||
SCP Eye Care, LLC |
||||||||
GSM Acquisition Corp |
December 31, 2023 |
December 31, 2022 |
|||||||
Medrina, LLC |
||||||||
Pinnacle Treatment Centers, Inc. |
||||||||
High Street Buyer, Inc. |
||||||||
ENS Holdings III Corp, LLC |
||||||||
CC SAG Holdings Corp. (Spectrum Automotive) |
||||||||
Crewline Buyer, Inc. |
||||||||
Exactcare Parent, Inc. |
||||||||
WCI-BXC Purchaser, LLC |
||||||||
All States Ag Parts, LLC |
||||||||
Vessco Midco Holdings, LLC |
||||||||
TAUC Management, LLC |
||||||||
Outset Medical, Inc. |
||||||||
Apeel Technology, Inc. |
||||||||
Human Interest, Inc. |
||||||||
Glooko, Inc. |
||||||||
World Insurance Associates, LLC |
||||||||
Spectrum Pharmaceuticals, Inc. |
||||||||
Arcutis Biotherapeutics, Inc. |
||||||||
Atria Wealth Solutions, Inc. |
||||||||
Accession Risk Management Group, Inc. |
||||||||
Cerapedics, Inc. |
||||||||
Maurices, Incorporated |
||||||||
Meditrina, Inc. |
||||||||
Plastics Management, LLC |
||||||||
Pediatric Home Respiratory Services, LLC |
||||||||
Ivy Fertility Services, LLC |
||||||||
Composite Technology Acquisition Corp. |
||||||||
NAC Holdings Corporation |
||||||||
Montefiore Nyack Hospital |
||||||||
Enverus Holdings, Inc. |
||||||||
American Teleconferencing Services, Ltd. |
||||||||
BayMark Health Services, Inc. |
||||||||
|
|
|
|
|||||
Total Commitments |
$ | $ | ||||||
|
|
|
|
* |
The Company controls the funding of these commitments and may cancel them at its discretion. |
Shares |
Amount |
|||||||||||||||
For the year ended December 31, 2023 |
For the year ended December 31, 2022 |
For the year ended December 31, 2023 |
For the year ended December 31, 2022 |
|||||||||||||
Shares issued in connection with the Mergers |
$ | $ | ||||||||||||||
Shares repurchased |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) |
( |
) | $ | ( |
) | $ | ||||||||||
|
|
|
|
|
|
|
|
Description |
Industry |
Spread Above Index (1) |
Floor |
Interest Rate (2) |
Maturity Date |
Par Amount |
Cost |
Fair Value (3) |
||||||||||||||||||||||
Aegis Toxicology Sciences Corporation (4) |
Health Care Providers & Services | S+ |
% | % | $ | $ | $ | |||||||||||||||||||||||
Alkeme Intermediary Holdings, LLC (4) |
Insurance | S+ |
% | % | ||||||||||||||||||||||||||
All States Ag Parts, LLC (4) |
Trading Companies & Distributors | S+ |
% | % | ||||||||||||||||||||||||||
Apex Service Partners, LLC |
Diversified Consumer Services | S+ |
% | % | ||||||||||||||||||||||||||
Atria Wealth Solutions, Inc. (4) |
Diversified Financial Services | S+ |
% | % | ||||||||||||||||||||||||||
BayMark Health Services, Inc. (4) |
Health Care Providers & Services | S+ |
% | % | ||||||||||||||||||||||||||
CC SAG Holdings Corp. (4) |
Diversified Consumer Services | S+ |
% | % | ||||||||||||||||||||||||||
CVAUSA Management, LLC (4) |
Health Care Providers & Services | S+ |
% | % | ||||||||||||||||||||||||||
ENS Holdings III Corp. & ES Opco USA LLC (4) |
Trading Companies & Distributors | S+ |
% | % | ||||||||||||||||||||||||||
Erie Construction Mid-west, LLC |
Building Products | S+ |
% | % |
Description |
Industry |
Spread Above Index (1) |
Floor |
Interest Rate (2) |
Maturity Date |
Par Amount |
Cost |
Fair Value (3) |
||||||||||||||||||||||
Fertility (ITC) Investment Holdco, LLC (4) |
Health Care Providers & Services | S+ |
% | % | $ | $ | $ | |||||||||||||||||||||||
Foundation Consumer Brands, LLC (4) |
Personal Products | S+ |
% | % | ||||||||||||||||||||||||||
GSM Acquisition Corp. (4) |
Leisure Equipment & Products | S+ |
% | % | ||||||||||||||||||||||||||
Higginbotham Insurance Agency, Inc. (4) |
Insurance | S+ |
% | % | ||||||||||||||||||||||||||
High Street Buyer, Inc. |
Insurance | S+ |
% | % | ||||||||||||||||||||||||||
iCIMS, Inc. (4) |
Software | S+ |
% | % | ||||||||||||||||||||||||||
Kaseya, Inc. (4) |
Software | S+ |
% | % | ||||||||||||||||||||||||||
Kid Distro Holdings, LLC (4) |
Software | S+ |
% | % | ||||||||||||||||||||||||||
Maxor Acquisition, Inc. (4) |
Health Care Providers & Services | S+ |
% | % | ||||||||||||||||||||||||||
ONS MSO, LLC (4) |
Health Care Providers & Services | S+ |
% | % | ||||||||||||||||||||||||||
Pinnacle Treatment Centers, Inc. (4) |
Health Care Providers & Services | S+ |
% | % | ||||||||||||||||||||||||||
Plastics Management, LLC (4) |
Health Care Providers & Services | S+ |
% | % | ||||||||||||||||||||||||||
RQM+ Corp. (4) |
Life Sciences Tools & Services | S+ |
% | % | ||||||||||||||||||||||||||
RxSense Holdings LLC (4) |
Diversified Consumer Services | S+ |
% | % | ||||||||||||||||||||||||||
SunMed Group Holdings, LLC (4) |
Health Care Equipment & Supplies | S+ |
% | % | ||||||||||||||||||||||||||
The Townsend Company, LLC (4) |
Commercial Services & Supplies | S+ |
% | % | ||||||||||||||||||||||||||
Tilley Distribution, Inc. (4) |
Trading Companies & Distributors | S+ |
% | % | ||||||||||||||||||||||||||
Ultimate Baked Goods Midco LLC (4) |
Packaged Foods & Meats | S+ |
% | % | ||||||||||||||||||||||||||
United Digestive MSO Parent, LLC (4) |
Health Care Providers & Services | S+ |
% | % | ||||||||||||||||||||||||||
Urology Management Holdings, Inc. (4) |
Health Care Providers & Services | S+ |
% | % | ||||||||||||||||||||||||||
Vessco Midco Holdings, LLC (4) |
Water Utilities | S+ |
% | % | ||||||||||||||||||||||||||
West-NR Parent, Inc.(4) |
Insurance | S+ |
% | % | ||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||
$ | $ | |||||||||||||||||||||||||||||
|
|
|
|
(1) | Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor. |
(2) | Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2023. |
(3) | Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. |
(4) | The Company also holds this security on its Consolidated Statements of Assets and Liabilities. |
Description |
Industry |
Spread Above Index (1) |
Floor |
Interest Rate (2) |
Maturity Date |
Par Amount |
Cost |
Fair Value (3) |
||||||||||||||||||||||
Atria Wealth Solutions, Inc. (4) |
Diversified Financial Services | S+ |
% | % | $ | $ | $ | |||||||||||||||||||||||
BayMark Health Services, Inc. (4) |
Health Care Providers & Services | L+ |
% | % | ||||||||||||||||||||||||||
ENS Holdings III Corp. & ES Opco USA LLC (4) |
Trading Companies & Distributors | L+ |
% | % | ||||||||||||||||||||||||||
Foundation Consumer Brands, LLC (4) |
Personal Products | L+ |
% | % | ||||||||||||||||||||||||||
High Street Buyer, Inc. (4) |
Insurance | L+ |
% | % | ||||||||||||||||||||||||||
Ivy Fertility Services, LLC (4) |
Health Care Providers & Services | L+ |
% | % | ||||||||||||||||||||||||||
Kid Distro Holdings, LLC (4) |
Software | L+ |
% | % | ||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||
$ | $ | |||||||||||||||||||||||||||||
|
|
|
|
(1) | Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor. |
(2) | Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022. |
(3) | Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. |
(4) | The Company also holds this security on its Consolidated Statements of Assets and Liabilities. |
December 31, 2023 |
December 31, 2022 |
|||||||
Selected Balance Sheet Information for SSLP: |
||||||||
Investments at fair value (cost $ |
$ | $ | ||||||
Cash and other assets |
||||||||
|
|
|
|
|||||
Total assets |
$ | $ | ||||||
|
|
|
|
|||||
Debt outstanding ($ 106,900 and $0 face amounts, respectively, reported net of unamortized debt issuance costs of $1,697 and $0 , respectively) |
$ | $ | ||||||
Distributions payable |
||||||||
Interest payable and other credit facility related expenses |
||||||||
Accrued expenses and other payables |
||||||||
|
|
|
|
|||||
Total liabilities |
$ | $ | ||||||
|
|
|
|
|||||
Members’ equity |
$ | $ | ||||||
|
|
|
|
|||||
Total liabilities and members’ equity |
$ | $ | ||||||
|
|
|
|
Year ended December 31, 2023 |
For the Period December 1, 2022 (commencement of operations) through December 31, 2022 |
|||||||
Selected Income Statement Information for SSLP: |
||||||||
Interest income |
$ | $ | ||||||
|
|
|
|
|||||
Service fees* |
$ | $ | ||||||
Interest and other credit facility expenses |
||||||||
Organizational costs |
||||||||
Other general and administrative expenses |
||||||||
|
|
|
|
|||||
Total expenses |
$ | $ | ||||||
|
|
|
|
|||||
Net investment income (loss) |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Realized gain on investments |
||||||||
Net change in unrealized gain on investments |
||||||||
|
|
|
|
|||||
Net realized and unrealized gain on investments |
||||||||
|
|
|
|
|||||
Net income (loss) |
$ | $ | ( |
) | ||||
|
|
|
|
* | Service fees are included within the Company’s Consolidated Statements of Operations as other income. |
Item 9. |
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure |
Item 9A. |
Controls and Procedures |
Item 9B. |
Other Information |
Item 9C. |
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections |
Item 10. |
Directors, Executive Officers and Corporate Governance |
Name, Address and Age(1) |
Position(s) Held with Company |
Terms of Office and Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Number of Portfolios in Fund Complex Overseen by Director(2) |
Other Directorships Held by Director or Nominee for Director During Past 5 Years That Are Not Part of the Fund Complex | |||||
Interested Director |
||||||||||
Michael S. Gross, 62 |
Chairman of the Board of Directors, Co-Chief Executive Officer and President. |
Class III Director since 2007; Term expires 2024. | Co-Chief Executive Officer of SLR Investment Corp. and SCP Private Credit Income BDC LLC since June 2019, of SLR HC BDC LLC since September 2020 and of SLR Private Credit BDC II LLC since April 2022, and President of SLR Investment Corp. since 2007, of SCP Private Credit Income BDC LLC since 2018, of SLR HC BDC LLC since 2020 and of SLR Private Credit BDC II LLC since 2022; Sole Chief Executive Officer of SLR Investment Corp. (February 2007-June 2019), and of SCP Private Credit Income BDC LLC (June 2018- June 2019). Previously, Co-Chief Executive Officer and President of SLR Senior Investment Corp. |
4 | Chairman of the Board of Directors of Global Ship Lease Inc. Previously Chairman of the Board of Directors of SLR Senior Investment Corp., where he served from 2010 to April 2022. |
Name, Address and Age(1) |
Position(s) Held with Company |
Terms of Office and Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Number of Portfolios in Fund Complex Overseen by Director(2) |
Other Directorships Held by Director or Nominee for Director During Past 5 Years That Are Not Part of the Fund Complex | |||||
Interested Director |
||||||||||
Bruce Spohler, 63 |
Co-Chief Executive Officer, Chief Operating Officer and Director |
Class II Director since 2009; Term expires 2026. | Co-Chief Executive Officer of SLR Investment Corp. and SCP Private Credit Income BDC LLC since June 2019, of SLR HC BDC LLC since September 2020 and of SLR Private Credit BDC II LLC since April 2022; Chief Operating Officer of SLR Investment Corp. since February 2007, of SCP Private Credit Income BDC LLC since June 2018, of SLR HC BDC LLC since September 2020 and of SLR Private Credit BDC II LLC since April 2022. |
4 | Previously a member of the board of directors of SLR Senior Investment Corp., where he served from 2010 to April 2022. |
Name, Address and Age(1) |
Position(s) Held with Company |
Terms of Office and Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Number of Portfolios in Fund Complex Overseen by Director(2) |
Other Directorships Held by Director or Nominee for Director During Past 5 Years That Are Not Part of the Fund Complex | |||||
Independent Director |
||||||||||
Steven Hochberg, 62 | Director | Class II Director since 2007; Term expires 2026. | Operating Partner of Deerfield Management, a healthcare investment firm, since 2022. Partner of Deerfield Management from 2013 to 2021. Co-Founder and Manager of Ascent Biomedical Ventures, a venture capital firm focused on early stage investment and development of biomedical companies, since 2004. Co-Founder and Co-General Partner of Triatomic Capital, a technology focused venture capital firm, since 2022. |
4 | Since 2011, Mr. Hochberg had been the Chairman of the Board of Continuum Health Partners until its merger with Mount Sinai in 2013, where he is a Vice Chairman of Mount Sinai Health System, a non-profit healthcare integrated delivery system in New York City. Director of a number of private healthcare companies and the Cardiovascular |
Name, Address and Age(1) |
Position(s) Held with Company |
Terms of Office and Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Number of Portfolios in Fund Complex Overseen by Director(2) |
Other Directorships Held by Director or Nominee for Director During Past 5 Years That Are Not Part of the Fund Complex | |||||
Research Foundation, an organization focused on advancing new technologies and education in the field of cardiovascular medicine. Previously a member of the board of directors of SLR Senior Investment Corp., where he served from 2011 to April 2022. |
Name, Address and Age(1) |
Position(s) Held with Company |
Terms of Office and Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Number of Portfolios in Fund Complex Overseen by Director(2) |
Other Directorships Held by Director or Nominee for Director During Past 5 Years That Are Not Part of the Fund Complex | |||||
Independent Director |
||||||||||
Leonard A. Potter, 62 | Director | Class III Director since 2009; Term expires 2024. | President and Chief Investment Officer of Wildcat Capital Management, LLC since 2011; Senior Managing Director of Vida Ventures I and II, each a biotech venture fund, since 2017; Managing Director of Soros Private Equity at Soros Fund Management LLC from 2002 to 2009. | 4 | Director of Hilton Grand Vacations Inc. since 2017, of SuRo Capital Corp. since 2011, and of several private companies. Previously a member of the board of directors of SLR Senior Investment Corp., where he served from 2011 to April 2022. |
Name, Address and Age(1) |
Position(s) Held with Company |
Terms of Office and Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Number of Portfolios in Fund Complex Overseen by Director(2) |
Other Directorships Held by Director or Nominee for Director During Past 5 Years That Are Not Part of the Fund Complex | |||||
Independent Director |
||||||||||
David S. Wachter, 60 | Director | Class I Director since 2007; Term expires 2025. | Founding Partner and Managing Partner of W Capital Partners, a private equity fund manager, since 2001. | 4 | Previously a member of the board of directors of SLR Senior Investment Corp., where he served from 2011 to April 2022. |
Name, Address and Age(1) |
Position(s) Held with Company |
Terms of Office and Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Number of Portfolios in Fund Complex Overseen by Director |
Other Directorships Held by Director or Nominee for Director During Past 5 Years That Are Not Part of the Fund Complex | |||||
Independent Director |
||||||||||
Andrea C. Roberts, 67 | Director | Class I Director since 2023; Term expires 2025. | Co-Founder and Managing Director of Genesis Capital Corporation, an investment banking firm, since 1994; President and sole owner of Orbis Associates, Inc., a consulting firm providing consulting services to Genesis Capital Corporation on an exclusive basis, since 1994. |
1 | Director of Trinity Episcopal School from 2019 to 2022. |
(1) | The business address of the director nominees and other directors is c/o SLR Investment Corp., 500 Park Avenue, New York, New York 10022. |
(2) | The Company is part of a “Fund Complex,” as that term is defined in Schedule 14A and Regulation 14A under the 1934 Act. Messrs. Gross, Spohler, Hochberg, Potter and Wachter each also have served as directors of SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC since 2018, 2020 and 2022, respectively, which are investment companies that have each elected to be regulated as a business development company (“BDC”) and are part of the Fund Complex. Mr. Gross has served as Chairman of SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC since 2018, 2020 and 2022, respectively. Mr. Potter also serves as a director of SuRo Capital Corp., which is a closed-end management investment company that has elected to be regulated as a BDC. |
Name, Address, and Age (1) |
Position(s) Held with Company |
Number of Portfolios in Fund Complex Overseen by Officer |
Principal Occupation(s) During Past 5 Years | |||
Shiraz Y. Kajee, 44 | Chief Financial Officer and Treasurer | 4 | Chief Financial Officer and Treasurer of the Company, SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC since April 2023. From December 2015 through March 2023, Mr. Kajee served as a Managing Director at New Mountain Capital, L.L.C., which included serving as Chief Financial Officer and Treasurer of New Mountain Finance Corporation since 2015, of NMF SLF I, Inc. since 2019, of New Mountain Guardian III BDC, L.L.C. since 2019 and of New Mountain Guardian IV BDC, L.L.C. since 2022. | |||
Guy Talarico, 68 | Chief Compliance Officer and Secretary | 4 | Chief Compliance Officer of the Company since July 2008, chief compliance officer of SCP Private Credit Income BDC LLC since June 2018, chief compliance officer of SLR HC BDC LLC since September 2020, and chief compliance officer of SLR Private Credit BDC II LLC since April 2022. Secretary of the Company, SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC since November 2023; Mr. Talarico currently serves as General Counsel and Chief Compliance Officer for SLR Capital Partners, LLC since May 2023. In addition, Mr. Talarico previously served as the chief compliance officer of SLR Senior Investment Corp. from December 2010 until April 2022. Mr. Talarico previously served as managing director of ACA Group, LLC (successor to Foreside Consulting Services LLC, and ultimate successor to Alaric Compliance Services, LLC, which he founded in December 2005). Mr. Talarico holds a B.S. ChE from Lehigh University, an M.B.A. from Fairleigh Dickinson University and a J.D. from New York Law School. |
(1) | The business address of the executive officers is c/o SLR Investment Corp., 500 Park Avenue, New York, New York 10022. |
Item 11. |
Executive Compensation |
Name |
Fees Earned or Paid in Cash (1) |
Stock Awards (2) |
All Other Compensation |
Total |
||||||||||||
Interested Directors |
||||||||||||||||
Michael S. Gross |
— | — | — | — | ||||||||||||
Bruce Spohler |
— | — | — | — | ||||||||||||
Independent Directors |
||||||||||||||||
Steven Hochberg |
$ | 133,000 | — | — | $ | 133,000 | ||||||||||
David S. Wachter |
$ | 128,000 | — | — | $ | 128,000 | ||||||||||
Leonard A. Potter |
$ | 128,000 | — | — | $ | 128,000 | ||||||||||
Andrea C. Roberts (3) |
$ | 41,239 | — | — | $ | 41,239 |
(1) | For a discussion of the independent directors’ compensation, see below. |
(2) | We do not maintain a stock or option plan, non-equity incentive plan or pension plan for our directors. However, our independent directors have the option to receive all or a portion of the directors’ fees to which they would otherwise be entitled in the form of shares of our common stock issued at a price per share equal to the greater of our then current net asset value per share or the market price at the time of payment. No shares were issued to any of our independent directors in lieu of cash during 2023. |
(3) | Ms. Roberts was appointed to the board of directors on August 28, 2023. |
Item 12. |
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
Name and Address of Beneficial Owner |
Number of Shares Owned Beneficially(1) |
Percentage of Class(2) |
||||||
Interested Directors |
||||||||
Michael S. Gross(3)(4) |
3,829,913 | 7.0 | % | |||||
Bruce Spohler(3) |
3,516,273 | 6.4 | % | |||||
Independent Directors |
||||||||
Steven Hochberg |
2,742 | * | ||||||
Leonard A. Potter |
14,872 | * | ||||||
David S. Wachter |
53,494 | * | ||||||
Andrea C. Roberts |
— | — | ||||||
Executive Officers |
||||||||
Shiraz Y. Kajee |
7,500 | * | ||||||
Guy Talarico |
31,899 | * | ||||||
All executive officers and directors as a group (8 persons) |
4,458,780 |
8.2 |
% | |||||
Thornburg Investment Management Inc.(5) |
4,338,599 | 8.0 | % |
* | Represents less than one percent. |
(1) |
Beneficial ownership has been determined in accordance with Rule 13d-3 under the 1934 Act. Assumes no other purchases or sales of our common stock since the most recently available SEC filings. This assumption has been made under the rules and regulations of the SEC and does not reflect any knowledge that we have with respect to the present intent of the beneficial owners of our common stock listed in this table. |
(2) |
Based on a total of 54,554,634 shares of the Company’s common stock issued and outstanding as of February 23, 2024. |
(3) |
Includes 1,285,013 shares held by Solar Capital Investors, LLC and 715,000 shares held by Solar Capital Investors II, LLC, 355,107 shares held by Solar Senior Capital Investors, LLC and 77 shares held by SLR Capital Management, LLC, a portion of each which may be deemed to be indirectly beneficially owned by Michael S. Gross, by Bruce Spohler and a grantor retained annuity trust (“GRAT”) setup by and for Mr. Gross by virtue of their collective ownership interest therein. Also includes 642,716 shares held by Solar Capital Partners Employee Stock Plan LLC, which is controlled by SLR Capital Partners, LLC. Mr. Gross and Mr. Spohler may be deemed to beneficially own a portion of the shares held by Solar Capital Partners Employee Stock Plan LLC by virtue of their collective ownership interest in SLR Capital Partners, LLC. Each of Mr. Gross and Mr. Spohler disclaim beneficial ownership of any shares of our common stock directly held by Solar Capital Partners Employee Stock Plan LLC, Solar Capital Investors, LLC, Solar Capital Investors II, LLC, Solar Senior Capital Investors, LLC and SLR Capital Management, LLC, except to the extent of their respective pecuniary interest therein. Also includes 199,466 shares held in a trust of which Bruce Spohler became co-trustee in which he and certain members of his immediate family are beneficiaries (the “Spohler Trust”) and 243,021 shares held by a limited liability company in which he owns a pro rata interest (the “Spohler LLC”). Mr. Spohler disclaims beneficial ownership of the shares in the Spohler Trust and the Spohler LLC. |
(4) |
Includes 152,166 shares directly held by Michael S. Gross’ profit sharing plan (the “Profit Sharing Plan”). Mr. Gross may be deemed to directly beneficially own these shares as the sole participant in the Profit |
Sharing Plan. Also includes 117,617 shares held by certain trusts for the benefit of family members for which Mr. Gross serves as trustee (the “Family Trusts”). The total includes 334,428 shares held by the GRAT. Mr. Gross may be deemed to directly beneficially own these shares by virtue of his control with respect to the Family Trusts, and disclaims beneficial ownership of the securities held by the Family Trusts except to the extent of his pecuniary interest therein. |
(5) |
Based upon information contained in the Schedule 13G filed February 9, 2024 by Thornburg Investment Management Inc. Such securities are held by certain investment vehicles controlled and/or managed by Thornburg Investment Management Inc. or its affiliates. The address for Thornburg Investment Management Inc. is 2300 North Ridgetop Road, Santa Fe, New Mexico 87506. |
Name of Director |
Dollar Range of Equity Securities Beneficially Owned in the Company(1)(2) |
Dollar Range of Equity Securities Beneficially Owned in the Fund Complex(1)(2)(3) | ||
Interested Directors |
||||
Michael S. Gross |
Over $ 100,000 | Over $ 100,000 | ||
Bruce Spohler |
Over $ 100,000 | Over $ 100,000 | ||
Independent Directors |
||||
Steven Hochberg |
$10,001- $50,000 |
$10,001- $50,000 | ||
Leonard A. Potter |
Over $ 100,000 | Over $ 100,000 | ||
David S. Wachter |
Over $ 100,000 | Over $ 100,000 | ||
Andrea C. Roberts |
None | None |
(1) |
The dollar ranges are: None, $1-$10,000, $10,001-$50,000, $50,001-$100,000, or Over $100,000. |
(2) |
The dollar range of equity securities beneficially owned in us is based on the closing price for our common stock of $14.89 on February 23, 2024 on the NASDAQ Global Select Market. Beneficial ownership has been determined in accordance with Rule 16a-1(a)(2) of the 1934 Act. |
(3) |
The dollar range of equity securities in the Fund Complex beneficially owned by directors of the Company, if applicable, is the total dollar range of equity securities in the Company beneficially owned by the directors, as no director has beneficial ownership of SCP Private Credit Income BDC LLC, SLR HC BDC LLC or SLR Private Credit BDC II LLC. |
Item 13. |
Certain Relationships and Related Transactions, and Director Independence |
• | the nature, extent and quality of advisory services to be rendered, including information about the investment performance of the Company relative to its stated objectives and in comparison to the |
performance of the Company’s peer group and relevant market indices, and concluded that such services are satisfactory and the Company’s investment performance is reasonable; |
• | the experience and qualifications of the personnel of SLR Capital Partners providing such services, including information about the backgrounds of the investment personnel, the allocation of responsibilities among such personnel and the process by which investment decisions are made, and concluded that SLR Capital Partners’ personnel have extensive experience and are well qualified; |
• | the current fee structure, the existence of any fee waivers, and the Company’s anticipated expense ratios in relation to those of other investment companies having comparable investment policies and limitations, and concluded that the proposed fee structure is reasonable; |
• | the fees charged by SLR Capital Partners to the Company, to SCP Private Credit Income BDC LLC, to SLR HC BDC LLC and to SLR Private Credit BDC II LLC, and comparative data regarding the advisory fees charged by other investment advisers to similar investment companies, and concluded that the fees to be charged by SLR Capital Partners to the Company are reasonable; |
• | the direct and indirect costs, including for personnel and office facilities, that may be incurred by SLR Capital Partners and its affiliates in performing services for the Company and the basis of determining and allocating these costs, and concluded that the direct and indirect costs, including the allocation of such costs, are reasonable; |
• | possible economies of scale arising from the Company’s size and/or anticipated growth, and the extent to which such economies of scale are reflected in the advisory fees charged by SLR Capital Partners to the Company, and concluded that some economies of scale may be possible in the future; |
• | other possible benefits to SLR Capital Partners and its affiliates arising from their relationships with the Company, and concluded that all such other benefits were not material to SLR Capital Partners and its affiliates; and |
• | possible alternative fee structures or bases for determining fees, and concluded that the Company’s current fee structure and bases for determining fees are satisfactory. |
Item 14. |
Principal Accountant Fees and Services |
Fiscal Year Ended December 31, 2023 |
Fiscal Year Ended December 31, 2022 |
|||||||
Audit Fees |
$ | 803.0 | $ | 828.1 | ||||
Audit-Related Fees |
— | — | ||||||
Tax Fees |
186.6 | 166.3 | ||||||
All Other Fees |
— | 20.0 | ||||||
Total Fees: |
$ | 989.6 | $ | 1,014.4 |
Item 15. |
Exhibit and Financial Statement Schedules |
Page |
||||
107 | ||||
108 | ||||
111 | ||||
112 | ||||
113 | ||||
114 | ||||
115 | ||||
136 |
(1) | Previously filed in connection with SLR Investment Corp.’s registration statement on Form N-2 Pre-Effective Amendment No. 7 (File No. 333-148734) filed on January 7, 2010. |
(2) | Previously filed in connection with SLR Investment Corp.’s registration statement on Form N-2 (File No 333-148734) filed on February 9, 2010. |
(3) | Previously filed in connection with SLR Investment Corp.’s report on Form 8-K filed on November 29, 2010. |
(4) | Previously filed in connection with SLR Senior Investment Corp.’s report on Form 8-K (File No. 814-00849) filed on August 31, 2011. |
(5) | Previously filed in connection with SLR Investment Corp.’s registration statement on Form N-2 Post-Effective Amendment No. 6 (File No. 333-172968) filed on November 16, 2012. |
(6) | Previously filed in connection with SLR Investment Corp.’s registration statement on Form N-2 Post-Effective Amendment No. 10 (File No. 333-172968) filed on November 12, 2013. |
(7) | Previously filed in connection with SLR Investment Corp.’s report on Form 10-K filed on February 25, 2014. |
(8) | Previously filed in connection with SLR Investment Corp.’s registration statement on Form N-2 Post-Effective Amendment No. 5 (File No. 333-194870) filed on November 22, 2017. |
(9) | Previously filed in connection with SLR Investment Corp.’s report on Form 10-Q filed on August 6, 2018. |
(10) | Previously filed in connection with SLR Investment Corp.’s report on Form 10-K filed on February 20, 2020. |
(11) | Previously filed in connection with SLR Senior Investment Corp.’s report on Form 10-Q (File No. 814-00849) filed on May 7, 2020. |
(12) | Previously filed in connection with SLR Investment Corp.’s report on Form 10-K filed on February 24, 2021. |
(13) | Previously filed in connection with SLR Investment Corp.’s report on Form 8-K filed on February 25, 2021. |
(14) | Previously filed in connection with SLR Investment Corp.’s report on Form 8-K filed on December 1, 2021. |
(15) | Previously filed in connection with SLR Investment Corp.’s report on Form 8-K filed on January 3, 2022. |
(16) | Previously filed in connection with SLR Investment Corp.’s report on Form 8-K filed on January 12, 2022. |
(17) | Previously filed in connection with SLR Investment Corp.’s report on Form 10-K filed on March 1, 2022. |
(18) | Previously filed in connection with SLR Investment Corp.’s report on Form 8-K filed on April 1, 2022. |
(19) | Previously filed in connection with SLR Investment Corp.’s report on Form 8-K filed on October 12, 2022. |
(20) | Previously filed in connection with SLR Investment Corp.’s report on Form 10-K filed on February 28, 2023. |
(21) | Previously filed in connection with SLR Investment Corp.’s report on Form 8-K filed on August 30, 2023. |
* | Filed herewith. |
Item 16. |
Form 10-K Summary |
SLR INVESTMENT CORP. |
||||||||
By: | / S / MICHAEL S. GROSS |
/ S / BRUCE J. SPOHLER | ||||||
Michael S. Gross Co-Chief Executive Officer, President, Chairman of the Board and DirectorDate: February 27, 2024 |
Bruce J. Spohler Co-Chief Executive Officer, Chief Operating Officer and DirectorDate: February 27, 2024 |
Date |
Signature |
Title | ||
February 27, 2024 | / S / MICHAEL S. GROSS Michael S. Gross |
Co-Chief Executive Officer, President, Chairman of the Board and Director (Principal Executive Officer) | ||
February 27, 2024 | / S / BRUCE J. SPOHLER Bruce J. Spohler |
Co-Chief Executive Officer, Chief Operating Officer and Director (Principal Executive Officer) | ||
February 27, 2024 | / S / STEVEN HOCHBERG Steven Hochberg |
Director | ||
February 27, 2024 | / S / DAVID S. WACHTER David S. Wachter |
Director | ||
February 27, 2024 | / S / LEONARD A. POTTER Leonard A. Potter |
Director | ||
February 27, 2024 | / S / ANDREA C. ROBERTS Andrea C. Roberts |
Director | ||
February 27, 2024 | / S / SHIRAZ Y. KAJEE Shiraz Y. Kajee |
Chief Financial Officer (Principal Financial Officer) |
Exhibit 21.1
Subsidiaries of SLR Investment Corp.
The following list sets forth our consolidated subsidiaries, the state or country under whose laws the subsidiaries are organized, and the percentage of voting securities or membership interests owned by us in each such subsidiary:
NEFCORP LLC (Delaware) 100%
NEFPASS LLC (Delaware) 100%
ESP SSC Corporation (Delaware) 100%
SUNS SPV LLC (Delaware) 100%
The subsidiaries listed above are consolidated for financial reporting purposes. We may also be deemed to control certain portfolio companies.
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statement on Form N-2 of SLR Investment Corp. of our report dated February 27, 2024, with respect to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in the annual report on Form 10-K of SLR Investment Corp. for the year ended December 31, 2023, and to the use of our report dated February 27, 2024 on the senior securities table included herein as an exhibit to the Form 10-K. We also consent to the reference to our firm under the heading Controls and Procedures in the Form 10-K.
/s/ KPMG LLP
New York, New York
February 27, 2024
Exhibit 23.2
CONSENT OF INDEPENDENT AUDITOR
SLR Investment Corp.
New York, New York
We consent to the incorporation by reference in the Registration Statement (No. 333-255662) on Form N-2 of SLR Investment Corp. of our report dated February 9, 2024, relating to the consolidated financial statements of KBH Topco, LLC, appearing in this Annual Report on Form 10-K of SLR Investment Corp. dated February 27, 2024.
/s/ FGMK, LLC
Bannockburn, Illinois
February 27, 2024
Exhibit 23.3
Consent of Independent Auditor
We hereby consent to the incorporation by reference of our report dated February 14, 2024 on the consolidated financial statements of NEF Holdings, LLC and Subsidiaries, which report appears in the annual report on Form 10-K of SLR Investment Corp. dated February 27, 2024, in the Registration Statement on Form N-2 (No. 333-255662) of SLR Investment Corp.
/s/ Baker Tilly US, LLP
Philadelphia, Pennsylvania
February 27, 2024
Exhibit 23.4
Consent of Independent Auditor
We hereby consent to the incorporation by reference of our report dated February 14, 2024 on the consolidated financial statements of Crystal Financial LLC, which report appears in the annual report on Form 10-K of SLR Investment Corp. dated February 27, 2024, in the Registration Statement on Form N-2 (No. 333-255662) of SLR Investment Corp.
/s/ Baker Tilly US, LLP
Philadelphia, Pennsylvania
February 27, 2024
Exhibit 23.5
Consent of Independent Auditor
We hereby consent to the incorporation by reference of our report dated February 15, 2024 on the consolidated financial statements of Gemino Healthcare Finance, LLC, which report appears in the annual report on Form 10-K of SLR Investment Corp. dated February 27, 2024, in the Registration Statement on Form N-2 (No. 333-255662) of SLR Investment Corp.
/s/ Baker Tilly US, LLP
Philadelphia, Pennsylvania
February 27, 2024
Exhibit 23.6
Consent of Independent Auditor
We consent to the incorporation by reference in the Registration Statement (No. 333-255662) on Form N-2 of SLR Investment Corp. of our report dated February 23, 2024, relating to the consolidated financial statements of North Mill Holdco LLC and Subsidiaries, appearing in this Annual Report on Form 10-K of SLR Investment Corp. for the year ended December 31, 2023.
/s/ RSM US LLP
Philadelphia, Pennsylvania
February 27, 2024
1
Exhibit 31.1
Certification Pursuant to Section 302
Certification of Co-Chief Executive Officer
I, Michael S. Gross, certify that:
1. I have reviewed this annual report on Form 10-K of SLR Investment Corp.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Dated this 27th day of February 2024.
By: | /s/ MICHAEL S. GROSS | |
Michael S. Gross Co-Chief Executive Officer |
Exhibit 31.2
Certification Pursuant to Section 302
Certification of Co-Chief Executive Officer
I, Bruce J. Spohler, certify that:
1. I have reviewed this annual report on Form 10-K of SLR Investment Corp.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Dated this 27th day of February 2024.
By: | /s/ BRUCE J. SPOHLER | |
Bruce J. Spohler Co-Chief Executive Officer |
Exhibit 31.3
Certification Pursuant to Section 302
Certification of Chief Financial Officer
I, Shiraz Y. Kajee, certify that:
1. I have reviewed this annual report on Form 10-K of SLR Investment Corp.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Dated this 27th day of February 2024.
By: | /s/ SHIRAZ Y. KAJEE | |
Shiraz Y. Kajee Chief Financial Officer |
Exhibit 32.1
Certification of Co-Chief Executive Officer
Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
In connection with the Annual Report on Form 10-K for the year ended December 31, 2023 (the Report) of SLR Investment Corp. (the Registrant), as filed with the Securities and Exchange Commission on the date hereof, I, Michael S. Gross, the Co-Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
/s/ MICHAEL S. GROSS | ||
Name: | Michael S. Gross | |
Date: | February 27, 2024 |
Exhibit 32.2
Certification of Co-Chief Executive Officer
Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
In connection with the Annual Report on Form 10-K for the year ended December 31, 2023 (the Report) of SLR Investment Corp. (the Registrant), as filed with the Securities and Exchange Commission on the date hereof, I, Bruce J. Spohler, the Co-Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
/s/ BRUCE J. SPOHLER | ||
Name: | Bruce J. Spohler | |
Date: | February 27, 2024 |
Exhibit 32.3
Certification of Chief Financial Officer
Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
In connection with the Annual Report on Form 10-K for the year ended December 31, 2023 (the Report) of SLR Investment Corp. (the Registrant), as filed with the Securities and Exchange Commission on the date hereof, I, Shiraz Y. Kajee, the Chief Financial Officer of the Registrant, hereby certify, to the best of my knowledge, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
/s/ SHIRAZ Y. KAJEE | ||
Name: | Shiraz Y. Kajee | |
Date: | February 27, 2024 |
Exhibit 97.1
SLR INVESTMENT CORP.
CLAWBACK POLICY
EFFECTIVE NOVEMBER 6, 2023
1. | Purpose. The purpose of this SLR Investment Corp. (the Company) Clawback Policy (this Policy) is to enable the Company to recover Erroneously Awarded Compensation from Covered Executive Officers in the event that the Company is required to prepare an Accounting Restatement. The Company, as an externally-managed business development company under the Investment Company Act of 1940, as amended, currently neither pays nor has any plans to pay or otherwise award Incentive-Based Compensation to Covered Executive Officers, but nevertheless has designed and implemented this Policy to comply with, and shall be interpreted to be consistent with, Section 10D of the Securities Exchange Act of 1934, as amended (the Exchange Act), Rule 10D-1 promulgated under the Exchange Act (Rule 10D-1) and Listing Rule 5608 of the corporate governance rules of The Nasdaq Stock Market (Nasdaq) (the Listing Standards). The Listing Standards require the Company to adopt this Policy regardless of whether Incentive-Based Compensation is paid or otherwise awarded by the Company to Covered Executive Officers. Unless otherwise defined in this Policy, capitalized terms shall have the meaning ascribed to such terms in Section 2. |
2. | Definitions. As used in this Policy, the following capitalized terms shall have the meanings set forth below. |
a. | Accounting Restatement means an accounting restatement of the Companys financial statements due to the Companys material noncompliance with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements (i.e., a Big R restatement), or to correct an error that is not material to the previously issued financial statements, but that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (i.e., a little r restatement). |
b. | Accounting Restatement Date means the earlier to occur of: (i) the date the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if the Boards action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement and (ii) the date a court, regulator, or other legally authorized body directs the Company to prepare an Accounting Restatement. |
c. | Applicable Period means, with respect to any Accounting Restatement, the three completed fiscal years immediately preceding the date on which the Company is required to prepare an Accounting Restatement, as well as any transition period (that results from a change in the Companys fiscal year) within or immediately following those three completed fiscal years (except that a transition period that comprises a period of at least nine months shall count as a completed fiscal year). |
d. | Board means the board of directors of the Company. |
e. | Code means the U.S. Internal Revenue Code of 1986, as amended. Any reference to a section of the Code or regulation thereunder includes such section or regulation, any valid regulation or other official guidance promulgated under such section, and any comparable provision of any future legislation or regulation amending, supplementing, or superseding such section or regulation. |
f. | Covered Executive Officer means an individual who is currently or previously served as the Companys principal executive officer, principal financial officer, principal accounting officer (or, if there is no such accounting officer, the controller), vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or finance), an officer who performs (or performed) a policy-making function, or any other person who performs (or performed) similar policy-making functions for the Company or is an executive officer of the Company identified pursuant to 17 CFR 229.401(b). An executive officer of the Companys parent or subsidiary is deemed a Covered Executive Officer if the executive officer performs (or performed) such policy making functions for the Company. |
g. | Erroneously Awarded Compensation means, in the event of an Accounting Restatement, the amount of Incentive-Based Compensation previously received that exceeds the amount of Incentive-Based Compensation that otherwise would have been received had it been determined based on the restated amounts in such Accounting Restatement, and must be computed without regard to any taxes paid by the relevant Covered Executive Officer; provided, however, that for Incentive-Based Compensation based on stock price or total stockholder return, where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in an Accounting Restatement: (i) the amount of Erroneously Awarded Compensation must be based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or total stockholder return upon which the Incentive-Based Compensation was received and (ii) the Company must maintain documentation of the determination of that reasonable estimate and provide such documentation to the Stock Exchange. |
h. | Financial Reporting Measure means any measure that is determined and presented in accordance with the accounting principles used in preparing the Companys financial statements and any measure that is derived wholly or in part from such measure. Financial Reporting Measures include, but are not limited to, the following (and any measures derived from the following): the Company stock price; total shareholder return; revenues; net income; operating income; profitability of one or more reportable segments; financial ratios (e.g., accounts receivable turnover and inventory turnover rates); earnings before interest, taxes, depreciation and amortization; funds from operations and adjusted funds from operations; liquidity measures (e.g., working capital, operating cash flow); return measures (e.g., return on invested capital, return on assets); earnings measures (e.g., earnings per share); sales per square foot or same store sales, where sales is subject to an Accounting Restatement; revenue per user, or average revenue per user, where revenue is subject to an Accounting Restatement; cost per employee, where cost is subject to an Accounting Restatement; any of such financial reporting measures relative to a peer group, where the Companys financial reporting measure is subject to an Accounting Restatement; and tax basis income. A Financial Reporting Measure is not required to be presented within the Companys financial statements or included in a filing with the U.S. Securities and Exchange Commission to qualify as a Financial Reporting Measure. |
2
i. | Incentive-Based Compensation means any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure. Incentive-Based Compensation is deemed received for purposes of this Policy in the Companys fiscal period during which the Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even if the payment or grant of such Incentive-Based Compensation occurs after the end of that period. |
3. | Administration. This Policy shall be administered by the Compensation Committee of the Board (the Compensation Committee). For purposes of this Policy, the body charged with administering this Policy shall be referred to herein as the Administrator. The Administrator is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate or advisable for the administration of this Policy, in each case, to the extent permitted under the Listing Standards and in compliance with (or pursuant to an exemption from the application of) Section 409A of the Code. All determinations and decisions made by the Administrator pursuant to the provisions of this Policy shall be final, conclusive and binding on all persons, including the Company, its affiliates, its stockholders and Covered Executive Officers, and need not be uniform with respect to each person covered by this Policy. |
In the administration of this Policy, the Administrator is authorized and directed to consult with the full Board or such other committees of the Board as may be necessary or appropriate as to matters within the scope of such other committees responsibility and authority. Subject to any limitation at applicable law, the Administrator may authorize and empower any officer or employee of the Company to take any and all actions necessary or appropriate to carry out the purpose and intent of this Policy (other than with respect to any recovery under this Policy involving such officer or employee). Any action or inaction by the Administrator with respect to a Covered Executive Officer under this Policy in no way limits the Administrators decision to act or not to act with respect to any other Covered Executive Officer under this Policy or under any similar policy, agreement or arrangement, nor shall any such action or inaction serve as a waiver of any rights the Company may have against any Covered Executive Officer other than as set forth in this Policy.
4. | Application. This Policy applies to all Incentive-Based Compensation received by a person: (a) after beginning service as a Covered Executive Officer; (b) who served as a Covered Executive Officer at any time during the performance period for such Incentive-Based Compensation; (c) while the Company had a listed class of securities on a national securities exchange; and (d) during the Applicable Period. For the avoidance of doubt, Incentive-Based Compensation that is subject to both a Financial Reporting Measure vesting condition and a service-based vesting condition shall be considered received when the relevant Financial Reporting Measure is achieved, even if the Incentive-Based Compensation continues to be subject to the service-based vesting condition. |
5. | Recovery Requirement. In the event of an Accounting Restatement, the Company must recover Erroneously Awarded Compensation reasonably promptly, in amounts determined pursuant to this Policy. The Companys obligation to recover Erroneously Awarded Compensation is not dependent on the filing of restated financial statements. Recovery under this Policy with respect to a Covered Executive Officer shall not require the finding of any misconduct by such Covered Executive Officer or such Covered Executive Officer being found responsible for the accounting error leading to an Accounting Restatement. In the event of an Accounting Restatement, the method for recouping Erroneously Awarded Compensation shall be determined by the Administrator in its sole and absolute discretion, to the extent permitted under the Listing Standards and in compliance with (or pursuant to an exemption from the application of) Section 409A of the Code. |
Recovery may include, without limitation, (i) reimbursement of all or a portion of any incentive compensation award, (ii) cancellation of incentive compensation awards and (iii) any other method authorized by applicable law or contract.
3
The Company is authorized and directed pursuant to this Policy to recover Erroneously Awarded Compensation in compliance with this Policy unless the Compensation Committee has determined that recovery would be impracticable solely for the following limited reasons, and subject to the following procedural and disclosure requirements:
a. | The direct expenses paid to a third party to assist in enforcing this Policy would exceed the amount to be recovered. Before reaching such conclusion, the Administrator must make a reasonable attempt to recover such Erroneously Awarded Compensation, document such reasonable attempt(s) to recover, and provide that documentation to Nasdaq; |
b. | Recovery would violate home country law where that law was adopted prior to November 28, 2022. Before reaching such conclusion, the Administrator must obtain an opinion of home country counsel, acceptable to Nasdaq, that recovery would result in such a violation, and must provide such opinion to Nasdaq; or |
c. | Recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of Section 401(a)(13) or Section 411(a) of the Code. |
6. | Prohibition on Indemnification and Insurance Reimbursement. The Company is prohibited from indemnifying any Covered Executive Officer against the loss of any Erroneously Awarded Compensation. Further, the Company is prohibited from paying or reimbursing a Covered Executive Officer for the cost of purchasing insurance to cover any such loss. The Company is also prohibited from entering into any agreement or arrangement whereby this Policy would not apply or fail to be enforced against a Covered Executive Officer. |
7. | Required Policy-Related Filings. The Company shall file all disclosures with respect to this Policy in accordance with the requirements of the federal securities laws, including disclosures required by U.S. Securities and Exchange Commission filings. A copy of this Policy and any amendments hereto shall be posted on the Companys website and filed as an exhibit to the Companys annual report on Form 10-K. |
8. | Amendment; Termination. The Board may amend this Policy from time to time in its sole and absolute discretion and shall amend this Policy as it deems necessary to reflect the Listing Standards or to comply with (or maintain an exemption from the application of) Section 409A of the Code. The Board may terminate this Policy at any time; provided, that the termination of this Policy would not cause the Company to violate any federal securities laws, rules promulgated by the U.S. Securities and Exchange Commission or the Listing Standards. |
9. | Effective Date. This Policy shall be effective as of November 6, 2023 (the Effective Date). The terms of this Policy shall apply to any Incentive-Based Compensation that is received by Covered Executive Officers on or after the Effective Date, even if such Incentive-Based Compensation was approved, awarded or granted to Covered Executive Officers prior to the Effective Date. |
10. | Other Recovery Obligations; General Rights. The Board intends that this Policy shall be applied to the fullest extent of the law. To the extent that the application of this Policy would provide for recovery of Incentive-Based Compensation that the Company already recovered pursuant to Section 304 of the Sarbanes-Oxley Act or other recovery obligations, any such amount recovered from a Covered Executive Officer will be credited to any recovery required under this Policy in respect of such Covered Executive Officer. |
4
This Policy shall not limit the rights of the Company to take any other actions or pursue other remedies that the Company may deem appropriate under the circumstances and under applicable law, in each case, to the extent permitted under the Listing Standards and in compliance with (or pursuant to an exemption from the application of) Section 409A of the Code.
This Policy is binding and enforceable against all Covered Executive Officers and their beneficiaries, heirs, executors, administrators or other legal representatives.
5
Exhibit 99.1
Crystal Financial LLC
dba SLR Credit Solutions
(A Delaware Limited Liability Company)
Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
Crystal Financial LLC dba SLR Credit Solutions
Index
Years Ended December 31, 2023 and 2022
Page(s) | ||||
Independent Auditors Report |
1-2 | |||
Consolidated Financial Statements |
||||
Consolidated Balance Sheets |
3 | |||
Consolidated Statements of Operations |
4 | |||
Consolidated Statements of Changes in Members Equity |
5 | |||
Consolidated Statements of Cash Flows |
6 | |||
Notes to Consolidated Financial Statements |
719 |
Independent Auditors Report
To the Board of Managers and Member of
Crystal Financial LLC
Opinion
We have audited the consolidated financial statements of Crystal Financial LLC dba SLR Credit Solutions (the Company), which comprise the consolidated balance sheets as of December 31, 2023 and 2022, and the related consolidated statements of operations, changes in members equity and cash flows for the years then ended, and the related notes to the consolidated financial statements.
In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of their operations and their cash flows for the years then ended in accordance with accounting principles generally accepted in the United States of America.
Basis for Opinion
We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditors Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Responsibilities of Management for the Consolidated Financial Statements
Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the consolidated financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Companys ability to continue as a going concern within one year after the date that the financial statements are available to be issued.
Auditors Responsibilities for the Audit of the Consolidated Financial Statements
Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the consolidated financial statements.
1
In performing an audit in accordance with GAAS, we:
| Exercise professional judgment and maintain professional skepticism throughout the audit. |
| Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. |
| Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Companys internal control. Accordingly, no such opinion is expressed. |
| Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the consolidated financial statements. |
| Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Companys ability to continue as a going concern for a reasonable period of time. |
We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings and certain internal control-related matters that we identified during the audit.
Philadelphia, Pennsylvania
February 14, 2024
2
Crystal Financial LLC dba SLR Credit Solutions
Consolidated Balance Sheets
Years Ended December 31, 2023 and 2022
2023 | 2022 | |||||||
Assets: |
||||||||
Cash and cash equivalents |
$ | 4,155,344 | $ | 1,455,691 | ||||
Restricted cash |
14,204,878 | 20,631,283 | ||||||
Loan interest and fees receivable |
3,853,372 | 5,935,984 | ||||||
Loans |
406,553,535 | 439,484,085 | ||||||
Less: Unearned fee income |
(7,437,788 | ) | (7,117,828 | ) | ||||
Allowance for credit losses |
(9,448,619 | ) | (9,130,536 | ) | ||||
|
|
|
|
|||||
Total loans, net |
389,667,128 | 423,235,721 | ||||||
Property and equipment, net |
16,469 | 16,022 | ||||||
Goodwill |
5,156,542 | 5,156,542 | ||||||
Investment in Crystal Financial SBIC LP |
| 2,575,336 | ||||||
Other assets |
21,368,095 | 1,676,876 | ||||||
|
|
|
|
|||||
Total assets |
$ | 438,421,828 | $ | 460,683,455 | ||||
|
|
|
|
|||||
Liabilities: |
||||||||
Revolving credit facility, net |
$ | 215,343,743 | $ | 222,093,034 | ||||
Accrued expenses |
5,872,387 | 3,660,447 | ||||||
Distributions payable |
5,000,000 | 5,000,000 | ||||||
Other liabilities |
6,525,994 | 3,469,397 | ||||||
Collateral held for borrower obligations |
9,783,573 | 17,193,751 | ||||||
|
|
|
|
|||||
Total liabilities |
242,525,697 | 251,416,629 | ||||||
|
|
|
|
|||||
Commitments and Contingencies (see Note 8) |
||||||||
Members equity: |
||||||||
Class A units |
279,191,400 | 279,191,400 | ||||||
Accumulated deficit |
(83,295,269 | ) | (69,924,574 | ) | ||||
|
|
|
|
|||||
Total members equity |
195,896,131 | 209,266,826 | ||||||
|
|
|
|
|||||
Total liabilities and members equity |
$ | 438,421,828 | $ | 460,683,455 | ||||
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
3
Crystal Financial LLC dba SLR Credit Solutions
Consolidated Statements of Operations
Years Ended December 31, 2023 and 2022
2023 | 2022 | |||||||
Net interest income: |
||||||||
Interest income |
$ | 57,823,000 | $ | 35,062,888 | ||||
Interest expense |
20,308,902 | 8,873,508 | ||||||
|
|
|
|
|||||
Net interest income |
37,514,098 | 26,189,380 | ||||||
Provision for credit losses |
17,481,887 | 4,923,481 | ||||||
|
|
|
|
|||||
Net interest income after provision for credit losses |
20,032,211 | 21,265,899 | ||||||
|
|
|
|
|||||
Operating expenses: |
||||||||
Compensation and benefits |
10,517,444 | 6,551,451 | ||||||
Depreciation and amortization |
12,628 | 12,808 | ||||||
General and administrative expenses |
3,008,930 | 1,820,712 | ||||||
|
|
|
|
|||||
Total operating expenses |
13,539,002 | 8,384,971 | ||||||
|
|
|
|
|||||
Other income (loss): |
||||||||
(Loss) from equity method investment |
(22,796 | ) | (4,738,951 | ) | ||||
Realized (loss) on investment in equity securities |
| (620,223 | ) | |||||
|
|
|
|
|||||
Total other income (loss), net |
(22,796 | ) | (5,359,174 | ) | ||||
|
|
|
|
|||||
Realized (loss) gain from foreign currency transactions, net |
69,572 | (121,552 | ) | |||||
Unrealized (loss) gain from foreign currency translations, net |
(64,164 | ) | 120,547 | |||||
|
|
|
|
|||||
Net income |
$ | 6,475,821 | $ | 7,520,749 | ||||
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
4
Crystal Financial LLC dba SLR Credit Solutions
Consolidated Statements of Changes in Members Equity
Years Ended December 31, 2023 and 2022
Class A Units | Accumulated Deficit | Total Members Equity | ||||||||||
Balance, December 31, 2021 |
$ | 279,191,400 | $ | (56,945,323 | ) | $ | 222,246,077 | |||||
Distributions |
| (20,500,000 | ) | (20,500,000 | ) | |||||||
Net income |
| 7,520,749 | 7,520,749 | |||||||||
|
|
|
|
|
|
|||||||
Balance, December 31, 2022 |
279,191,400 | (69,924,574 | ) | 209,266,826 | ||||||||
Cumulative effect of adopting new accounting standard (see Note 2) |
| 153,484 | 153,484 | |||||||||
Distributions |
| (20,000,000 | ) | (20,000,000 | ) | |||||||
Net income |
| 6,475,821 | 6,475,821 | |||||||||
|
|
|
|
|
|
|||||||
Balance, December 31, 2023 |
$ | 279,191,400 | $ | (83,295,269 | ) | $ | 195,896,131 | |||||
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
5
Crystal Financial LLC dba SLR Credit Solutions
Consolidated Statements of Cash Flows
Years Ended December 31, 2023 and 2022
2023 | 2022 | |||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 6,475,821 | $ | 7,520,749 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Provision for credit losses |
17,481,887 | 4,923,481 | ||||||
Accretion of original issue discount |
(869,532 | ) | (369,719 | ) | ||||
Depreciation |
12,628 | 12,808 | ||||||
Amortization of debt issuance costs |
961,665 | 1,134,607 | ||||||
Paid-in-kind interest and fee income |
(925,689 | ) | (895,655 | ) | ||||
Loss from equity method investment |
22,796 | 4,738,951 | ||||||
Unrealized loss (gain) on foreign currency transactions |
64,271 | (122,735 | ) | |||||
Realized loss on foreign currency transactions |
7,709 | 121,141 | ||||||
Write down of amounts classified as other assets |
282,107 | 496,604 | ||||||
Net change in loan interest and fees receivable |
1,706,725 | (2,227,312 | ) | |||||
Net change in other assets |
(2,164,850 | ) | 731,670 | |||||
Net change in unearned fees |
686,448 | 1,514,751 | ||||||
Net change in accrued expenses |
2,213,631 | (1,997,388 | ) | |||||
Net change in other liabilities |
2,957,432 | 2,233,179 | ||||||
|
|
|
|
|||||
Net cash provided by operating activities |
28,913,049 | 17,815,132 | ||||||
|
|
|
|
|||||
Cash flows from investing activities: |
||||||||
Purchases of property and equipment |
(13,075 | ) | (13,922 | ) | ||||
Investment in term loans |
(193,501,153 | ) | (205,566,011 | ) | ||||
Repayment of term loans |
176,268,136 | 73,952,547 | ||||||
Lending on revolving lines of credit, net |
17,836,797 | (24,676,942 | ) | |||||
Distributions received from Crystal Financial SBIC LP |
2,552,540 | 1,027,010 | ||||||
Net change in collateral held for borrower obligations |
(7,410,178 | ) | 3,326,200 | |||||
|
|
|
|
|||||
Net cash used in investing activities |
(4,266,933 | ) | (151,951,118 | ) | ||||
|
|
|
|
|||||
Cash flows from financing activities: |
||||||||
Net borrowings (repayments) on revolving credit facility |
(6,103,274 | ) | 124,200,000 | |||||
Distributions to members |
(20,000,000 | ) | (21,000,000 | ) | ||||
Payment of debt issuance costs |
(2,265,869 | ) | (1,876,134 | ) | ||||
Payment of finance lease obligations |
(3,725 | ) | (4,440 | ) | ||||
|
|
|
|
|||||
Net cash (used in) provided by financing activities |
(28,372,868 | ) | 101,319,426 | |||||
|
|
|
|
|||||
Net change in cash, cash equivalents, and restricted cash |
(3,726,752 | ) | (32,816,560 | ) | ||||
Cash, cash equivalents, and restricted cash at beginning of year |
22,086,974 | 54,903,534 | ||||||
|
|
|
|
|||||
Cash, cash equivalents and restricted cash at end of year |
$ | 18,360,222 | $ | 22,086,974 | ||||
|
|
|
|
|||||
Supplemental disclosure of cash flow information: |
||||||||
Cash paid for interest |
$ | 19,253,926 | $ | 6,744,449 | ||||
|
|
|
|
|||||
Supplemental disclosure of non-cash investing and financing activities: |
||||||||
Use of loan to obtain equity interest in joint venture (see Note 3) |
$ | 17,808,297 | $ | | ||||
Right-of-use assets obtained in exchange for new operating lease liabilities |
$ | 2,818,752 | $ | 1,696,309 | ||||
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
6
Crystal Financial LLC dba SLR Credit Solutions
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
1. | Organization |
Crystal Financial LLC (Crystal Financial or the Company), along with its wholly owned subsidiary, Crystal Financial SPV LLC (Crystal Financial SPV), is a commercial finance company based in Boston, Massachusetts, that primarily originates, underwrites, and manages secured debt to middle market companies within various industries. The Company was formed in the state of Delaware on March 18, 2010. During 2021, the Company executed a dba filing to do business using the name SLR Credit Solutions.
At December 31, 2023 and 2022, SLR Investment Corp. (SLR) owns 100% of the outstanding ownership units of the Company.
2. | Summary of Significant Accounting Policies |
The following is a summary of significant accounting policies adopted by the Company:
Basis of Accounting
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP).
Principles of Consolidation
The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary Crystal Financial SPV. All inter-company investments, accounts and transactions have been eliminated in these consolidated financial statements.
Use of Estimates
The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements as well as the reported amounts of revenues and expenses during the reporting period. Estimates most susceptible to change include the allowance for credit losses and the valuation of intangible assets as determined during impairment testing. Actual results could differ materially from those estimates.
Cash, Cash Equivalents, and Restricted Cash
The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash includes all deposits held at banks. Deposits in excess of amounts insured by the Federal Deposit Insurance Corporation (FDIC) are exposed to loss in the event of nonperformance by the institution. The Company has had cash deposits in excess of the FDIC insurance coverage and has not experienced any losses on such accounts.
Restricted cash consists of interest and fees collected on those loans held within Crystal Financial SPV that serve as collateral against the Companys outstanding line of credit. Upon receipt, these funds are restricted from the Companys access until the fifteenth of the following month. Also included in restricted cash may be funds that serve as collateral against loans outstanding to certain borrowers as well as funds that serve as collateral to outstanding letters of credit
7
Crystal Financial LLC dba SLR Credit Solutions
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
2. | Summary of Significant Accounting Policies continued |
Cash, Cash Equivalents, and Restricted Cash continued
In accordance with Financial Accounting Standards Board (FASB) Accounting Standard Codification (ASC) 230, Statement of Cash Flows, the Company presents the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash in the consolidated statements of cash flows. Accordingly, amounts generally described as restricted cash will be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the consolidated statements of cash flows.
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheet that sum to the total of the same such amounts shown in the consolidated statements of cash flows.
December 31, | ||||||||
2023 | 2022 | |||||||
Cash and cash equivalents |
$ | 4,155,344 | $ | 1,455,691 | ||||
Restricted cash |
14,204,878 | 20,631,283 | ||||||
|
|
|
|
|||||
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows |
$ | 18,360,222 | $ | 22,086,974 | ||||
|
|
|
|
Loans
The Company typically classifies all loans as held to maturity. Loans funded by the Company are recorded at the amount of unpaid principal, net of unearned fees, discounts and the allowance for credit losses in the Companys consolidated balance sheets.
Interest income is recorded on the accrual basis in accordance with the terms of the respective loan. Generally, interest is not accrued on loans with interest or principal payments 90 days or greater past due or on other loans when management believes collection is doubtful. Loans considered impaired, as defined below, are non-accruing. When a loan is placed on nonaccrual status, all interest previously accrued, but not collected, is reversed against current interest income and all future proceeds received will generally be applied against principal or interest, in the judgment of management. Interest on loans classified as nonaccrual is accounted for on the cash basis or cost-recovery method, until qualifying for return to accrual status. Loans are generally returned to accrual status when all of the principal and interest amounts contractually due are brought current and future payments are reasonably assured. There were no loans on nonaccrual status at December 31, 2023 and one loan on nonaccrual status at December 31, 2022. The loan on nonaccrual status at December 31, 2022 is the same loan classified as Criticized, as defined by the Companys Loan Loss Policy, in the Allowance for Credit Losses footnote (see Note 3).
Allowance for Credit Losses
Effective January 1, 2023, the Company adopted Accounting Standards Update (ASU) 2016-13, Financial Instruments-Credit Losses (ASC 326): Measurement of Credit Losses on Financial Instruments, as amended (ASU 2016-13). ASU 2016-13 replaces the incurred loss methodology with an expected loss methodology, referred to as the current expected credit loss (CECL) methodology. The Company adopted ASU 2016-13 using the modified retrospective method. Results for 2023 are presented in accordance with ASU 2016-13 while prior period amounts continue to be reported in accordance with previously applicable accounting standards. The Company recorded a net increase to members equity of $153,484 as of the adoption date for the cumulative effect of adopting ASU 2016-13.
8
Crystal Financial LLC dba SLR Credit Solutions
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
2. | Summary of Significant Accounting Policies continued |
Allowance for Credit Losses continued
The allowance for credit losses reflects our current estimate of potential losses inherent in the loan portfolio at year end. Changes to the allowance are recognized through net income in the consolidated statements of operations. While ASU 2016-13 does not require any particular method for determining the allowance for credit losses, it does specify that the reserve should be based on relevant information about past events, including, but not limited to, historical loss rates, current portfolio composition, market conditions, and reasonable and supportable forecasts for the duration of each respective loan.
The Companys portfolio consists of both revolvers and term loans. The loans are further classified as either Pass or Criticized. These classifications are a direct result of the internal risk ratings assigned to each loan during regular loan review meetings. All loans in the Companys portfolio with similar risk characteristics are individually reviewed when determining the risk rating for each loan. Internal risk ratings are derived upon consideration of various factors related to both the borrower and the borrowers facility, with those factors related to the borrowers facility being the key determinant of the overall risk rating. A lower internal risk rating represents less risk while a higher internal risk rating represents more risk. Risk factors of the borrower that are considered include asset and earnings quality, historical and projected financial performance, borrowing liquidity and/or access to capital. Risk factors of the facility that are considered include collateral coverage and the facilitys position within the overall capital structure. Loans rated below a certain threshold are classified as Pass and loans rated above a certain threshold are classified as Criticized.
The allowance for credit losses on loans classified as Pass is assessed using historical loss data, the expected weighted-average remaining maturity of the portfolio, and a qualitative economic view. The Company also reviews trends in the weighted-average risk rating of the portfolio in order to determine whether risk characteristics of the current portfolio, relative to the historical portfolio, could signal a greater risk of expected loss.
In accordance with CECL, the Companys allowance for credit losses may be adjusted to reflect managements assessment of current and future economic conditions that may impact the performance of the borrowers. The assessment includes, but is not limited to, unemployment rates, interest rates, expectations of inflation and/or recession, as well as various other macroeconomic factors that could impact the likelihood of potential credit losses during a loans anticipated term.
Specific allowances for credit losses are generally applied to loans classified as Criticized. Generally, these loans are deemed to be impaired and are typically measured based on a comparison of the recorded carrying value of the loan to the present value of the loans expected cash flow using the loans effective interest rate, the loans estimated market price, or the estimated fair value of the underlying collateral, if the loan is collateral-dependent. Loans are charged off against the allowance at the earlier of either the substantial completion of the liquidation of assets securing the loan, or when senior management deems the loan to be permanently impaired.
A loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due in accordance with the contractual terms of the loan agreement. All loans are individually evaluated for impairment according to the Companys normal loan review process, including overall credit evaluation, nonaccrual status and payment experience. Loans identified as impaired are further evaluated to determine the estimated extent of impairment.
9
Crystal Financial LLC dba SLR Credit Solutions
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
2. | Summary of Significant Accounting Policies continued |
Goodwill
The Company typically assesses goodwill for impairment at the end of each fiscal year using a qualitative assessment.
Goodwill recognized in business combinations is assigned to the reporting units that are expected to benefit from the combination as of the acquisition date. Goodwill is not amortized; rather goodwill is tested annually for impairment or more frequently upon the occurrence of certain events or substantive changes in circumstances. The Company has elected to perform a qualitative assessment to determine if an impairment is more likely than not to have occurred. If the conclusion is supported that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then the Company would not need to perform a quantitative impairment test. If the conclusion cannot be supported, or if the Company does not elect to do the qualitative assessment, then the Company will perform a quantitative assessment. If a quantitative goodwill impairment assessment is performed, the Company utilizes a combination of market and income valuation approaches. If the fair value of a reporting unit is less than its carrying value, an impairment loss is recorded to the extent that the fair value of the reporting unit is less than its carrying value. No impairment of goodwill resulted from the annual impairment testing in 2023 or 2022.
Debt Issuance Costs
Debt issuance costs represent fees and other direct incremental costs incurred in connection with the Companys borrowings against its revolving credit facility (see Note 5). These amounts are amortized using the straight-line method into earnings as interest expense ratably over the contractual term of the facility. Net unamortized debt issuance costs totaled $3,534,603 and $2,232,090 at December 31, 2023 and 2022 and are recorded as a direct deduction in the carrying amount of the revolving credit facility on the accompanying consolidated balance sheets.
Fee Income Recognition
Certain loans in the Companys portfolio have been issued at a discount. Income related to the accretion of these discounts totaled $869,532 and $369,719 during the years ended December 31, 2023 and 2022, respectively.
Nonrefundable loan fees and costs associated with the origination or purchase of loans are deferred and included in loans, net, in the consolidated balance sheets. These commitment fees, as well as certain other fees charged to borrowers, such as amendment and prepayment fees, are recorded in interest income, after receipt, over the remaining life of the loan using a method which approximates the interest method. Unused line fees are recorded in interest income when received. Unamortized fees totaling $7,437,788 and $7,117,828 are recorded as unearned fee income on the accompanying consolidated balance sheets at December 31, 2023 and 2022, respectively.
Property and Equipment
Property and equipment are carried at cost. Such items are depreciated or amortized on a straight-line basis over the following useful lives:
Furniture and fixtures | 5-7 years | |
Computer equipment | 3-5 years | |
Computer software | 3 years | |
Leasehold improvements | shorter of remaining lease term or the assets estimated useful life |
10
Crystal Financial LLC dba SLR Credit Solutions
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
2. | Summary of Significant Accounting Policies continued |
Lease Accounting
The Company adopted Accounting Standards Update 2016-02, Leases (ASC 842) (ASU 2016-02) effective January 1, 2022 using the modified retrospective approach. The Company leases office space and equipment under various operating and finance lease agreements. The leases have varying terms and may include escalation clauses or lease concessions. Lease expense for operating leases is recognized on a straight-line basis over the lease term. Depreciation expense for finance leases is recognized over either the useful life of the asset or the lease term based on the terms of the lease agreement and is recorded as a component of depreciation and amortization on the consolidated statements of operations.
The Company recognizes a right-of-use asset and a lease liability in the consolidated balance sheets as of December 31, 2023 and 2022 for those leases classified as operating or finance leases with a term in excess of twelve months. The lease term is determined at lease commencement and includes any noncancellable period for which the Company has the right to use the underlying asset together with any periods covered by an option to extend the lease, if it is reasonably certain that the Company will exercise the option to extend. The initial determination of the lease liability is calculated as the net present value of the lease payments not yet paid. The discount rate used to determine the present value is the rate implicit in the lease, if present, or if not present, the Companys incremental borrowing rate. The incremental borrowing rate is defined as the rate that reflects the amount of interest that would have to be paid to borrow funds on a collateralized basis over a similar term to the lease in a similar economic environment. Lease payments include fixed payments less any lease incentives available to the Company plus variable lease payments (see Note 5). During 2023, the right-of-use asset and lease liability were increased by $2,818,752 as a result of a lease modification and extension.
Investment in Equity Securities
The Company accounts for equity securities in accordance with the guidance set forth in Financial Instruments (ASC 825). The Company obtained an equity interest in an entity formed to acquire certain assets of a former borrower during the year ended December 31, 2023 (see Note 3) and elected the measurement alternative set forth in FASB ASC 321-10. The measurement alternative is optional and may be applied to equity securities without a readily determinable fair value. In accordance with the measurement alternative, the interest is recorded at cost, less impairment, plus or minus any changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. No impairment or price changes were recorded on the equity interest during the year ended December 31, 2023. The Company recorded a realized loss on LLC units outstanding totaling $620,223 during the year ended December 31, 2022.
Foreign Currency
The functional currency of the Company is the US Dollar. At December 31, 2023, the Company has two loans denominated in foreign currency in its portfolio. The Company had one loan denominated in a foreign currency in its portfolio at December 31, 2022. The Company also has the ability to borrow foreign currency denominated funds under its revolving line of credit (see Note 5). Gains and losses arising from exchange rate fluctuations on transactions denominated in currencies other than the US Dollar are included in earnings as incurred. The Company recorded unrealized losses on foreign currency translations totaling $64,164 during the year ended December 31, 2023 and unrealized gains on foreign currency translations totaling $120,547 during the year ended December 31, 2022. Realized gains totaling $69,572 and realized losses totaling $121,552 were recorded during the years ended December 31, 2023 and December 31, 2022, respectively.
Distributions
Distributions to members are recorded as of the date of declaration and are approved by the Companys Board of Managers. Distributions totaling $5,000,000 were declared by the Company at both December 31, 2023 and 2022 but were not paid until the following year.
11
Crystal Financial LLC dba SLR Credit Solutions
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
2. | Summary of Significant Accounting Policies continued |
Income Taxes
The Company is a single member LLC treated as a disregarded entity for tax purposes. The sole member of Crystal Financial is individually liable for the taxes, if any.
The Company applies the provisions set forth in Accounting for Uncertainty in Income Taxes (ASC 740-10). ASC 740-10 provides a comprehensive model for the recognition, measurement and disclosure of uncertain income tax positions. The Company recognizes the tax effect of certain tax positions when it is more likely than not that the tax position will be sustained upon examination, based solely on the technical merits of the tax position. As of December 31, 2023, the Company does not have any uncertain tax positions that meet the recognition or measurement criteria of ASC 740-10.
As a disregarded entity, the Company has no obligation to file a U.S. federal return for tax periods beginning after July 28, 2016, the date the Company became a disregarded entity for tax purposes. The Company does however continue to file certain state tax returns. As of December 31, 2023, the Company is subject to examination by various state tax authorities for tax years beginning after December 31, 2019.
Recently Issued Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (ASU 2020-04). The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 (ASU 2022-06). ASU 2022-06 deferred the sunset date of ASU 2020-04 to December 31, 2024. The Company has been successful in modifying outstanding loan receivable agreements and its outstanding debt facility in order to replace references to the London Inter-Bank Offered Rate (LIBOR) with the Secured Overnight Financing Rate (SOFR) or another alternative reference rate. Application of this pronouncement has not had a material impact on the Companys consolidated financial statements taken as a whole.
3. | Allowance for Credit Losses |
There are no individually evaluated loans and no interest or principal payments outstanding as of December 31, 2023. At December 31, 2022, one loan with an aggregate principal balance outstanding of $800,000, was deemed to be impaired. The loan was fully reserved for at December 31, 2022. Although not being accrued for at December 31, 2022, interest on the impaired loan was paid-in-kind and therefore there are no interest payments due at December 31, 2022.
During 2023, the Company placed a loan with outstanding principal of $37,232,381 on non-accrual. The loan was restructured and the Company used $17,808,297 of the outstanding loan balance to purchase an equity ownership in an entity formed to acquire certain assets of the borrower during the bankruptcy process. After applying cash repayments received, the remaining loan balance was written-off in accordance with ASU 2016-13. The equity ownership is deemed to be a variable interest entity of the Company, however it is not subject to consolidation (see Note 9) and is recorded as a component of other assets on the accompanying consolidated balance sheet as of December 31, 2023.
Depending on the assigned internal risk rating, loans are classified as either Pass or Criticized. Generally, once a loan is classified as Criticized, the loan is individually evaluated and a specific reserve analysis is required. There are no loans classified as Criticized at December 31, 2023. One loan, totaling $800,000 is classified as Criticized at December 31, 2022.
12
Crystal Financial LLC dba SLR Credit Solutions
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
3. | Allowance for Credit Losses continued |
The Company also maintains an allowance on unfunded revolver and delayed draw term loan commitments. At December 31, 2023 and 2022, an allowance of $516,768 and $422,834, respectively, was recorded relating to these commitments. This amount is recorded as a component of other liabilities on the Companys consolidated balance sheets with changes recorded in the provision for credit losses on the Companys consolidated statements of operations. The methodology for determining the allowance for unfunded revolver and delayed draw term loan commitments is consistent with the methodology used for determining the allowance for credit losses, with the exception that only the portion of the outstanding commitment expected to be drawn is applied against the unfunded commitments.
The summary of changes in the allowance for credit losses relating to funded commitments for the years ended December 31, 2023 and 2022 is as follows:
Year Ended December 31, 2023 | ||||||||||||
Revolvers | Term Loans | Total | ||||||||||
Allowance for credit losses: |
||||||||||||
Beginning balance, prior to adoption of ASU 2016-13 |
$ | 629,962 | $ | 8,500,574 | $ | 9,130,536 | ||||||
Impact of adopting ASU 2016-13 |
(16,684 | ) | (136,800 | ) | (153,484 | ) | ||||||
Provision for credit losses |
43,311 | 17,344,643 | 17,387,954 | |||||||||
Loans charged-off |
| (16,916,387 | ) | (16,916,387 | ) | |||||||
|
|
|
|
|
|
|||||||
Ending allowance for credit losses |
$ | 656,589 | $ | 8,792,030 | $ | 9,448,619 | ||||||
|
|
|
|
|
|
|||||||
Year Ended December 31, 2022 | ||||||||||||
Revolvers | Term Loans | Total | ||||||||||
Allowance for credit losses: |
||||||||||||
Beginning balance, |
$ | 79,186 | $ | 7,752,756 | $ | 7,831,942 | ||||||
Provision for credit losses |
550,776 | 4,428,489 | 4,979,265 | |||||||||
Loans charged-off |
| (3,680,671 | ) | (3,680,671 | ) | |||||||
|
|
|
|
|
|
|||||||
Ending allowance for credit losses |
$ | 629,962 | $ | 8,500,574 | $ | 9,130,536 | ||||||
|
|
|
|
|
|
The Companys primary credit quality indicator is its internal risk ratings, which are used to determine whether a loan should be classified as Pass or Criticized. The following table presents the net book value of the Companys loan portfolio as of December 31, 2023, by year of origination, loan type, and risk classification.
13
Crystal Financial LLC dba SLR Credit Solutions
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
3. | Allowance for Credit Losses continued |
December 31, 2023 |
||||||||||||||||||||||||
Net Book Value of Loans Receivable by Year of Origination | ||||||||||||||||||||||||
2023 | 2022 | 2021 | Prior | Revolving Loans Amortized Cost Basis |
Total | |||||||||||||||||||
Revolvers |
||||||||||||||||||||||||
Pass |
$ | | $ | | $ | | $ | | $ | 26,058,783 | $ | 26,058,783 | ||||||||||||
Criticized |
| | | | | | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total revolvers |
| | | | 26,058,783 | 26,058,783 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Term loans |
||||||||||||||||||||||||
Pass |
168,134,079 | 90,866,630 | 48,117,243 | 65,939,012 | | 373,056,964 | ||||||||||||||||||
Criticized |
| | | | | | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total term loans |
168,134,079 | 90,866,630 | 48,117,243 | 65,939,012 | | 373,056,964 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total loans receivable |
$ | 168,134,079 | $ | 90,866,630 | $ | 48,117,243 | $ | 65,939,012 | $ | 26,058,783 | 399,115,747 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Allowance for credit losses |
(9,448,619 | ) | ||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Loans receivable, net |
$ | 389,667,128 | ||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Loans charged-off |
$ | | $ | | $ | 16,916,387 | $ | | $ | | $ | 16,916,387 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
4. | Property and Equipment |
The cost basis of the Companys property and equipment as well as the accumulated depreciation at December 31, 2023 and 2022, are as follows:
December 31, | ||||||||
2023 | 2022 | |||||||
Furniture and fixtures |
$ | 26,954 | $ | 26,954 | ||||
Computer equipment |
232,272 | 223,675 | ||||||
Computer software |
20,846 | 20,629 | ||||||
|
|
|
|
|||||
$280,072 | $271,258 | |||||||
Less: Accumulated depreciation |
(263,603 | ) | (255,236 | ) | ||||
|
|
|
|
|||||
$16,469 | $16,022 | |||||||
|
|
|
|
Finance lease assets totaling $25,907 and $17,310 are included as a component of computer equipment in the above schedule at December 31, 2023 and 2022, respectively.
Depreciation expense of $12,628 and $12,808 was recognized during the years ended December 31, 2023 and 2022.
14
Crystal Financial LLC dba SLR Credit Solutions
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
5. | Debt Obligations and Financings |
Revolving Credit Facility
On May 12, 2011, the Company entered into a Loan Financing and Servicing Agreement (the Credit Agreement) in the form of a revolving credit facility.
The Company has the ability to borrow funds denominated in certain foreign currencies under the facility. The maximum amount available to be borrowed in foreign denominated currencies is the US Dollar equivalent of $120,000,000. During 2023 and 2022, the Company incurred fees and expenses totaling $2,264,178 and $1,876,134 in connection with certain amendments to the credit facility. These costs were deferred and are being amortized on a straight-line basis over the contractual term of the Credit Agreement as an adjustment to interest expense.
At December 31, 2023, the amount available to be borrowed under the facility is the lesser of (a) $300,000,000 or (b) the amount calculated and available per the Borrowing Base, as defined in the amended Credit Agreement. Borrowings on the facility bear interest at a rate of 2.95% plus the Lenders cost of funds, as defined in the Credit Agreement. The applicable cost of funds varies depending on the currency in which the funds are borrowed. At December 31, 2023, the effective rates were between 8.29% and 8.42%. The Company also pays an undrawn fee on unfunded commitments and an administrative agent fee.
The revolving credit facility is comprised of the following at December 31, 2023 and 2022:
December 31, | ||||||||
2023 | 2022 | |||||||
Principal borrowings |
$ | 218,878,346 | $ | 224,325,124 | ||||
Unamortized debt issuance costs |
(3,534,603 | ) | (2,232,090 | ) | ||||
|
|
|
|
|||||
Revolving credit facility, net |
$ | 215,343,743 | $ | 222,093,034 | ||||
|
|
|
|
The credit facility terminates on the earlier of August 15, 2027 or upon the occurrence of a Facility Termination Event, as defined in the amended Credit Agreement.
Commencing on February 15, 2026 and continuing every three months until the facilitys termination date, the Company may be required to make principal pay-downs on certain amounts outstanding. The amount to be paid down is contingent upon the future amount outstanding as well as the amount of future non-mandatory prepayments made on the credit facility.
Cash, as well as those of the Companys loans that are held within Crystal Financial SPV, serve as collateral against the facility. The Company has made certain customary representations and warranties under the facility, and is required to comply with various covenants, reporting requirements, and other customary requirements for similar credit facilities. The Credit Agreement includes usual and customary events of default for credit facilities of this nature. The Company is in compliance with all covenants at December 31, 2023 and 2022.
15
Crystal Financial LLC dba SLR Credit Solutions
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
5. | Debt Obligations and Financings continued |
Leases
The Company has recorded a right-of-use asset and a lease liability for the Companys operating lease totaling $3,318,438 and $3,306,627, respectively, at December 31, 2023 and $1,081,490 and $1,121,552, respectively, at December 31, 2022. The operating lease right-of-use asset and liability are recorded as a component of other assets and other liabilities on the accompanying consolidated balance sheets. The lease has a weighted average remaining lease term of 6.01 years and a weighted average discount rate of 3.50%.
The cost of the Companys operating lease totaled $657,878 and $666,033 during the years ended December 31, 2023 and December 31, 2022 respectively.
As of December 31, 2023, future minimum lease commitments under the lease include:
Operating Lease | ||||
2024 |
$ | 493,502 | ||
2025 |
597,824 | |||
2026 |
609,624 | |||
2027 |
621,688 | |||
2028 |
677,959 | |||
Thereafter |
690,463 | |||
|
|
|||
Total lease payments |
3,691,060 | |||
Less: interest expense |
(384,433 | ) | ||
|
|
|||
Lease liability balance |
$ | 3,306,627 | ||
|
|
6. | Related Party Activity |
On March 15, 2013, Crystal Financial committed $50,750,000 of capital to Crystal Financial SBIC LP (the Fund) in exchange for a 65.91% limited partner interest. Crystal Financial SBIC LP was established to operate as a small business investment company under the Small Business Investment Company (SBIC) Act. The Fund ceased operations and was dissolved effective December 20, 2023.
Certain of the managing members of the Funds general partner, Crystal SBIC GP LLC (the General Partner), are also members of Crystal Financials management team. Crystal Financial and the General Partner entered into a Services Agreement whereby Crystal Financial provided certain administrative services to the General Partner in exchange for a waiver of the quarterly management fee that it owed to the General Partner.
The Company accounted for its limited partner interest in the Fund as an equity method investment in the accompanying consolidated financial statements (see Note 9). Crystal Financial did not make any contributions to the Fund during 2023 or 2022. Cash distributions from the Fund totaled $2,552,540 and $1,027,010 during 2023 and 2022, respectively. In accordance with the equity method of accounting, the Company was allocated net losses from the Fund totaling $22,796 for the year ended December 31, 2023 and $4,738,951 for the year ended December 31, 2022. These amounts represent the Companys allocation of the Funds net loss in accordance with the Funds Limited Partnership Agreement. Prior to being dissolved, Crystal Financials investment in the Fund was recorded as Investment in Crystal Financial SBIC LP in the accompanying consolidated balance sheets and its share of earnings and losses were recorded as losses from equity method investee on the consolidated statements of operations.
The Company may co-invest with SLR in certain loans and investments. These transactions occur in the normal course of business.
16
Crystal Financial LLC dba SLR Credit Solutions
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
7. | Members Capital |
Crystal Financial has issued limited liability company interests, referred to as Class A Units. Each unit entitles its holder to one vote on all matters submitted to a vote of the members. At December 31, 2023 and 2022, the Company has 280,303 outstanding Class A Units, all of which are owned by SLR.
8. | Commitments and Contingencies |
The Company is party to financial instruments with off-balance sheet risk including unfunded revolver and delayed draw term loan commitments to certain borrowers.
Under the revolving credit and delayed draw term loans, aggregate unfunded commitments total $74,645,250 and $72,109,377 at December 31, 2023 and 2022, respectively. These agreements have fixed expiration dates. The revolving credit agreements typically require payment of a monthly fee equal to a certain percentage times the unused portion of the revolving line of credit. As the unfunded commitments may expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements. The amount of credit that can be extended under each of the revolving credit agreements and delayed draw term loan agreements is typically limited to the borrowers available collateral, which is used in calculating the borrowers borrowing base at the time of a respective draw.
9. | Variable Interest Entity |
In accordance with US GAAP, the Company evaluates (a) whether it holds a variable interest in an entity, (b) whether the entity is a variable interest entity (VIE) and (c) whether the Company is the primary beneficiary of the VIE.
In evaluating whether or not Crystal Financial SBIC LP is a VIE of the Company, it is noted that the Limited Partnership Agreement of Crystal Financial SBIC LP does not permit a simple majority of the limited partners to exercise kick-out rights, and therefore these rights are deemed to not be substantive. Accordingly, Crystal Financial SBIC LP is deemed to be a VIE. In assessing whether or not the VIE should be consolidated, it was determined that substantially all of the VIEs activities are not conducted on behalf of Crystal Financial or its de facto agents. Accordingly, the Company does not consolidate Crystal Financial SBIC LP in the accompanying consolidated financial statements.
As part of a loan restructuring (see Note 3), the Company obtained a 10.2% ownership interest in a joint venture operating company during 2023. It was determined that the Company has a variable interest in the joint venture. The Company does not have the individual power to direct the joint ventures activities and it does not share disproportionally in the obligation to absorb potential losses or the right to receive expected returns of the joint venture. Accordingly, it was determined that the Company is not the primary beneficiary and the VIE is not consolidated in the accompanying consolidated financial statements.
The following table sets forth the information with respect to the unconsolidated VIEs in which the Company holds a variable interest as of December 31, 2023 and 2022.
December 31 , 2023 | December 31 , 2022 | |||||||
Equity interest included in Other assets on the consolidated balance sheets |
$ | 17,808,297 | $ | | ||||
Equity interest included in Investment in Crystal Financial SBIC LP on the consolidated balance sheets |
| 2,575,336 | ||||||
Maximum risk of loss (1) |
17,808,297 | 24,458,650 |
(1) | includes the equity investment the Company has made, or could be required to make |
17
Crystal Financial LLC dba SLR Credit Solutions
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
10. | Fair Value of Financial Instruments |
Fair Value Measurements (Topic 820) establishes a three-level hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows:
Level 1- inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2- inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
Level 3- inputs to the valuation methodology are unobservable and significant to the fair value measurement.
A financial instruments categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
There were no financial assets or financial liabilities measured at fair value on a recurring basis at December 31, 2023 or December 31, 2022.
Financial instruments that are not recorded at fair value on a recurring basis consist of cash, restricted cash, interest receivable, loans receivable, investment in Crystal Financial SBIC LP, collateral held for borrower obligations and the revolving credit facility. Due to the short-term nature of the Companys cash, restricted cash, interest receivable, and collateral held for borrower obligations, the carrying value approximates fair value.
The Companys loans receivable are recorded at outstanding principal, net of any deferred fees and costs, unamortized purchase discounts and the allowance for credit losses. If the Company elected the fair value option, the estimated fair value of the Companys loans receivable would be derived using among other things, a discounted cash flow methodology that considers various factors including the type of loan and related collateral, current market yields for similar debt investments, estimated cash flows, as well as a discount rate that reflects the Companys assessment of risk inherent in the cash flow estimates.
If the Company elected the fair value option, the estimated fair value of the Companys investment in Crystal Financial SBIC LP at December 31, 2022 and the revolving credit facility at December 31, 2023 and 2022, would approximate the carrying value. The fair value is estimated based on consideration of current market interest rates for similar debt instruments.
18
Crystal Financial LLC dba SLR Credit Solutions
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
10. | Fair Value of Financial Instruments continued |
The following table presents the carrying amounts, estimated fair values, and placement in the fair value hierarchy of the Companys long-term financial instruments, at December 31, 2023 and 2022.
December 31, 2023 |
||||||||||||||||||||
Fair Value Measurements | ||||||||||||||||||||
Carrying Amount |
Estimated Fair Value |
Level 1 | Level 2 | Level 3 | ||||||||||||||||
Financial assets: |
||||||||||||||||||||
Loans receivable |
$ | 406,553,535 | $ | 406,553,535 | $ | | $ | | 406,553,535 | |||||||||||
Financial liabilities: |
||||||||||||||||||||
Revolving credit facility |
218,878,346 | 218,878,346 | | | 218,878,346 | |||||||||||||||
December 31, 2022 |
||||||||||||||||||||
Fair Value Measurements | ||||||||||||||||||||
Carrying Amount |
Estimated Fair Value |
Level 1 | Level 2 | Level 3 | ||||||||||||||||
Financial assets: |
||||||||||||||||||||
Loans receivable |
$ | 439,484,085 | $ | 438,684,085 | $ | | $ | | $ | 438,684,085 | ||||||||||
Investment in Crystal Financial SBIC LP |
2,575,336 | 2,575,336 | | | 2,575,336 | |||||||||||||||
Financial liabilities: |
||||||||||||||||||||
Revolving credit facility |
224,325,124 | 224,325,124 | | | 224,325,124 |
11. | Subsequent Events |
The Company has evaluated subsequent events through February 14, 2024, the date which the financial statements were available to be issued.
19
Exhibit 99.2
CONSOLIDATED FINANCIAL STATEMENTS
NEF Holdings, LLC and Subsidiaries (A Limited Liability Company) Years ended December 31, 2023 and December 31, 2022 With Independent Auditors Report |
NEF Holdings, LLC and Subsidiaries
Consolidated Financial Statements
Years ended December 31, 2023 and December 31, 2022
Contents
Independent Auditors Report |
1 | |||
Consolidated Balance Sheets |
3 | |||
Consolidated Statements of Operations |
4 | |||
Consolidated Statements of Comprehensive Income/(Loss) |
5 | |||
Consolidated Statements of Changes in Members Capital |
6 | |||
Consolidated Statements of Cash Flows |
7 | |||
Notes to the Consolidated Financial Statements |
8 |
Independent Auditors Report
To the Board of Managers and Members of
NEF Holdings, LLC and Subsidiaries
Opinion
We have audited the consolidated financial statements of NEF Holdings, LLC and Subsidiaries (the Company), which comprise the consolidated balance sheets as of December 31, 2023 and 2022, and the related consolidated statements of operations, comprehensive income/(loss), changes in members capital, and cash flows for the years then ended, and the related notes to the consolidated financial statements.
In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022 and the results of their operations and their cash flows for the years then ended in accordance with accounting principles generally accepted in the United States of America (GAAP).
Basis for Opinion
We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditors Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Responsibilities of Management for the Consolidated Financial Statements
Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with GAAP, and for the design, implementation and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the consolidated financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Companys ability to continue as a going concern within one year after the date that the financial statements are available to be issued.
Auditors Responsibilities for the Audit of the Consolidated Financial Statements
Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the consolidated financial statements.
Baker Tilly US, LLP, trading as Baker Tilly, is a member of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities.
1
In performing an audit in accordance with GAAS, we:
| Exercise professional judgment and maintain professional skepticism throughout the audit. |
| Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. |
| Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Companys internal control. Accordingly, no such opinion is expressed. |
| Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the consolidated financial statements. |
| Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Companys ability to continue as a going concern for a reasonable period of time. |
We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.
Philadelphia, Pennsylvania
February 14, 2024
2
NEF Holdings, LLC and Subsidiaries
Consolidated Balance Sheets
At December 31, 2023 and December 31, 2022
(In Thousands)
2023 | 2022 | |||||||
Assets |
||||||||
Cash |
$ | 13,789 | $ | 12,639 | ||||
Restricted cash |
71 | 71 | ||||||
Financing receivables: |
||||||||
Financing receivables, gross |
207,091 | 195,726 | ||||||
Allowance for credit losses on financing receivables |
(3,417 | ) | (4,896 | ) | ||||
|
|
|
|
|||||
Financing receivables, net |
203,674 | 190,830 | ||||||
Equipment off lease, net of impairment |
1,665 | | ||||||
Fixed assets, net |
278 | 325 | ||||||
Goodwill |
29,832 | 29,832 | ||||||
Other assets |
5,388 | 8,116 | ||||||
|
|
|
|
|||||
Total assets |
$ | 254,697 | $ | 241,813 | ||||
|
|
|
|
|||||
Liabilities and Members Capital |
||||||||
Liabilities: |
||||||||
Senior secured credit facility, net |
$ | 138,071 | $ | 115,371 | ||||
Loans from affiliate |
14,734 | 16,342 | ||||||
Accounts payable and accrued expenses |
1,998 | 2,705 | ||||||
Good faith deposits |
518 | 606 | ||||||
Other liabilities |
3,554 | 3,761 | ||||||
|
|
|
|
|||||
Total liabilities |
158,875 | 138,785 | ||||||
|
|
|
|
|||||
Members capital: |
||||||||
Members capital |
95,822 | 103,028 | ||||||
|
|
|
|
|||||
Total members capital |
95,822 | 103,028 | ||||||
|
|
|
|
|||||
Total liabilities & members capital |
$ | 254,697 | $ | 241,813 | ||||
|
|
|
|
See accompanying notes to the consolidated financial statements.
3
NEF Holdings, LLC and Subsidiaries
Consolidated Statements of Operations
For the Years ended December 31, 2023 and December 31, 2022
(In Thousands)
2023 | 2022 | |||||||
Net operating income: |
||||||||
Interest income |
$ | 16,334 | $ | 14,944 | ||||
Interest expense |
10,732 | 6,938 | ||||||
|
|
|
|
|||||
Net interest income |
5,602 | 8,006 | ||||||
Other income |
3,284 | 5,436 | ||||||
|
|
|
|
|||||
Net operating income |
8,886 | 13,442 | ||||||
Provision for credit losses and impairments of equipment off lease |
2,861 | 4,137 | ||||||
|
|
|
|
|||||
Net operating income after provisions and impairments |
6,025 | 9,305 | ||||||
Expenses: |
||||||||
Compensation and benefits |
8,748 | 8,437 | ||||||
General and administrative expenses |
3,036 | 3,311 | ||||||
Lease and loan restructuring costs |
551 | 338 | ||||||
Depreciation and amortization |
75 | 86 | ||||||
|
|
|
|
|||||
Total expenses |
12,410 | 12,172 | ||||||
|
|
|
|
|||||
Net income/(loss) |
$ | (6,385 | ) | $ | (2,867 | ) | ||
|
|
|
|
See accompanying notes to the consolidated financial statements.
4
NEF Holdings, LLC and Subsidiaries
Consolidated Statements of Comprehensive Income/(Loss)
For the Years ended December 31, 2023 and December 31, 2022
(In Thousands)
2023 | 2022 | |||||||
Net income/(loss) |
$ | (6,385 | ) | $ | (2,867 | ) | ||
Other comprehensive income/(loss): |
||||||||
Derivative instruments designated and qualifying as cash flow hedges: |
||||||||
Unrealized holding gain/(loss) arising during the year |
(754 | ) | 1,194 | |||||
Reclassification adjustment for losses/(gains) included in net income/(loss) |
67 | (98 | ) | |||||
|
|
|
|
|||||
Total other comprehensive income/(loss) |
(687 | ) | 1,096 | |||||
|
|
|
|
|||||
Total comprehensive income/(loss) |
$ | (7,072 | ) | $ | (1,771 | ) | ||
|
|
|
|
See accompanying notes to the consolidated financial statements.
5
NEF Holdings, LLC and Subsidiaries
Consolidated Statements of Changes in Members Capital
For the Years ended December 31, 2023 and December 31, 2022
(In Thousands)
Members capital at December 31, 2021 |
$ | 105,089 | ||
Capital distributions |
(290 | ) | ||
Other comprehensive income/(loss) |
1,096 | |||
Net income/(loss) |
(2,867 | ) | ||
|
|
|||
Members capital at December 31, 2022 |
$ | 103,028 | ||
Capital distributions |
(134 | ) | ||
Other comprehensive income/(loss) |
(687 | ) | ||
Net income/(loss) |
(6,385 | ) | ||
|
|
|||
Members capital at December 31, 2023 |
$ | 95,822 | ||
|
|
See accompanying notes to the consolidated financial statements.
6
NEF Holdings, LLC and Subsidiaries
Consolidated Statements of Cash Flows
For the Years ended December 31, 2023 and December 31, 2022
(In Thousands)
2023 | 2022 | |||||||
Cash flows from operating activities |
||||||||
Net income/(loss) |
$ | (6,385 | ) | $ | (2,867 | ) | ||
Adjustments to reconcile net income/(loss) to net cash provided by/(used in) operating activities: |
||||||||
Provision for credit losses and impairments of equipment off lease |
2,861 | 4,137 | ||||||
Depreciation |
75 | 86 | ||||||
Amortization of deferred financing costs |
549 | 482 | ||||||
Amortization of upfront fees received and initial direct costs paid |
311 | 370 | ||||||
Change in interest rate derivative value |
725 | (462 | ) | |||||
Changes in operating assets and liabilities: |
||||||||
(Increase)/Decrease in other assets |
(117 | ) | 1,126 | |||||
(Increase)/Decrease in interest receivable |
80 | (23 | ) | |||||
Increase/(Decrease) in interest payable |
277 | 403 | ||||||
Increase/(Decrease) in accounts payable and accrued expenses |
(707 | ) | (973 | ) | ||||
Increase/(Decrease) in good faith deposits |
(88 | ) | (392 | ) | ||||
Increase/(Decrease) in other liabilities |
102 | (1,740 | ) | |||||
|
|
|
|
|||||
Net cash provided by/(used in) operating activities |
(2,317 | ) | 147 | |||||
|
|
|
|
|||||
Cash flows from investing activities |
||||||||
Investments in secured loans and direct finance leases |
(95,623 | ) | (66,760 | ) | ||||
Collections of principal on secured loans and direct finance leases |
78,350 | 85,096 | ||||||
Initial direct costs paid |
(528 | ) | (326 | ) | ||||
Proceeds from sales of equipment on lease |
| 1,200 | ||||||
Proceeds from sales of equipment off lease |
1,163 | 1,824 | ||||||
Cash from sale of NEF Auto Transport assets |
| 150 | ||||||
Cash flows from (purchases)/sales of fixed assets |
(28 | ) | (33 | ) | ||||
|
|
|
|
|||||
Net cash provided by/(used in) investing activities |
(16,666 | ) | 21,151 | |||||
|
|
|
|
|||||
Cash flows from financing activities |
||||||||
Borrowings on credit facility and loans from affiliate |
121,754 | 87,542 | ||||||
Repayments on credit facility and loans from affiliate |
(101,160 | ) | (104,900 | ) | ||||
Payment of credit facility closing fees |
(327 | ) | | |||||
Capital distributions |
(134 | ) | (290 | ) | ||||
|
|
|
|
|||||
Net cash provided by/(used in) financing activities |
20,133 | (17,648 | ) | |||||
|
|
|
|
|||||
Net increase/(decrease) in cash and restricted cash |
1,150 | 3,650 | ||||||
Cash and restricted cash at the beginning of period |
12,710 | 9,060 | ||||||
|
|
|
|
|||||
Cash and restricted cash at the end of period |
$ | 13,860 | $ | 12,710 | ||||
|
|
|
|
|||||
Supplemental disclosures of cash flow information |
||||||||
Interest paid |
$ | 9,180 | $ | 5,967 | ||||
|
|
|
|
See accompanying notes to the consolidated financial statements
7
NEF Holdings, LLC and Subsidiaries
Notes to the Consolidated Financial Statements
For the Years ended December 31, 2023 and December 31, 2022
(In Thousands)
1. Organization and Business
NEF Holdings, Inc. was organized on June 7, 2013 as a Delaware corporation and commenced its operations in June 2013. Effective January 1, 2014, NEF Holdings, Inc. converted from a corporation to a limited liability company (LLC), NEF Holdings, LLC (NEF Holdings), pursuant to Section 18-214 of the Limited Liability Act in the State of Delaware. Subsequent to the close of business on July 31, 2017, NEF Holdings was acquired by SLR Investment Corp., formerly Solar Capital Ltd. (SLR).
As of December 31, 2023 and December 31, 2022, NEF Holdings had five wholly-owned subsidiaries: Nations Fund I, LLC (Fund I), Nations Equipment Finance, LLC (NEF), Equipment Operating Leases, LLC (EOL), NEF Auto Transport, LLC (NEF Auto Transport) and Loyer Capital LLC (Loyer Capital) (collectively, the Company). The Company is headquartered in Wilton, Connecticut.
Nations Fund I, Inc. was organized on September 17, 2010 as a Delaware corporation. Effective January 1, 2014, Nations Fund I, Inc. converted from a corporation to a LLC, Nations Fund I, LLC, pursuant to Section 18-214 of the Limited Liability Act in the State of Delaware. Fund I is a commercial equipment finance company that provides term loans and leases primarily to middle market and privately held companies. Fund I focuses on direct origination of loans and equipment leases secured by equipment collateral, such as trailers, trucks, transportation and construction equipment.
NEF was organized as a LLC under the laws of the State of Delaware and commenced operations on August 24, 2010. NEF, doing business as SLR Equipment Finance, serves as the investment manager for the Company. Services provided by NEF include, among other things, identifying, structuring and negotiating transactions, monitoring, advising and managing investments, exercising control rights, options or warrants, liquidating investments, cash management, accounting, tax, compliance and legal services.
NEF Investments, LLC, a wholly owned subsidiary of NEF Holdings, was organized as a Delaware LLC on January 22, 2018. On April 18, 2018, NEF Investments LLC agreement was amended which changed the companys name to Equipment Operating Leases, LLC. EOL is a commercial equipment finance company that provides term loans and leases primarily to middle market and privately held companies.
NEF Auto Transport was organized as a LLC under the laws of the State of Delaware and commenced operations in December 2018 through the acquisition of a former customer. NEF Auto Transport was an auto transport carrier providing direct auto-hauling services. As discussed in note 3, in February 2022 the Company sold substantially all of the assets of NEF Auto Transport and ceased operations.
Loyer Capital was organized as a LLC under the laws of the State of Delaware and commenced operations in May 2019. Loyer Capital is a commercial equipment finance company that provides term loans and leases primarily to middle market and privately held companies.
8
NEF Holdings, LLC and Subsidiaries
Notes to the Consolidated Financial Statements (continued)
(In Thousands)
2. Summary of Significant Accounting Policies
Basis of Presentation
The consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). These consolidated financial statements include the accounts of NEF Holdings and its wholly owned subsidiaries, Fund I, NEF, EOL, Loyer Capital and NEF Auto Transport. All significant intercompany balances and transactions are eliminated in consolidation. Certain amounts in the prior period financial statements have been reclassified to conform to the current years presentation.
Use of Estimates
The presentation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that impact the amounts reported in the consolidated financial statements and accompanying notes. Such estimates and assumptions are subject to change in the future as additional information becomes available or as circumstances are modified. Actual results could differ materially from these estimates. Managements estimates and assumptions are used in estimating an allowance for credit losses on financing receivables, impairments of equipment off lease, useful lives of leasing equipment and fixed assets, fair values of unguaranteed residual values, intangible assets and fair values of assets acquired and liabilities assumed.
Cash
At December 31, 2023 and December 31, 2022, the Companys cash balance totaled $13,860, and $12,710, respectively. Included in the Companys cash balance as of December 31, 2023 and December 31, 2022 is restricted cash of $71, which is maintained in connection with the lease of the Companys office space.
Financing Receivables
Included in financing receivables in the consolidated balance sheets are the Companys net investments in direct financing leases and secured loans.
Net investment in direct finance leases is reported net of unearned income, deferred non-refundable fees and initial direct costs associated with their origination, and inclusive of guaranteed and unguaranteed residual values. Direct finance leases are usually long-term in nature, typically ranging for a period of three to seven years and include either a nominal or fair market value purchase option at the end of the lease term. Non-refundable fees received and initial direct costs incurred associated with the origination of direct finance leases are deferred and are recognized as an adjustment to interest income over the contractual life of the direct finance leases using the interest method.
Secured loans are reported at the principal amount outstanding, net of non-refundable fees, initial direct costs and accrued interest. These fees and initial direct costs are deferred and recognized as an adjustment to interest income over the contractual life of the loans using the interest method.
Income Recognition
The Company recognizes revenue in accordance with the Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers, which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. The core principle of the revenue model is for an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. While this guidance replaced most existing revenue recognition guidance in U.S. GAAP, ASC 606 is not applicable to financial instruments and, therefore, does not impact most of the Companys revenues.
9
NEF Holdings, LLC and Subsidiaries
Notes to the Consolidated Financial Statements (continued)
(In Thousands)
2. Summary of Significant Accounting Policies (continued)
Income Recognition (continued)
For direct finance leases, the difference between the cost of the equipment and the total finance lease receivable plus, where applicable, the unguaranteed or guaranteed residual value is recorded as unearned income. Unearned income is amortized as earned income over the term of the transaction using the interest method. For the years ended December 31, 2023 and December 31, 2022, interest income from direct financing leases totaled $11,543 and $9,504, respectively, which is included in interest income in the consolidated statements of operations. For secured loans, interest income is recorded on the accrual basis in accordance with the terms of the respective loan. For the years ended December 31, 2023 and December 31, 2022, interest income from secured loans totaled $4,791 and $5,440, respectively, which is included in interest income in the consolidated statements of operations.
The Companys revenue recognition pattern for revenue streams within the scope of ASC 606 include fees for providing administrative and collateral monitoring services, which are earned ratably over the period in which the services are provided, and revenues associated with its auto-hauling operations (see note 3). Such revenues are recognized when evidence of an arrangement exists, the performance obligations are satisfied, collections are probable and the price is fixed or determinable. With respect to the Companys auto-hauling operations, the sole performance obligation is deemed to be satisfied at a single point in time, that is, when the customer takes physical possession of the automobile.
Other Income
Amounts in other income in the consolidated statements of operations primarily include gains on sales of equipment, fees charged for early terminations of financing arrangements, other miscellaneous fees earned in connection with the administration of such financing arrangements and net impacts of foreign currency translation. Also included in other income in the consolidated statements of operations for the year ended December 31, 2022 are the revenues and cost of sales associated with the Companys auto-hauling business, which was sold in February 2022 (see note 3).
Fixed Assets
Fixed assets consist of furniture and fixtures, software, computers, leasehold improvements, automobiles, telephone and office equipment and auto hauling trucks, and are stated at cost less accumulated depreciation and amortization. Expenditures for repairs and maintenance that do not extend the useful life of the asset are expensed as incurred and are included in general and administrative expenses in the Companys consolidated statements of operations.
Depreciation and amortization of fixed assets are calculated using the straight-line method over their respective useful lives, and recorded in depreciation and amortization in the consolidated statements of operations.
Useful Life (Years) | ||
Furniture and fixtures |
7 | |
Telephone |
7 | |
Office equipment |
5 | |
Automobile |
5 | |
Auto hauling trucks |
5 | |
Computers |
3 | |
Software |
Lesser of 5 years or license period | |
Leasehold improvements |
Lesser of the useful life of the asset or lease term |
10
NEF Holdings, LLC and Subsidiaries
Notes to the Consolidated Financial Statements (continued)
(In Thousands)
2. Summary of Significant Accounting Policies (continued)
Good Faith Deposits
Good faith deposits represent cash received from the Companys customers, when the proposal for a potential transaction is signed. These deposits are used to pay expenses such as third-party appraisals, document fees and travel and related costs incurred by the Company in connection with the origination of the transaction. If the deposit exceeds the expenses incurred by the Company, the excess amount may be refundable to the customer. If the expenses incurred exceed the deposits received, the Companys customers are liable for the overage. Such overages are included in other assets on the consolidated balance sheets. In the event the Company approves a transaction with a customer and the customer elects not to pursue the transaction, the Company recognizes any remaining good faith deposit into income, as allowed by the agreed upon terms of the signed proposal. Such amounts are included in other income in the consolidated statements of operations.
In certain instances, the Company incurs costs to restructure financing receivables, which are in excess of the customers good faith deposit, such as legal fees and other expenses associated with the repossession and liquidation of equipment. If these costs are deemed not collectable from the Companys customers, then such costs are expensed and recorded as lease and loan restructuring costs on the consolidated statements of operations.
Allowance for Credit Losses on Financing Receivables
In June 2016, the FASB issued ASU 2016-13 Financial Instruments Credit Losses. This ASU requires companies to broaden the information considered in developing its expected credit loss estimates on financing receivables measured either individually or collectively. In November 2019, the FASB issued ASU 2019-10, Financial Instruments Credit Losses, which delayed the effective date of ASU 2016-13 and made the adoption effective for the Company for the fiscal year beginning after December 15, 2022. The Company adopted this guidance on January 1, 2023 using the modified retrospective approach, which did not have a material impact on its consolidated balance sheets and consolidated statements of operations, however expanded the disclosure requirements surrounding this topic.
The Company maintains an allowance for credit losses on financing receivables at a level sufficient to absorb credit losses expected to arise over the life of the financing receivables, as of the date of the consolidated financial statements. The Companys financing receivables are all secured by the underlying collateral. Additionally, the Company looks to three forms of repayment in analyzing the risk of loss associated with underwriting an individual transaction, namely, cash flows of the obligors existing operations, the value of the underlying collateral securing the financing receivable and where applicable, the potential for repayment from a personal or corporate guarantor.
In determining its allowance for credit losses on financing receivables, the Company considers numerous factors including forward looking industry benchmarks and equipment trends, type of financing receivable, credit quality of its customer, historical loss rates, collateral coverage, and remaining term to maturity of the financing arrangement, which are reviewed and updated, as appropriate, on an ongoing basis. The Companys application of its credit loss policy is applied on an individual transaction basis.
Individually identified non-performing secured loans and direct finance leases are measured based on the specific circumstances of the transaction and a specific allowance for credit loss is established, if necessary. Amounts determined to be uncollectible are charged directly to provision for credit losses in the consolidated statements of operations.
11
NEF Holdings, LLC and Subsidiaries
Notes to the Consolidated Financial Statements (continued)
(In Thousands)
2. Summary of Significant Accounting Policies (continued)
Allowance for Credit Losses on Financing Receivables (continued)
The Company classifies a financing receivable as delinquent when it is overdue by more than 60 days. As of December 31, 2023, financing receivables with an outstanding balance of $0, $21, and $0 were between 61-90 days past due, 91-120 days past due and greater than 120 days past due, respectively. As of December 31, 2022, financing receivables with an outstanding balance of $0, $0, and $22,995 were between 61-90 days past due, 91-120 days past due and greater than 120 days past due, respectively.
Non-Accrual Financing Receivables
Income recognition is generally suspended for financing receivables after 90 days of non-payment, or if full recovery becomes doubtful based on the assessment by the Company. Income recognition is resumed when financing receivables are less than 90 days past due. At December 31, 2023 and December 31, 2022, financing receivables with an outstanding balance of $17,943 and $22,995, respectively, were on non-accrual of income.
Equipment on Lease
Leasing equipment is comprised of equipment under operating leases. Leasing equipment is recorded at cost and depreciated on a straight-line basis over the estimated useful life of the equipment. Income is recorded on a straight-line basis over the term of the lease which is included in interest income in the consolidated statements of operations.
The estimated useful lives and residual values of the Companys leasing equipment are based on independent third-party appraisals and managements judgment. The Company reviews its depreciation policies on a regular basis to determine whether changes have taken place that would suggest that a change in its depreciation policies, useful lives of its equipment or the assigned residual values is warranted. At December 31, 2023, and December 31, 2022 the Company had no leasing equipment under operating leases.
Leasing equipment is tested for impairment whenever events or changes in circumstances indicate that its carrying amount may not be recovered. Key indicators of impairment on leasing equipment include, among other factors, a sustained decrease in operating profitability, a sustained decrease in utilization, or indications of technological obsolescence.
Equipment off Lease
Equipment off lease arises when the Company repossesses collateral that secured a financing receivable in a customer default scenario. Such equipment is intended to be sold and is classified as assets held for sale, in accordance with the provisions of ASC 360, Property, Plant & Equipment. At the time of repossession, the financing receivable is transferred to equipment off lease at the lower of cost or fair value. At December 31, 2023 and December 31, 2022, equipment off lease totaled $1,665 and $0, respectively, in the consolidated balance sheets.
A review for impairment of equipment off lease is performed at least annually or when events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. During the years ended December 31, 2023 and December 31, 2022, the Company recorded impairment charges of $2,683 and $2,571, respectively, which are included in provision for credit losses and impairments of equipment off lease on the consolidated statements of operations.
12
NEF Holdings, LLC and Subsidiaries
Notes to the Consolidated Financial Statements (continued)
(In Thousands)
2. Summary of Significant Accounting Policies (continued)
Derivative Instruments
The Company manages exposure to interest rates through the use of interest rate caps traded in the over-the-counter markets with other financial institutions. The Company does not enter into derivative financial instruments for speculative purposes. Derivative instruments are recognized at fair value and included in other assets in the consolidated balance sheets.
Interest rate caps are used to manage the Companys interest rate exposure on its senior secured credit facility. At December 31, 2023 and December 31, 2022, such derivatives had notional amounts of $15,000 and $45,000, respectively, and fair values of $452 and $1,865, respectively, which are included in other assets in the consolidated balance sheets. For the years ended December 31, 2023 and December 31, 2022, changes in fair value of interest rate caps totaled ($1,413) and $1,558, respectively.
The Company designated certain of these interest rate caps as highly effective hedges. On the date the derivative contract is entered into, the Company formally documents the relationships between the hedging instrument and the hedged item, as well as its risk management objective and strategy for undertaking various hedge transactions. Hedge effectiveness is measured at the hedges inception and, on an on-going basis, to determine whether the derivatives are highly effective in offsetting the changes in cash flows of the hedged item.
At December 31, 2023, as mentioned above, the Company held one interest rate cap that was deemed highly effective that had a notional value of $15,000 and a fair value of $452. At December 31, 2022, the Company held two interest rate caps that were deemed highly effective that had a notional value of $30,000 and a fair value of $1,206. Changes in fair values of interest rate caps, which were deemed highly effective during the years ended December 31, 2023 and December 31, 2022, totaled ($754) and $1,194, respectively and are included in other comprehensive income, offset by reclassification gains/(losses) into earnings of ($67) and $98, respectively. Reclassifications into earnings are included in interest expense in the consolidated statements of operations. At December 31, 2023, the Company did not hold any interest rate caps that were not deemed highly effective. At December 31, 2022, the Company also held an interest rate cap that was not deemed highly effective that had a notional value of $15,000 and a fair value of $659. Changes in fair values of interest rate caps, which were not deemed highly effective, totaled $659 and $462 for the years ended December 31, 2023 and December 31, 2022, respectively, and are included in interest expense in the consolidated statements of operations.
Debt
Senior secured credit facility represents the Companys principal balance under its long-term revolver, which is carried at amortized cost, along with the related accrued interest payable, net of unamortized deferred financing costs.
Loans from affiliate represent the Companys unpaid principal balance on term loans, along with the related accrued interest payable to SLR, a related party, as described in note 1. Maturity dates range from January 27, 2024 through April 27, 2025 and carry interest rates ranging from 8.37% to 11.52%. Future scheduled principal payments on loans from affiliate are $11,846 in 2024, and $2,884 in 2025.
Deferred Financing Costs
Deferred financing costs represent fees and other incremental costs incurred in connection with the financing of the Companys senior secured credit facility. Such costs are amortized using the straight-line method into earnings over the contractual term of the facility. The unamortized balance of such costs are included as a reduction to the senior secured credit facility balance.
13
NEF Holdings, LLC and Subsidiaries
Notes to the Consolidated Financial Statements (continued)
(In Thousands)
2. Summary of Significant Accounting Policies (continued)
Contingencies and Commitments
The Company may be subject to various legal proceedings, claims, and litigation, either asserted or unasserted that arise in the ordinary course of business. The Company records accruals for contingent losses when such losses are probable and reasonably estimable. In the event that estimates or assumptions prove to differ from actual results, adjustments are made in subsequent periods to reflect more current information. Legal fees are expensed as incurred.
Financial Asset Transfers
The Company accounts for transfers of financial assets under FASB ASC 860, Transfers and Servicing, utilizing a control oriented, financial components approach to financial asset transfer transactions whereby the Company: (1) recognizes the financial and servicing assets it controls and the liabilities it has incurred; (2) derecognizes financial assets when control has been surrendered; and (3) derecognizes liabilities once they are extinguished. Control is considered to have been surrendered only if: (i) the transferred assets have been isolated from the Company and its creditors, even in the event of bankruptcy or other receivership; (ii) the purchaser has the right to pledge or exchange the transferred assets, or, is a qualifying special purpose entity (as defined) and the holders of beneficial interests in that entity have the right to pledge or exchange those interests; and (iii) the Company does not maintain effective control over the transferred assets through an agreement which both entitles and obligates it to repurchase or redeem those assets prior to maturity, or through an agreement which both entitles or obligates it to repurchase or redeem those assets if they were not readily obtainable elsewhere. If any of these conditions are not met, the Company accounts for the transfer as a secured borrowing.
Foreign Currencies
Assets and liabilities recorded in foreign currencies are translated at the exchange rate on the date of the consolidated balance sheets. Income and expenses are translated at average rates of exchange prevailing during the year. Translation adjustments resulting from this process, which totaled $4 and ($19) for the years ended December 31, 2023 and December 31, 2022, respectively, are recorded in other income in the consolidated statements of operations. At December 31, 2023 and December 31, 2022, the Company had cash, financing receivables and debt denominated in the Canadian dollar.
Income Taxes
The Company is a LLC and has elected to be taxed as a partnership. Accordingly, the Company is not subject to federal or state income taxes. Taxable income, losses and deductions flow through to the Companys members.
Fair Value Measurement
Fair value is defined as the amount for which an asset could be exchanged, or a liability settled, between knowledgeable, willing parties in an arms length transaction at the measurement date. In determining fair value of financial instruments and intangibles, the Company uses various valuation approaches, which utilize certain assumptions that market participants would use in pricing the asset or liability, including assumptions about risk to the valuation technique. The inputs can be readily observable, market corroborated or generally unobservable internal inputs. The Company utilizes valuation techniques that rely on both observable and unobservable inputs.
14
NEF Holdings, LLC and Subsidiaries
Notes to the Consolidated Financial Statements (continued)
(In Thousands)
2. Summary of Significant Accounting Policies (continued)
Leases
The Company accounts for leases in accordance with ASC 842, Leases. Included in other assets and other liabilities on the consolidated balance sheets as of December 31, 2023 and December 31, 2022, are right of use assets and corresponding lease obligations, associated with the Companys office spaces, of $2,958 and $3,267, respectively. The Company paid $385 and $456 for the years ended December 31, 2023 and December 31, 2022, respectively, for such leases. The Companys aggregate scheduled remaining contractual payments under these leases are $393, $401, $409, $417, $425 and $1,212 for 2024, 2025, 2026, 2027, 2028 and thereafter, respectively.
Goodwill and Intangible Asset
Goodwill represents the excess of consideration paid for the Company over the fair value of the related assets acquired and liabilities assumed from the acquisition of the Company on July 31, 2017, as discussed in note 1. As discussed in note 3, in connection with the acquisition of the assets of one of its former customers, the Company acquired an intangible asset related to customer relationships with a five year useful life. For the years ended December 31, 2023 and December 31, 2022, the Company recorded no amortization expense. In February 2022, the Company sold substantially all of the assets of NEF Auto Transport, including the intangible asset related to customer relationships of $767 (see note 3).
The Company assesses goodwill for impairment, annually or more frequently if events or changes in circumstances occur, by comparing the carrying value to its fair value. If the fair value is less than the carrying value, an impairment charge is recorded in that period. Goodwill recognized in business combinations is assigned to the reporting units that are expected to benefit from the combination as of the acquisition date. Goodwill is not amortized; rather goodwill is tested annually for impairment or more frequently upon the occurrence of certain events or substantive changes in circumstances. The Company has the option to perform a qualitative assessment to determine if an impairment is more likely than not to have occurred. If the conclusion is supported that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then the Company would not need to perform a quantitative impairment test. If the conclusion cannot be supported, or if the Company does not elect to do the qualitative assessment, then the Company will perform a quantitative assessment. If a quantitative goodwill impairment test is performed, the Company utilizes a combination of market and income valuation approaches. If the fair value of a reporting unit is less than its carrying value, an impairment loss is recorded to the extent that the fair value of the reporting unit is less than its carrying value. No impairment of goodwill resulted from the annual impairment assessment in 2023 or 2022.
3. Business Combinations
On December 11, 2018, the Company, through its wholly owned subsidiary NEF Auto Transport, acquired the assets of a privately held auto transport hauler. The entity, which was one of the Companys former customers, was acquired out of bankruptcy in satisfaction of all of the amounts due to the Company. Total consideration of $7,082 (of which $250 was in the form of cash) was allocated to the fair value of the identifiable assets acquired and liabilities assumed. In connection with the acquisition, the Company recorded an intangible asset of $3,950, which was included in other assets in the consolidated balance sheets, net of accumulated amortization.
On January 17, 2019, the Company, through its wholly owned subsidiary NEF Auto Transport, acquired a privately owned auto transport carrier based in Enumclaw, Washington. Total consideration of $975 was allocated to the fair value of the identifiable assets acquired and liabilities assumed, which included cash of $33, receivables of $197, fixed assets of $788, other assets of $37, and payables of $80.
15
NEF Holdings, LLC and Subsidiaries
Notes to the Consolidated Financial Statements (continued)
(In Thousands)
3. Business Combinations (continued)
During 2019, the Company integrated the operations of both auto transport carriers to form one business and reporting unit. For the year ended December 31, 2022 such operations generated net losses of $17, which included revenues of $517 and direct costs of $534.
In February 2022, the Company sold substantially all of the assets of NEF Auto Transport for gross proceeds of $2,850, which included $150 of cash at closing and the remainder in the form of a note from the buyer which is included in financing receivables in the consolidated balance sheets. The assets sold included auto hauling trucks and ancillary equipment of $1,683 and an intangible asset related to customer relationships of $767. Subsequent to the sale, the Company ceased all operations of NEF Auto Transport.
4. Financing Receivables
Net investment in direct finance leases consists of the following at December 31, 2023 and December 31, 2022:
2023 | 2022 | |||||||
Gross finance lease receivables |
$ | 137,344 | $ | 106,866 | ||||
Guaranteed residuals |
11,386 | 15,108 | ||||||
Unguaranteed residuals |
10,340 | 12,088 | ||||||
Unearned income |
(27,208 | ) | (22,537 | ) | ||||
Deferred non-refundable fees collected |
(167 | ) | (281 | ) | ||||
Deferred initial direct costs paid |
682 | 480 | ||||||
|
|
|
|
|||||
132,377 | 111,724 | |||||||
Allowance for credit losses on direct finance leases |
(2,246 | ) | (3,460 | ) | ||||
|
|
|
|
|||||
Total net investment in direct finance leases |
$ | 130,131 | $ | 108,264 | ||||
|
|
|
|
Secured loans, net, consist of the following at December 31, 2023 and December 31, 2022:
2023 | 2022 | |||||||
Secured loans, principal |
$ | 74,240 | $ | 83,318 | ||||
Accrued interest receivable |
257 | 336 | ||||||
|
|
|
|
|||||
Total secured loans, gross |
74,497 | 83,654 | ||||||
Deferred non-refundable fees collected |
(3 | ) | (54 | ) | ||||
Deferred initial direct costs paid |
220 | 402 | ||||||
|
|
|
|
|||||
74,714 | 84,002 | |||||||
Allowance for credit losses on secured loans |
(1,171 | ) | (1,436 | ) | ||||
|
|
|
|
|||||
Total secured loans, net |
$ | 73,543 | $ | 82,566 | ||||
|
|
|
|
16
NEF Holdings, LLC and Subsidiaries
Notes to the Consolidated Financial Statements (continued)
(In Thousands)
4. Financing Receivables (continued)
Aggregate scheduled payments, contractual maturities including guaranteed residuals and unguaranteed residuals by year on the fixed and floating rate secured loans and direct finance leases at December 31, 2023, are as follows:
2024 | 2025 | 2026 | 2027 | 2028 | Thereafter | Total | ||||||||||||||||||||||
Secured loans: |
||||||||||||||||||||||||||||
Fixed Rate |
$ | 35,217 | $ | 11,015 | $ | 13,393 | $ | 8,168 | $ | 2,654 | $ | 401 | $ | 70,848 | ||||||||||||||
Floating Rate |
3,392 | | | | | | 3,392 | |||||||||||||||||||||
Direct Finance Leases |
39,422 | 43,150 | 35,191 | 17,583 | 13,581 | 10,143 | 159,070 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
$ | 78,031 | $ | 54,165 | $ | 48,584 | $ | 25,751 | $ | 16,235 | $ | 10,544 | $ | 233,310 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5. Allowance for Credit Losses on Financing Receivables
Allowance for credit losses on financing receivables was as follows for the years ended:
2023 | ||||||||||||
Direct Finance Leases |
Secured Loans |
Total | ||||||||||
Balance at beginning of year |
$ | 3,460 | $ | 1,436 | $ | 4,896 | ||||||
General provision for credit losses |
445 | (267 | ) | 178 | ||||||||
Specific provision for credit losses |
| | | |||||||||
Charge offs |
(1,659 | ) | | (1,659 | ) | |||||||
Foreign currency translation adjustments |
| 2 | 2 | |||||||||
|
|
|
|
|
|
|||||||
Balance at end of year |
$ | 2,246 | $ | 1,171 | $ | 3,417 | ||||||
|
|
|
|
|
|
2022 | ||||||||||||
Direct Finance Leases |
Secured Loans |
Total | ||||||||||
Balance at beginning of year |
$ | 1,983 | $ | 1,356 | $ | 3,339 | ||||||
General provision for credit losses |
(182 | ) | 89 | (93 | ) | |||||||
Specific provision for credit losses |
1,659 | | 1,659 | |||||||||
Charge offs |
| | | |||||||||
Foreign currency translation adjustments |
| (9 | ) | (9 | ) | |||||||
|
|
|
|
|
|
|||||||
Balance at end of year |
$ | 3,460 | $ | 1,436 | $ | 4,896 | ||||||
|
|
|
|
|
|
As of December 31, 2023 and December 31, 2022, the Company maintained a general allowance for credit losses of $3,417 and $3,237, respectively. As of December 31, 2023 and December 31, 2022, the Company maintained an allowance for credit losses on specifically identified accounts of $0 and $1,659 on financing receivables of $0 and $4,318, respectively. The Company has no material off balance sheet credit exposures at December 31, 2023 and December 31, 2022 which would require additional allowances for credit losses.
17
NEF Holdings, LLC and Subsidiaries
Notes to the Consolidated Financial Statements (continued)
(In Thousands)
6. Fixed Assets, net
At December 31, 2023 and December 31, 2022, fixed assets, net consists of the following:
2023 | 2022 | |||||||
Leasehold improvements |
$ | 153 | $ | 153 | ||||
Furniture and fixtures |
141 | 141 | ||||||
Computers |
47 | 35 | ||||||
Software |
46 | 30 | ||||||
Office equipment |
45 | 45 | ||||||
Automobile |
| 59 | ||||||
|
|
|
|
|||||
Fixed assets, gross |
432 | 463 | ||||||
Accumulated depreciation |
(154 | ) | (138 | ) | ||||
|
|
|
|
|||||
Fixed assets, net |
$ | 278 | $ | 325 | ||||
|
|
|
|
Depreciation and amortization expense related to fixed assets totaled $75 and $86 for the years ended December 31, 2023 and December 31, 2022, respectively. For the years ending 2024, 2025, 2026 and thereafter, the Company will recognize annual amortization expense related to software of $11, $5, $4, and $4, respectively.
7. Senior Secured Credit Facility
Senior secured credit facility consists of the following at December 31, 2023 and December 31, 2022:
2023 | 2022 | |||||||
Senior secured credit facility, principal |
$ | 137,178 | $ | 114,977 | ||||
Accrued interest payable |
950 | 674 | ||||||
Unamortized deferred financing costs |
(57 | ) | (280 | ) | ||||
|
|
|
|
|||||
Total senior secured credit facility |
$ | 138,071 | $ | 115,371 | ||||
|
|
|
|
At December 31, 2023 and December 31, 2022, Fund I maintained a revolving credit facility (the Facility) which consists of two separate revolvers, one for U.S. dollars and one for Canadian dollars. At December 31, 2022, the total availability on the U.S. dollar revolver was $180,000 and the total availability on the Canadian dollar revolver was the lesser of CAD 45,000 and the U.S. dollar equivalent of $33,957. Interest was based on London Interbank Offering Rate (LIBOR), plus an applicable margin. The applicable margin ranged from 2.25% to 2.50%, based on Fund Is leverage ratio. The leverage ratio represents the ratio of the outstanding balance of the Facility to Fund Is total members capital, as described in the Facility agreement. The Facility had a contractual maturity date of July 31, 2023, with the principal payable in full at maturity, but was extended to January 31, 2024. At December 31, 2023, the total availability on the U.S. dollar revolver was $147,620 and the total availability on Canadian dollar revolver was the lesser of CAD 6,000 and the U.S. dollar equivalent of $4,528. In connection with the extension of the Facility, interest was adjusted to one month term Secured Overnight Financing Rate (SOFR) plus an applicable margin ranging from 2.65% to 2.90%, based on Fund Is leverage ratio. All assets of Fund I are pledged as collateral under the Facility. Fund I is also required to pay a 0.375% per annum unused line fee. The Facility requires Fund I and the Company to maintain certain periodic financial covenants surrounding capitalization, cash flow and default, delinquency and charge-off ratios. The Company provides a limited guaranty to the Facility for all interest, fees and expenses that cannot otherwise be charged to Fund I. The Company refinanced the Facility subsequent to December 31, 2023 (see note 13).
18
NEF Holdings, LLC and Subsidiaries
Notes to the Consolidated Financial Statements (continued)
(In Thousands)
8. Employee Compensation and Benefit Plans
As of December 31, 2023, the Company employed personnel at its headquarters in Wilton, Connecticut and regional offices throughout the United States. Employee compensation and benefits are comprised of base salaries, discretionary bonuses, health care benefits, employer 401(k) contributions and payroll taxes. As a part of their employment agreements, certain members of senior management are eligible for an annual bonus amount, which is calculated as a percentage of their annual salaries, based on certain financial performance metrics, as described in their employment agreements.
Effective August 1, 2017, the Company formed a Long-Term Incentive Plan (LTIP) that provides for an annual bonus pool to certain members of senior management based on the Company achieving certain performance criteria.
The Company sponsors a 401(k) plan, where the Company contributes a defined percentage of employees annual earnings up to the maximum annual contribution amount as determined by the Internal Revenue Service.
9. Fair Value of Financial Instruments
FASB ASC 820, Fair Value Measurements (ASC 820), establishes a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect managements market assumptions.
These two types of inputs create the following fair value hierarchy:
Level 1 Quoted prices for identical instruments in active markets.
Level 2 Observable inputs other than quoted prices in active markets for identical assets and liabilities, such as interest rates and foreign exchange rates that are observable at commonly quoted intervals. Financial assets utilizing Level 2 inputs include interest rate caps.
Level 3 Unobservable inputs.
As of December 31, 2023 and December 31, 2022, the Company measured its interest rate caps at fair value on a recurring basis. Total fair value of such derivative instruments as of December 31, 2023 and December 31, 2022 was $452 and $1,865, respectively, which was classified as Level 2 in the fair value hierarchy by the Company. The fair value of interest rate caps are measured using discounted cash flow calculations based on observable inputs from the relevant interest/exchange rate curves in effect at December 31, 2023 and December 31, 2022.
ASC 820 also requires that the Company disclose estimated fair values for its financial instruments. No quoted market exists for the Companys financial instruments. Therefore, fair value estimates are based on judgments, risk characteristics of various financial instruments and other factors. Changes in these assumptions could significantly affect the estimates.
The Company estimates the carrying amounts of cash approximated its fair values as of December 31, 2023 and December 31, 2022. Since there is no liquid secondary market for the Companys financing receivables, the Company estimates the fair value of its secured loans and net investment in direct finance leases by comparing the average yield of the portfolio to recent issuances of similar loans and leases. As of December 31, 2022, the Company estimated the fair value of its financial liabilities based on the Companys review of the terms of the Facility, and an indication of potential refinance terms, and recent transactions of loans from affiliate. As of December 31, 2023, the Company estimated the fair value of its financial liabilities based on the terms of its new senior secured credit facility, closed in January 2024 (see note 13), and recent transactions of loans from affiliate.
19
NEF Holdings, LLC and Subsidiaries
Notes to the Consolidated Financial Statements (continued)
(In Thousands)
9. Fair Value of Financial Instruments (continued)
The carrying amount and estimated fair values of the Companys financial instruments at December 31, 2023 and December 31, 2022 were as follows:
2023 | 2022 | |||||||||||||||
Carrying Amount |
Estimated Fair Value |
Carrying Amount |
Estimated Fair Value |
|||||||||||||
Financial assets: |
||||||||||||||||
Cash and restricted cash |
$ | 13,860 | $ | 13,860 | $ | 12,710 | $ | 12,710 | ||||||||
Net investment in direct finance leases |
130,131 | 129,717 | 108,264 | 108,130 | ||||||||||||
Secured loans, net |
73,543 | 72,455 | 82,566 | 81,157 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total financing receivables, net of allowances |
203,674 | 202,172 | 190,830 | 189,287 | ||||||||||||
Financial liabilities: |
||||||||||||||||
Senior secured credit facility, net |
$ | 138,071 | $ | 137,254 | $ | 115,371 | $ | 115,371 | ||||||||
Loans from Affiliate |
14,734 | 14,764 | 16,342 | 16,482 |
10. Concentration of Credit Risk
Financing receivables subject the Company to credit risk. The Company monitors its portfolios by evaluating each of the customers financial condition and collateral. The Companys maximum exposure to credit risk at December 31, 2023 and December 31, 2022, without considering the underlying collateral, is represented by the carrying value of the financing receivables in the consolidated balance sheets. The Company monitors its financing receivables for geographic concentrations.
The following table reflects such concentrations as of December 31, 2023 and December 31, 2022:
Geographic Concentration
2023 | ||||
Texas |
$ | 51,616 | ||
Colorado |
18,710 | |||
New York |
18,097 | |||
Louisiana |
12,212 | |||
Missouri |
11,782 | |||
Pennsylvania |
11,521 | |||
California |
9,600 | |||
Massachusetts |
7,232 | |||
Connecticut |
7,118 | |||
Michigan |
7,068 | |||
Tennessee |
6,249 | |||
Kentucky |
6,202 | |||
Florida |
5,636 | |||
Other U.S. states / Canada |
34,048 | |||
|
|
|||
Total financing receivables, gross |
$ | 207,091 | ||
|
|
2022 | ||||
Texas |
$ | 32,153 | ||
New York |
23,935 | |||
Colorado |
22,564 | |||
Louisiana |
16,759 | |||
Kentucky |
13,635 | |||
Missouri |
13,301 | |||
Tennessee |
8,032 | |||
Pennsylvania |
6,883 | |||
British Columbia (Canada) |
6,440 | |||
Florida |
6,377 | |||
Washington |
4,678 | |||
Wisconsin |
4,520 | |||
Maine |
4,318 | |||
Other U.S. states / Canada |
32,131 | |||
|
|
|||
Total financing receivables, gross |
$ | 195,726 | ||
|
|
The amount and type of collateral required depends on an assessment of the credit risk of the counterparty. Guidelines are implemented regarding the acceptability of types of collateral and valuation parameters. Typically, the Company obtains access to collateral either through direct ownership or by a first lien security interest.
20
NEF Holdings, LLC and Subsidiaries
Notes to the Consolidated Financial Statements (continued)
(In Thousands)
10. Concentration of Credit Risk (continued)
The Company also monitors its financing receivables for collateral concentrations. The following tables reflect such concentrations as of December 31, 2023 and December 31, 2022:
Collateral Concentrations
2023 | ||||
Crane |
$ | 18,951 | ||
Barge rigs |
17,943 | |||
Package sorting equipment |
17,845 | |||
Truck |
17,671 | |||
Tractor |
16,005 | |||
Loader |
11,325 | |||
Flight simulator |
9,603 | |||
All other |
97,748 | |||
|
|
|||
Total financing receivables, gross |
$ | 207,091 | ||
|
|
2022 | ||||
Tractors |
$ | 23,051 | ||
Barge rigs |
18,283 | |||
Trucks |
13,947 | |||
Loaders |
13,732 | |||
Barges |
13,224 | |||
Aircraft |
12,671 | |||
Package sorting equipment |
11,439 | |||
All other |
89,379 | |||
|
|
|||
Total financing receivables, gross |
$ | 195,726 | ||
|
|
At December 31, 2023 and December 31, 2022, the Company had financing receivables outstanding to one customer that approximated 9% of total financing receivables for each period.
11. Contingencies and Commitments
As of December 31, 2023, the Company had a U.S. and a Canadian revolver financing arrangement with a total outstanding balance of $3,419 and CAD 600, respectively, which are included in financing receivables, net in the consolidated balance sheets. As of December 31, 2022, the Company had a U.S. and a Canadian revolver financing arrangements with a total outstanding balance of $3,593 and CAD 637 respectively, which are included in financing receivables, net in the consolidated balance sheets. The Companys maximum commitments under the U.S. and Canadian revolvers were $4,000 and CAD 1,500, respectively, for both years ending December 31, 2023 and December 31, 2022.
12. Members Capital
At December 31, 2023 and December 31, 2022, NEFCORP owns 100 Class A units and NEFPASS owns 100 Class B units, which represent the entire capital of the Company.
13. Subsequent Events
The Company has evaluated subsequent events through February 14, 2024, the issuing date of the consolidated financial statements.
In January 2024, the Company closed a three year $225,000 U.S. dollar and Canadian dollar credit facility which matures in January 2027.
21
Exhibit 99.3
KBH Topco, LLC
Consolidated Financial Statements and
Independent Auditors Report
December 31, 2023 and 2022
KBH TOPCO, LLC
TABLE OF CONTENTS
Page | ||||
INDEPENDENT AUDITORS REPORT |
1 - 2 | |||
CONSOLIDATED FINANCIAL STATEMENTS |
||||
Consolidated Balance Sheets |
3 | |||
Consolidated Statements of Comprehensive Income |
4 | |||
Consolidated Statements of Changes in Members Equity |
5 | |||
Consolidated Statements of Cash Flows |
6 | |||
Notes to the Consolidated Financial Statements |
7 - 19 |
The accompanying notes are an integral part of these statements.
INDEPENDENT AUDITORS REPORT
To the Management of
KBH Topco, LLC
Opinion
We have audited the accompanying consolidated financial statements of KBH Topco, LLC, which comprise the consolidated balance sheets as of December 31, 2023 and 2022, and the related consolidated statements of comprehensive income, changes in members equity, and cash flows for the years then ended, and the related notes to the consolidated financial statements.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of KBH Topco, LLC as of December 31, 2023 and 2022, and the results of its operations and its cash flows for the years then ended, in accordance with accounting principles generally accepted in the United States of America.
Basis for Opinion
We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Our responsibilities under those standards are further described in the Auditors Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are required to be independent of KBH Topco, LLC and to meet our other ethical responsibilities in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Responsibilities of Management for the Consolidated Financial Statements
Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the consolidated financial statements, management is required to evaluate whether there are conditions or events considered in the aggregate, that raise substantial doubt about KBH Topco, LLCs ability to continue as a going concern within one year after the date that the consolidated financial statements are available to be issued.
Auditors Responsibilities for the Audit of the Consolidated Financial Statements
Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with generally accepted auditing standards will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the consolidated financial statements.
The accompanying notes are an integral part of these statements.
Page 2
In performing an audit in accordance with generally accepted auditing standards, we:
| Exercise professional judgment and maintain professional skepticism throughout the audit. |
| Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. |
| Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of KBH Topco, LLCs internal control. Accordingly, no such opinion is expressed. |
| Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the consolidated financial statements. |
| Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about KBH Topco, LLCs ability to continue as a going concern for a reasonable period of time. |
We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control related matters that we identified during the audit.
Bannockburn, Illinois
February 9, 2024
Page 3
KBH TOPCO, LLC
CONSOLIDATED BALANCE SHEETS
DECEMBER 31, 2023 AND 2022
ASSETS | ||||||||
2023 | 2022 | |||||||
Cash |
$ | 12,979,548 | $ | 6,155,829 | ||||
Accounts receivable, net |
37,377,361 | 15,652,128 | ||||||
Inventory, prepaid expenses, deposits and other assets |
9,381,750 | 6,277,886 | ||||||
Investment in sales-type and direct finance leases, net |
193,150,746 | 79,084,973 | ||||||
Equipment under operating leases at cost, net of accumulated depreciation of $184,363,355 and $144,939,920 as of December 31, 2023 and 2022, respectively |
464,828,305 | 530,350,075 | ||||||
Equipment used in operations at cost, net of accumulated depreciation of $506,201 and $313,469 as of December 31, 2023 and 2022, respectively |
431,557 | 541,173 | ||||||
Right-of-use assets, real estate used in operations |
3,832,264 | 3,724,781 | ||||||
Goodwill |
135,364,402 | 135,364,402 | ||||||
|
|
|
|
|||||
$ | 857,345,933 | $ | 777,151,247 | |||||
|
|
|
|
|||||
LIABILITIES AND MEMBERS EQUITY | ||||||||
LIABILITIES |
||||||||
Accounts payable and accrued expenses |
$ | 35,963,023 | $ | 15,685,699 | ||||
Leased equipment accounts payable |
40,156,963 | 19,879,045 | ||||||
Customer deposits and advanced payments |
4,594,454 | 2,361,870 | ||||||
Lease liabilities, real estate used in operations |
3,931,718 | 3,795,511 | ||||||
Distributions payable |
3,000,000 | 4,500,000 | ||||||
Deferred income tax liability |
12,619,496 | 9,637,123 | ||||||
Secured borrowings |
33,964,128 | 63,134,022 | ||||||
Notes payableRecourse |
151,240,882 | 135,252,630 | ||||||
Notes payableNon-recourse |
335,684,049 | 296,835,798 | ||||||
Senior secured debtRelated-party |
96,000,000 | 80,000,000 | ||||||
|
|
|
|
|||||
717,154,713 | 631,081,698 | |||||||
MEMBERS EQUITY |
140,191,220 | 146,069,549 | ||||||
|
|
|
|
|||||
$ | 857,345,933 | $ | 777,151,247 | |||||
|
|
|
|
The accompanying notes are an integral part of these statements.
Page 4
KBH TOPCO, LLC
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
YEARS ENDED DECEMBER 31, 2023 AND 2022
2023 | 2022 | |||||||
REVENUE |
||||||||
Leasing revenues |
$ | 181,103,563 | $ | 177,594,714 | ||||
Sales of equipment and software |
134,690,606 | 111,468,003 | ||||||
Transfers of financial assets |
4,501,729 | 3,619,883 | ||||||
Service revenues |
1,562,161 | 1,365,200 | ||||||
Other income |
5,504,656 | 4,712,363 | ||||||
|
|
|
|
|||||
327,362,715 | 298,760,163 | |||||||
|
|
|
|
|||||
DIRECT LEASING EXPENSES AND COST OF GOODS AND SERVICES SOLD |
||||||||
Depreciation of equipment |
81,839,325 | 83,870,441 | ||||||
Interest expenseRecourse debt |
10,016,422 | 5,964,426 | ||||||
Interest expenseSecured borrowings |
2,808,125 | 4,093,820 | ||||||
Interest expenseNon-recourse debt |
17,485,490 | 10,547,276 | ||||||
Interest expenseSenior secured debtrelated party |
10,223,852 | 7,315,080 | ||||||
Cost of goods and services sold |
146,228,929 | 128,513,108 | ||||||
|
|
|
|
|||||
268,602,143 | 240,304,151 | |||||||
|
|
|
|
|||||
GROSS MARGIN |
58,760,572 | 58,456,012 | ||||||
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES |
46,422,636 | 40,326,719 | ||||||
|
|
|
|
|||||
INCOME BEFORE INCOME TAX PROVISION |
12,337,936 | 18,129,293 | ||||||
INCOME TAX PROVISION |
3,272,511 | 4,841,905 | ||||||
|
|
|
|
|||||
NET INCOME |
9,065,425 | 13,287,388 | ||||||
OTHER COMPREHENSIVE INCOME (LOSS) |
||||||||
Foreign currency translation adjustment |
56,246 | (386,031 | ) | |||||
|
|
|
|
|||||
COMPREHENSIVE INCOME |
$ | 9,121,671 | $ | 12,901,357 | ||||
|
|
|
|
The accompanying notes are an integral part of these statements.
Page 5
KBH TOPCO, LLC
CONSOLIDATED STATEMENTS OF CHANGES IN MEMBERS EQUITY
YEARS ENDED DECEMBER 31, 2023 AND 2022
Accumulated Other Comprehensive Income (loss) |
||||||||||||||||
Common Units | ||||||||||||||||
Units | Amount | Total | ||||||||||||||
BALANCEJANUARY 1, 2022 |
84,000,000 | $ | 150,478,967 | $ | 89,225 | $ | 150,568,192 | |||||||||
Net income |
| 13,287,388 | | 13,287,388 | ||||||||||||
Other comprehensive loss |
| | (386,031 | ) | (386,031 | ) | ||||||||||
Distributions |
| (17,400,000 | ) | | (17,400,000 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
BALANCEDECEMBER 31, 2022 |
84,000,000 | 146,366,355 | (296,806 | ) | 146,069,549 | |||||||||||
Net income |
| 9,065,425 | | 9,065,425 | ||||||||||||
Other comprehensive income |
| | 56,246 | 56,246 | ||||||||||||
Distributions |
| (15,000,000 | ) | | (15,000,000 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
BALANCEDECEMBER 31, 2023 |
84,000,000 | $ | 140,431,780 | $ | (240,560 | ) | $ | 140,191,220 | ||||||||
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these statements.
Page 6
KBH TOPCO, LLC
CONSOLIDATED STATEMENTS OF CASH FLOWS
YEARS ENDED DECEMBER 31, 2023 AND 2022
2023 | 2022 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES |
||||||||
Net income |
$ | 9,065,425 | $ | 13,287,388 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Sales-type and direct finance lease receipts |
52,731,072 | 33,708,587 | ||||||
Earned income from sales-type and direct finance leases |
(12,841,348 | ) | (4,375,939 | ) | ||||
Depreciation and amortization |
82,041,915 | 84,031,835 | ||||||
Non-cash lease expense, real estate used in operations |
993,866 | 733,593 | ||||||
Provision for impairments and net loss on sale of equipment held for |
13,734,794 | 14,430,739 | ||||||
Deferred income taxes |
2,982,373 | 4,594,732 | ||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
(21,725,233 | ) | 851,409 | |||||
Prepaid expenses, deposits and other assets |
766,698 | 859,297 | ||||||
Accounts payable and accrued expenses |
20,277,324 | 1,845,197 | ||||||
Customer deposits and advanced payments |
2,232,584 | (4,239,005 | ) | |||||
Lease liabilities, real estate used in operations |
(965,142 | ) | (662,863 | ) | ||||
|
|
|
|
|||||
Net Cash Provided By Operating Activities |
149,294,328 | 145,064,970 | ||||||
|
|
|
|
|||||
CASH FLOWS FROM INVESTING ACTIVITIES |
||||||||
Investment in sales-type and direct finance leases |
(126,383,456 | ) | (30,745,196 | ) | ||||
Purchases of equipment under operating leases |
(80,587,790 | ) | (200,232,804 | ) | ||||
Proceeds from sales of equipment and software |
39,376,953 | 68,007,509 | ||||||
Purchases of equipment used in operations |
(99,171 | ) | (200,167 | ) | ||||
|
|
|
|
|||||
Net Cash Used In Investing Activities |
(167,693,464 | ) | (163,170,658 | ) | ||||
|
|
|
|
|||||
CASH FLOWS FROM FINANCING ACTIVITIES |
||||||||
Principal payments on secured borrowings |
(29,169,894 | ) | (39,219,558 | ) | ||||
Proceeds from notes payableRecourse |
313,995,962 | 326,431,257 | ||||||
Principal payments on notes payableRecourse |
(298,007,710 | ) | (316,272,863 | ) | ||||
Proceeds from notes payableNon-recourse |
157,017,711 | 196,829,996 | ||||||
Principal payments on notes payableNon-recourse |
(118,169,460 | ) | (133,271,087 | ) | ||||
Proceeds from senior secured debtRelated-party |
16,000,000 | | ||||||
Distributions paid |
(16,500,000 | ) | (16,900,000 | ) | ||||
|
|
|
|
|||||
Net Cash Provided By Financing Activities |
25,166,609 | 17,597,745 | ||||||
|
|
|
|
|||||
EFFECTS OF CURRENCY TRANSLATION |
56,246 | (386,031 | ) | |||||
|
|
|
|
|||||
NET CHANGE IN CASH |
6,823,719 | (893,974 | ) | |||||
CASHBEGINNING OF YEAR |
6,155,829 | 7,049,803 | ||||||
|
|
|
|
|||||
CASHEND OF YEAR |
$ | 12,979,548 | $ | 6,155,829 | ||||
|
|
|
|
|||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION |
||||||||
Interest paid |
$ | 40,339,063 | $ | 27,710,221 | ||||
|
|
|
|
The accompanying notes are an integral part of these statements.
Page 7
KBH TOPCO, LLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation and Financial Reporting. The accompanying consolidated financial statements include the accounts of KBH Topco, LLC, a Delaware limited liability company (KBHT) formed on October 29, 2020, and its wholly-owned subsidiaries (each organized as either a Nevada limited liability company or a Delaware limited liability company), collectively referred to as the Company. All significant intercompany accounts and transactions have been eliminated in consolidation. In November 2020, 87.50% of the Company was acquired by SLR Investment Corp. f/k/a Solar Capital Ltd. (SLR).
Description of Business. The Company leases, rents, sells, manages, and remarkets technology, industrial, healthcare, and other general equipment and software. Their customers are located throughout the United States, Canada, France, Spain, and Italy.
Management Estimates and Assumptions. The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates. Significant estimates and assumptions are used for, but not limited to: (1) estimated useful lives and residual values of equipment under operating, sales-type and direct finance leases; (2) classification of leases; (3) impairment of equipment under operating leases; (4) impairment of goodwill; (5) revenue recognition; (6) allowance for credit losses; and (7) valuation of net deferred income tax assets or liabilities. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. Accounting estimates used in the preparation of these consolidated financial statements change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes.
Concentration of Credit Risk. The Company regularly maintains bank balances that exceed Federal Deposit Insurance Corporation limits.
Adoption of Recent Accounting Pronouncements. During 2023, the Company adopted new accounting guidance related to the measurement of estimated credit losses on accounts receivable and investment in sales-type and direct finance leases in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 326-20, Financial Instruments Credit Losses (FASB ASC 326-20). FASB ASC 326-20 requires the Company to estimate expected credit losses over the life of its financial assets as of the reporting date based on relevant information about past events, current conditions, and reasonable and supportable forecasts. The Company monitors its lessees performance and its lease exposure on an ongoing basis and assesses the performance of residual values based on historical results.
LeasesLessor. The Company adopted FASB ASC 842, Leases, on January 1, 2022. The standard modifies the accounting, presentation and disclosures for both lessors and lessees. The Company elected the optional transition method to apply the transition provisions from the effective date of adoption, which requires the Company to report the cumulative effect of the standard on the date of adoption with no changes to the prior period balances. There was no cumulative effect to beginning members equity as of January 1, 2022, from the adoption of FASB ASC 842. Pursuant to the practical expedients, the Company elected not to reassess: (i) whether expired or existing contracts are or contain leases, (ii) the lease classification for any expired or existing leases, or (iii) initial direct costs for any existing leases.
Leases not classified as a sales-type or direct finance lease are classified as operating leases. If a lease meets one or more of the following five criteria at lease commencement, the lease is classified as a sales-type lease:
| The lease transfers ownership of the underlying asset to the lessee by the end of the lease term; |
| The lease grants the lessee an option to purchase the underlying asset that the lessee is reasonably certain to exercise; |
| The lease term is for a major part of the remaining estimated economic life of the underlying asset; |
| The present value of the sum of the lease payments and any residual value guaranteed by the lessee that is not already reflected in the lease payments equals or exceeds substantially all of the fair value of the underlying asset; or |
| The underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease. |
(Continued)
Page 8
KBH TOPCO, LLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Leases (Concluded). Lessor Accounting When none of the sales-type lease criteria have been met, leases are classified as operating leases unless both of the following criteria are met, in which case the lessor shall classify the leases as direct finance leases: (1) the present value of the sum of the lease payments and any residual value guaranteed by the lessee and/or third party unrelated to the lessor equals or exceeds substantially all of the fair value of the underlying asset and (2) it is probable that the lessor will collect the lease payments plus any amount necessary to satisfy a residual value guarantee.
Residual Values The estimated residual values of equipment at the end of the useful life are recorded at the inception of each lease. The estimated residual values vary as a percentage of the original equipment cost and depend upon the equipment type. Residual values for sales-type and direct finance leases are recorded at their net present value and the unearned income is amortized over the life of the lease using the effective interest method. The residual values for operating leases are included in the leased equipments net book value. The Company manages and evaluates residual value risk by performing periodic reviews and any impairment, other than temporary, is recorded in the period in which the impairment is determined. No upward revision of residual values is made subsequent to lease inception.
Property taxes paid by the lessor which are reimbursed by the lessee are considered to be lessor costs of owning the asset and are recorded gross with revenue in other income and expense in selling, general and administrative expenses. The Company elected a lessor accounting policy to exclude sales taxes and other similar taxes on lease revenue-producing transactions collected from the lessee from revenue and expenses.
Lessor accounting was not fundamentally changed by FASB ASC 842 and remains similar to FASB ASC 840 and did not have a significant impact on classification of leases between sales-type, direct finance and operating.
Revenue Recognition. The Company recognizes revenue in accordance with the following accounting standards: (1) FASB ASC 842, Leases, (2) FASB ASC 860, Transfers and Servicing, and (3) FASB ASC 606, Revenue from Contracts with Customers.
Revenue from Leasing Transactions under FASB ASC 842 The Company accounts for certain leasing revenues in accordance with FASB ASC 842. The accounting for revenue is different depending on the type of lease.
For sales-type and direct finance leases, the Company records the net investment in leases, which consists of the sum of the minimum lease payments, initial direct costs, and unguaranteed residual value for sales-type leases and guaranteed residual value for direct finance leases (gross investment) less the unearned income. Revenue for sales-type and direct finance leases is recognized as the unearned income is amortized over the life of the lease using the effective interest method. For operating leases, rental amounts are accrued on a straight-line basis over the lease term and are recognized as leasing revenue.
Leasing revenues consist of rentals due under operating leases and the amortization of unearned income on sales-type and direct finance leases. Equipment under operating leases is recorded at cost and depreciated on a straight-line basis over the useful life.
Revenue from the Transfer of Financial Assets under FASB ASC 860The Company enters into arrangements to transfer the contractual payments due under sales-type and direct finance leases, which are accounted for in accordance with FASB ASC 860. These transfers are accounted for as either a pledge of collateral in a secured borrowing or a sale. For transfers accounted for as a secured borrowing, the corresponding investments serve as collateral for recourse and non-recourse notes payable. For transfers accounted for as sales, the Company derecognizes the carrying value of the asset transferred plus any liability and recognizes a net gain or loss on the sale, which are presented as transfers of financial assets in the consolidated statements of comprehensive income.
(Continued)
Page 9
KBH TOPCO, LLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Revenue Recognition (Continued). Revenue from Sales of Equipment, Software and Services under FASB ASC 606Under FASB ASC 606, revenue is recognized when the Company satisfies its performance obligations, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services.
Revenue from contracts with customers is measured based on the consideration specified in the contract with the customer, and excludes any sales incentives and amounts collected on behalf of third parties. Contracts with customers may include multiple promises that are distinct performance obligations. For such arrangements, the Company allocates the transaction price to each performance obligation based on its relative standalone selling price. A performance obligation is a promise in a contract to transfer a distinct good or service to a customer. The Company recognizes revenue when it satisfies a performance obligation by transferring control over a product or service to a customer. The amount of revenue recognized reflects the consideration the Company expects to be entitled to in exchange for such goods or services. After completion of the performance obligation, the Company has an unconditional right to consideration as outlined in the contract.
Service Revenues - The Company maintains service contracts for maintenance and repair services to customers for the customer owned equipment. The Companys arrangement is typically a single performance obligation comprised of a series of distinct services that are substantially the same and that have the same pattern of transfer. The Company typically recognizes sales from these services on a straight-line basis over the period services are provided. Payments are typically due within 30 days after an invoice is sent to the customer. Invoices for services are typically sent in advance.
Equipment and Software Sales - The Company sells equipment and software to both current lessees and third parties for leased equipment, brokerage of equipment, and lease transaction sales. Sales revenue is recorded at the amount of gross consideration received. Revenue is recognized at a point in time when the Company satisfies its performance obligations. Payments are typically due upon receipt of the invoice. Invoices for equipment and software sales are typically sent in advance.
The Company has adopted certain practical expedients under FASB ASC 606 with significant items disclosed herein. The Company has elected to apply the portfolio approach practical expedient allowed under FASB ASC 606 to evaluate contracts with customers that share the same revenue recognition patterns as the result of evaluating them as a group will have substantially the same result as evaluating them individually.
Disaggregation of Revenue - The table below summarizes the Companys revenues as presented in the consolidated statement of comprehensive income for the year ended December 31, 2023 by revenue type and by the applicable accounting standard:
Year Ended December 31, 2023 | ||||||||||||||||
FASB ASC 842 | FASB ASC 860 | FASB ASC 606 | Total | |||||||||||||
Operating lease revenues |
$ | 168,262,215 | $ | | $ | | $ | 168,262,215 | ||||||||
Sales-type and direct finance lease revenues |
12,841,348 | | | 12,841,348 | ||||||||||||
Sales of equipment and software |
| | 134,690,606 | 134,690,606 | ||||||||||||
Transfers of financial assets |
| 4,501,729 | | 4,501,729 | ||||||||||||
Service revenues |
| | 1,562,161 | 1,562,161 | ||||||||||||
Other income |
5,060,610 | | 444,046 | 5,504,656 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenue |
$ | 186,164,173 | $ | 4,501,729 | $ | 136,696,813 | $ | 327,362,715 | ||||||||
|
|
|
|
|
|
|
|
Total revenue subject to FASB ASC 606 recognized at a point in time and over time was $135,134,652 and $1,562,161, respectively, for the year ended December 31, 2023.
(Continued)
Page 10
KBH TOPCO, LLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Revenue Recognition (Concluded). Disaggregation of Revenue (Concluded) - The table below summarizes the Companys revenues as presented in the consolidated statement of comprehensive income for the year ended December 31, 2022 by revenue type and by the applicable accounting standard:
Year Ended December 31, 2022 | ||||||||||||||||
FASB ASC 842 | FASB ASC 860 | FASB ASC 606 | Total | |||||||||||||
Operating lease revenues |
$ | 173,218,775 | $ | | $ | | $ | 173,218,775 | ||||||||
Sales-type and direct finance lease revenues |
4,375,939 | | | 4,375,939 | ||||||||||||
Sales of equipment and software |
| | 111,468,003 | 111,468,003 | ||||||||||||
Transfers of financial assets |
| 3,619,883 | | 3,619,883 | ||||||||||||
Service revenues |
| | 1,365,200 | 1,365,200 | ||||||||||||
Other income |
4,580,006 | | 132,357 | 4,712,363 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenue |
$ | 182,174,720 | $ | 3,619,883 | $ | 112,965,560 | $ | 298,760,163 | ||||||||
|
|
|
|
|
|
|
|
Total revenue subject to FASB ASC 606 recognized at a point in time and over time was $111,600,360 and $1,365,200, respectively, for the year ended December 31, 2022.
Accounts Receivable. Accounts receivable represent customer obligations, which include base monthly, quarterly, and annual rentals due under the terms of each respective customers lease and equipment sales. The carrying amount of accounts receivable is reduced by an allowance for credit losses. Gross accounts receivable were $37,812,925 and $15,814,867 as of December 31, 2023 and December 31, 2022, respectively.
Allowance for Credit Losses. The Companys allowance for credit losses represents the estimate of expected credit losses related to accounts receivable and investment in sales-type and direct finance leases. The Company pools its accounts receivable and investment in sales-type and direct finance leases based on similar risk characteristics, such as geographic location, business channel, and other account data. To estimate the allowance for credit losses, the Company leverages information on historical losses, asset-specific risk characteristics, current conditions, and reasonable and supportable forecasts of future conditions. Account balances are written off against the allowance when the Company deems the amount is uncollectible. The allowance for credit losses related to accounts receivable was $435,564 and $162,739 as of December 31, 2023 and January 1, 2023, respectively. The allowance for doubtful accounts prior to the adoption of FASB ASC 326-20 was $162,739 as of December 31, 2022. There was no allowance for credit losses related to investment in sales-type and direct finance leases.
Depreciation and Amortization. Depreciation provisions for revenue-producing equipment are computed using the straight-line method over the related useful life of the equipment, after giving effect to an estimated residual value. The useful lives for leased equipment range from approximately six and ten years. For other equipment used in operations, depreciation and amortization is computed using the straight-line method over the estimated useful lives of the assets, ranging from approximately three to eight years and was $202,590 and $161,394 for the years ended December 31, 2023 and 2022, respectively.
Goodwill. Goodwill represents the excess of the consideration paid over the estimated fair value of the net assets acquired in a business combination. The Company performs an annual impairment test for goodwill at the entity level. There were no impairment charges or triggering events for the years ended December 31, 2023 or 2022.
(Continued)
Page 11
KBH TOPCO, LLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Foreign Operations. The functional currencies for the consolidated foreign operations are the Canadian dollar and Euro. The translation of the applicable foreign currencies into U.S. dollars is performed for monetary balance sheet accounts using current exchange rates in effect at the balance sheet date and for revenue and expense accounts using a weighted average exchange rate during the period. Nonmonetary balance sheet accounts and related revenue, expense, gain and loss accounts are remeasured using historical rates to produce the same results as if the items had been initially recorded in U.S. dollars. The gains or losses resulting from such translation of the Canadian dollar and Euro are included as a component of accumulated other comprehensive income in members equity. Assets located outside the United States and subject to foreign currency denominated transactions totaled $9,821,459 and $9,008,605 as of December 31, 2023 and 2022, respectively.
Leases Lessee. Operating lease right-of-use assets and operating lease liabilities are recognized at the present value of the future lease payments, generally for the base non-cancelable lease term, at the lease commencement date for each lease. The Company has elected a policy to use a risk-free rate as the discount rate used to determine the present value of the future lease payments because the interest rate implicit in most of the Companys leases is not readily determinable. The Companys lease agreements may contain lease and non-lease components. Variable lease payments are not included in the measurement of the right-of-use asset and lease liability, and they are recognized as lease expense is incurred.
Leases may contain options to renew or terminate lease terms. The exercise of these lease options is generally at the Companys sole discretion and included in the right-of-use asset and lease liability. The Company elected to apply the short-term lease measurement and recognition exemption to its leases where applicable.
Variable lease payments predominantly relate to variable operating expenses including common area maintenance, property taxes and other operating expenses. The Company records the amortization of the right-of-use asset and the interest accretion on the lease liability for operating leases as a component of selling, general, and administrative expenses in the statement of comprehensive income.
When lease agreements provide allowances for leasehold improvements, the Company assesses whether it is the owner of the leasehold improvements for accounting purposes. When the Company concludes that it is the owner, it capitalizes the leasehold improvement assets and recognizes the related amortization expense on a straight-line basis over the lesser of the related lease term, including renewals that are reasonably assured of being exercised, or the estimated useful life of the asset. Additionally, the Company recognizes the amounts of allowances to be received from the lessor as a reduction of the lease liability and the associated right-of-use asset. When the Company concludes that it is not the owner, the payments that the Company makes towards the leasehold improvements are accounted for as a component of the lease payments.
Income Taxes. The Company was formed as a limited liability company and elected to be taxed as a C-Corporation. Deferred income taxes are provided using the liability method whereby deferred income tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred income tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred income tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realized. Deferred income tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates at the date of enactment. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred income tax assets and liabilities.
KBHTs wholly-owned subsidiaries are disregarded entities for income tax purposes. Their operations are combined with the operations of KBHT and reported together in one income tax return.
(Continued)
Page 12
KBH TOPCO, LLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Concluded)
Fair Value Measurements. Fair value accounting guidance defines fair value, establishes a framework for measuring fair value under GAAP, and expands disclosures about fair value measurements for both financial and non-financial assets. It also provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of the fair value hierarchy are described as follows:
Level 1. Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the
Company has the ability to access.
Level 2. Inputs to the valuation methodology include the following:
| Quoted prices for similar assets or liabilities in active markets; |
| Quoted prices for identical or similar assets or liabilities in inactive markets; |
| Inputs other than quoted prices that are observable for the asset or liability; |
| Inputs that are derived principally from, or corroborated by, observable market data by correlation or other means. |
If the asset or liability has a specified (contractual) term, the level 2 input must be observable for substantially the full term of the asset or liability.
Level 3. Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
The assets or liabilitys fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.
Certain assets are measured at fair value on a nonrecurring basis subsequent to initial recognition. These assets are not measured at fair value on an ongoing basis but are subject to fair value adjustments only under certain circumstances, as GAAP does not permit the recording of unrealized appreciation of equipment held for sale and leased equipment.
In certain circumstances, these assets were written down to estimated fair value when it is determined that net realizable value is below cost. Adjustments to write down certain equipment held for sale and leased equipment to their net realizable value totaled approximately $10,121,000 and $15,900,000 for the years ended December 31, 2023 and 2022, respectively, and are included within cost of goods and services sold on the consolidated statements of comprehensive income. Equipment held for sale totaled approximately $7,300,000 and $3,400,000 as December 31, 2023 and 2022, respectively, and is included within inventory, prepaid expenses, deposits and other assets on the consolidated balance sheets.
Reclassification. Certain reclassifications were made to the 2022 financial statements to conform with the 2023 presentation. Such reclassifications had no impact on previously reported consolidated net income or members equity.
Page 13
KBH TOPCO, LLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2 INVESTMENT IN SALES-TYPE AND DIRECT FINANCE LEASES, NET
The investment in sales-type and direct finance leases consisted of the following as of December 31:
2023 | 2022 | |||||||
Minimum lease payments |
$ | 207,187,336 | $ | 79,264,530 | ||||
Estimated residual value |
40,196,048 | 10,415,588 | ||||||
|
|
|
|
|||||
Subtotal |
247,383,384 | 89,680,118 | ||||||
Less: Unearned lease income |
54,232,638 | 10,595,145 | ||||||
|
|
|
|
|||||
Investment in sales-type and direct finance leases, net |
$ | 193,150,746 | $ | 79,084,973 | ||||
|
|
|
|
As of December 31, 2023 and 2022, there were $28,493,846 and $-0- of investment in sales-type and direct finance leases in leased equipment accounts payable, respectively.
NOTE 3 FUTURE MINIMUM LEASE PAYMENTS TO BE RECEIVED
Approximate future minimum lease payments to be received under the terms of the non-cancelable operating, sales-type and direct finance leases as of December 31, 2023 were as follows:
Year Ending December 31 |
Sales-type and direct finance |
Operating | Total | |||||||||
2024 |
$ | 82,103,000 | $ | 117,827,000 | $ | 199,930,000 | ||||||
2025 |
56,659,000 | 88,301,000 | 144,960,000 | |||||||||
2026 |
25,143,000 | 55,905,000 | 81,048,000 | |||||||||
2027 |
19,389,000 | 32,180,000 | 51,569,000 | |||||||||
2028 |
11,366,000 | 17,842,000 | 29,208,000 | |||||||||
Thereafter |
12,527,000 | 8,067,000 | 20,594,000 | |||||||||
|
|
|
|
|
|
|||||||
Total minimum lease payments |
207,187,000 | $ | 320,122,000 | $ | 527,309,000 | |||||||
|
|
|
|
|||||||||
Less: Unearned Income |
54,232,000 | |||||||||||
|
|
|||||||||||
Sales-type and direct finance lease receivable, at present value |
$ | 152,955,000 | ||||||||||
|
|
NOTE 4 DEBT
Secured Borrowings. The Company enters into arrangements to transfer the contractual payments due under sales-type, direct finance and operating leases. Due to the rights retained on certain lease participations sold, the Company is deemed to have retained effective control over these leases and therefore these transfers are accounted for as secured borrowings. As of December 31, 2023, the Company has secured borrowing agreements totaling $33,964,128 of which $2,565,988 was recourse and $31,398,140 was non-recourse. As of December 31, 2022, secured borrowing agreements totaled $63,134,022 of which $6,841,422 was recourse and $56,292,600 was non-recourse. These secured borrowing agreements have various maturity dates through 2029 and interest rates ranging from 3.20% and 5.28%. The investment in sales-type and direct finance leases and the equipment under operating leases pledged under these secured borrowing agreements were $599,204 and $55,555,542, respectively, as of December 31, 2023 and $1,616,955 and $79,928,883, respectively, as of December 31, 2022.
(Continued)
Page 14
KBH TOPCO, LLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 4 DEBT (Continued)
Secured Borrowings (Concluded). Principal payments on secured borrowings as of December 31, 2023 were due as follows:
Year Ending December 31 |
Amount | |||
2024 |
$ | 24,526,899 | ||
2025 |
7,181,474 | |||
2026 |
2,198,557 | |||
2027 |
19,066 | |||
2028 |
19,066 | |||
Thereafter |
19,066 | |||
|
|
|||
$ | 33,964,128 | |||
|
|
Notes PayableRecourse. The Company has recourse borrowing arrangements with various financial institutions with $151,240,882 and $135,252,630 of recourse debt outstanding as of December 31, 2023 and 2022, respectively. Various rate structures for each line pricing exist, based upon either the U.S. prime rate (8.50% at December 31, 2023, Prime) plus a spread, or based upon 30-day Secured Overnight Financing Rate (SOFR) plus a spread, or the like term swap rate for the investment period, plus 2.50% to 4.50%. Borrowings are collateralized by either a first lien on the equipment and assignment of rent or a second lien on the equipment representing the leased equipments residual values.
Under a $30,000,000 facility, maturing in August 2025, principal payments are determined by the maturities of the underlying equipment leases, of which $19,351,128 and $19,738,090 was outstanding as of December 31, 2023 and 2022, respectively. Balances are priced at Prime plus 1.50%, with a floor of 5.00%. Outstanding balances as of December 31, 2023 were due between January 2024 and September 2029. The debt agreement includes covenants for minimum tangible net worth and leverage. Additionally, there is a $1,000,000 guidance facility available for lease equipment residual values, where the financial institution has been assigned rents under notes payable non-recourse, of which $663,456 and $213,446 was outstanding as of December 31, 2023 and 2022, respectively.
Under a $65,000,000 facility maturing in July 2024, secured by a first lien on the equipment, with principal payments due based on the following schedule: the first two months of borrowing are interest only, after which 1.00% of the original principal is due on the first of each month, and then at six months from the date of the individual borrowing for the purchase of the equipment, the remaining principal balance is due. On this facility, $36,268,984 and $28,903,069 was outstanding as of December 31, 2023 and 2022, respectively. Additionally, prior to December 2023, $10,000,000 of this facility was able to be used for borrowings on a term basis, secured by a first lien on the equipment representing the leased equipments residual values and assignment of rent, of which $-0- and $471,312 was outstanding as of December 31, 2023 and 2022, respectively. The debt agreement includes covenants for minimum tangible net worth.
Under a $50,000,000 facility maturing in November 2024, principal payments are due based on the following schedule: the first two months of borrowing are interest only, after which 1.00% of the original principal is due on the first of each month, and then at six months from the date of the individual borrowing for the purchase of the equipment, the remaining principal balance is due. On this facility, $35,075,304 and $27,944,804 was outstanding as of December 31, 2023 and 2022, respectively. Additionally, $10,000,000 of this facility is able to be used for borrowings on a term basis, secured by a second lien on the equipment representing the leased equipments residual values, of which $4,553,140 and $6,580,105 was outstanding as of December 31, 2023 and 2022, respectively. The debt agreement includes covenants for minimum tangible net worth.
(Continued)
Page 15
KBH TOPCO, LLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 4 DEBT (Continued)
Notes PayableRecourse (Continued). Under a $27,000,000 facility, subject to annual review, borrowings are collateralized by either a first lien on the equipment and assignment of rents or a second lien on the equipment representing the leased equipments residual values subject to a cap on residuals of $8,000,000. On this facility, $1,887,946 and $3,154,227 was outstanding as of December 31, 2023 and 2022, respectively. Outstanding balances as of December 31, 2023 were due between January 2024 and June 2028.
Under an additional facility, borrowings are collateralized by a combination of first lien on the equipment and assignment of rents and a second lien on the equipment representing the leased equipments residual values. On this facility, $362,743 and $481,950 was outstanding as of December 31, 2023 and 2022, respectively. Outstanding balances as of December 31, 2023 were due between January 2024 and May 2027.
Under a $10,000,000 facility, subject to annual review, borrowings are collateralized by a combination of first lien on the equipment and assignment of rents and a second lien on the equipment representing the leased equipments residual values. Rates are determined at the time of discounting based on the underlying lease term. On this facility, $3,483,057 and $2,703,153 was outstanding as of December 31, 2023 and 2022, respectively. Outstanding balances as of December 31, 2023 were due between January 2024 and May 2028. Management is currently in the processes of renewing this facility with the financial institution.
Under a $15,000,000 facility, subject to annual review, borrowings are collateralized by a combination of first lien on the equipment and assignment of rents and a second lien on the equipment representing the leased equipments residual values. On this facility, $7,140,817 and $3,681,997 was outstanding as of December 31, 2023 and 2022, respectively. Additionally, $9,000,000 of this facility is able to be used for borrowings collateralized by the Companys equipment leases with a subsidiary, secured by both the rental stream and equipment residual values. On this portion of the facility, $3,974,649 and $4,026,637 was outstanding as of December 31, 2023 and 2022, respectively. Outstanding balances as of December 31, 2023 were due between January 2024 and December 2028. The guidance line includes covenants for minimum net worth.
Under a $3,000,000 facility, subject to annual review, borrowings are collateralized by a combination of first lien on the equipment and assignment of rents and a second lien on the equipment representing the leased equipments residual values. On this facility, $2,365,787 and $1,984,246 was outstanding as of December 31, 2023 and 2022, respectively. Outstanding balances as of December 31, 2023 were due between January 2024 and December 2028.
Under an additional facility, the Company has borrowed either funding against lease stream payments or equity residual in equipment. The periodic payments are determined by the underlying equipment lease streams and/or residual values of equipment, with both interest rate and principal payments being determined at the time of line draw by the financial institution. Rates on borrowings from this facility range from 200 to 450 basis points over the like term swap rate at the time of borrowing, with $5,368,251 and $8,271,743 outstanding as of December 31, 2023 and 2022, respectively. Borrowings for equity residuals are priced at 2.00% over the corresponding non-recourse stream rate for the underlying transaction. Outstanding balances as of December 31, 2023 were due between January 2024 and March 2028. There are additional loans with this financial institution of which $308,397 and $288,855 was outstanding as of December 31, 2023 and 2022, respectively.
The Company has a borrowing arrangement collateralized by a first lien on the equipment and assignment of rents on a pool of lease transactions totaling $110,782,280 and $87,920,095 outstanding as of December 31, 2023 and 2022, respectively, at a borrowing rate ranging from 4.18% to 6.39%. Of the total transactions, $21,362,208 and $15,270,372 as of December 31, 2023 and 2022, respectively, is secured on a recourse basis for a portion of the equipments residual values. The recourse portion of this transaction will amortize with cash flow from residual values. Management estimates that this obligation will fully amortize by November 2030. An additional $13,000,000 was provided on a recourse basis at 5.52% of which $9,075,015 and $11,538,624 was outstanding as of December 31, 2023 and 2022, respectively.
(Continued)
Page 16
KBH TOPCO, LLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 4 DEBT (Continued)
Notes PayableRecourse (Concluded). Principal payments on recourse notes payable as of December 31, 2023 were due as follows:
Year Ending December 31 |
Amount | |||
2024 |
$ | 95,841,520 | ||
2025 |
16,948,566 | |||
2026 |
11,131,376 | |||
2027 |
8,196,931 | |||
2028 |
14,465,301 | |||
Thereafter |
4,657,188 | |||
|
|
|||
$ | 151,240,882 | |||
|
|
Notes PayableNon-Recourse. Non-recourse notes payable are collateralized by the assignment of rent and the equipment value under lease. The financial institutions and a related party have a first lien on the underlying leased equipment with no further recourse against the Company in the event of default by lessee. Interest rates range from 1.5% to 12.0%. Under these arrangements, each lease is financed under a separate borrowing. Non-recourse debt and related interest expense is paid by funds from assigned committed term lease payments with various financial institutions. The outstanding balance was $335,684,049 and $296,835,798 as of December 31, 2023 and 2022, respectively, of which $21,976,624 and $11,376,355 with an average interest rate of 9.23% was due to a related party under common control as of December 31, 2023 and 2022, respectively.
Principal payments on non-recourse notes payable as of December 31, 2023 were due as follows:
Year Ending December 31 |
Amount | |||
2024 |
$ | 105,847,540 | ||
2025 |
76,965,841 | |||
2026 |
59,040,199 | |||
2027 |
44,319,887 | |||
2028 |
31,509,976 | |||
Thereafter |
18,000,606 | |||
|
|
|||
$ | 335,684,049 | |||
|
|
Senior Secured DebtRelated-Party. The Company has a recourse senior secured debt facility with SLR. The facility was amended in 2023 to allow the Company to borrow up to $96,000,000. The interest rate on the facility is SOFR plus 7.00%. Interest payments are due quarterly until maturity in December 2024. The debt is collateralized by a subordinated lien on the Companys leased assets and the Companys outstanding rollover equity interests. The debt agreement includes covenants for minimum tangible net worth and leverage. The outstanding balance including accrued interest was $96,000,000 and $80,000,000 as of December 31, 2023 and 2022, respectively. Related-party interest expense was approximately $10,224,000 and $7,315,000 for the years ended December 31, 2023 and 2022, respectively.
Page 17
KBH TOPCO, LLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 5 MEMBERS EQUITY
All members of the Company have the same rights, preferences, and privileges. Profits, losses, and distributions are allocated in accordance with the Operating Agreement.
The Company has two classes of units: Common units and Preferred units. There were no Preferred units issued and outstanding as of December 31, 2023 and 2022.
NOTE 6 OPERATING LEASES
The Company leases various facilities under the terms of non-cancelable operating leases which expire from June 2024 through July 2028 which call for monthly rental payments ranging from approximately $2,000 to $30,000 per month. The Company does not believe it will exercise the options to extend the leases. The office leases generally require the Company to pay taxes, insurance, utilities, and maintenance costs in addition to base rent.
The components of lease expense were as follows for the years ended December 31:
2023 | 2022 | |||||||
Fixed operating lease cost |
$ | 1,130,177 | $ | 733,593 | ||||
Variable and short-term lease costs |
300,922 | 419,623 | ||||||
|
|
|
|
|||||
Total lease expense |
$ | 1,431,099 | $ | 1,153,216 | ||||
|
|
|
|
Other information related to lease was as follows for the years ended December 31:
2023 | 2022 | |||||||
Weighted-average remaining lease term (in years) |
3.96 | 4.69 | ||||||
Weighted-average discount rate |
3.26 | % | 2.89 | % |
Cash flows related to leases were as follows for the years ended December 31:
2023 | 2022 | |||||||
Cash flows from operating activities: |
||||||||
Cash paid for amounts included in the measurement of operating lease liabilities |
$ | 1,101,453 | $ | 662,863 | ||||
Supplemental disclosure of cash flow information: |
||||||||
Right-of-use assets obtained in exchange for operating lease obligations |
$ | 1,101,349 | $ | 4,395,457 |
(Continued)
Page 18
KBH TOPCO, LLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 6 OPERATING LEASES (Continued)
Approximate future maturities of lease liabilities under non-cancelable operating leases were as follows as of December 31, 2023:
Year Ending December 31 |
Amount | |||
2024 |
$ | 1,125,000 | ||
2025 |
1,014,000 | |||
2026 |
947,000 | |||
2027 |
879,000 | |||
2028 |
241,000 | |||
|
|
|||
4,206,000 | ||||
Less: Imputed interest |
274,000 | |||
|
|
|||
$ | 3,932,000 | |||
|
|
NOTE 7 INCOME TAXES
A reconciliation of the statutory federal income tax rate and effective rate of the benefit for (provision from) income taxes is as follows:
December 31, 2023 |
December 31, 2022 |
|||||||
Federal statutory rate |
21.0 | % | 21.0 | % | ||||
State income taxes, net of federal benefit |
5.05 | 6.08 | ||||||
Deferred true up |
(0.05 | ) | (0.13 | ) | ||||
Permanent items |
0.52 | (0.24 | ) | |||||
|
|
|
|
|||||
Effective tax rate |
26.52 | % | 26.71 | % | ||||
|
|
|
|
The income tax provision consisted of the following components for the years ended December 31:
2023 | 2022 | |||||||
Deferred |
$ | 2,982,373 | $ | 4,594,732 | ||||
Current |
290,138 | 247,173 | ||||||
|
|
|
|
|||||
$ | 3,272,511 | $ | 4,841,905 | |||||
|
|
|
|
(Continued)
Page 19
KBH TOPCO, LLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 7 INCOME TAXES (Concluded)
The Companys deferred income tax assets and liabilities consisted of the following components as of December 31:
2023 | 2022 | |||||||
Deferred income tax asset (liability) |
||||||||
Depreciation and amortization |
$ | (34,229,411 | ) | $ | (30,452,940 | ) | ||
Allowance for doubtful accounts |
112,407 | 41,998 | ||||||
Interest expense carryforward |
3,372,581 | 3,431,247 | ||||||
Net operating loss |
18,124,927 | 17,342,572 | ||||||
|
|
|
|
|||||
Net deferred income tax liability |
$ | (12,619,496 | ) | $ | (9,637,123 | ) | ||
|
|
|
|
The Company has a pre-tax net operating loss (NOL) carryforward of $14,749,274 for Federal tax purposes as of December 31, 2023. The Company has apportioned after-tax state NOLs of up to $3,375,653 as of December 31, 2023 with the earliest expiration date in 2028.
NOTE 8 LITIGATION
From time to time, the Company is subject to litigation arising in the ordinary course of business. It is the opinion of the Companys management that any claims pending are either covered by insurance or that there is no material exposure to the Company in connection with any proceedings.
NOTE 9 SUBSEQUENT EVENTS
Management has evaluated all known subsequent events from December 31, 2023 through February 9, 2024, the date the accompanying consolidated financial statements were available to be issued and is not aware of any material subsequent events occurring during this period.
Exhibit 99.4
Gemino Healthcare Finance, LLC
d/b/a SLR Healthcare ABL
Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Table of Contents
Years Ended December 31, 2023 and 2022
Page | ||||
Independent Auditors Report |
1 | |||
Consolidated Financial Statements |
||||
Consolidated Balance Sheets |
3 | |||
Consolidated Statements of Operations |
4 | |||
Consolidated Statements of Changes in Members Equity |
5 | |||
Consolidated Statements of Cash Flows |
6 | |||
Notes to Consolidated Financial Statements |
7 |
Independent Auditors Report
To the Board of Managers of
Gemino Healthcare Finance, LLC and Subsidiary
Opinion
We have audited the consolidated financial statements of Gemino Healthcare Finance, LLC and Subsidiary d/b/a SLR Healthcare ABL (the Company), which comprise the consolidated balance sheets as of December 31, 2023 and 2022, and the related consolidated statements of operations, changes in members equity and cash flows for the years then ended, and the related notes to the consolidated financial statements.
In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022 and the results of its operations and its cash flows for the years then ended in accordance with accounting principles generally accepted in the United States of America (GAAP).
Basis for Opinion
We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditors Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Responsibilities of Management for the Consolidated Financial Statements
Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with GAAP, and for the design, implementation and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the consolidated financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Companys ability to continue as a going concern within one year after the date that the financial statements are available to be issued.
Auditors Responsibilities for the Audit of the Consolidated Financial Statements
Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the consolidated financial statements.
Baker Tilly US, LLP, trading as Baker Tilly, is a member of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities. © 2020 Baker Tilly US, LLP
1
In performing an audit in accordance with GAAS, we:
| Exercise professional judgment and maintain professional skepticism throughout the audit. |
| Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. |
| Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Companys internal control. Accordingly, no such opinion is expressed. |
| Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the consolidated financial statements. |
| Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Companys ability to continue as a going concern for a reasonable period of time. |
We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.
Philadelphia, Pennsylvania
February 15, 2024
2
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Consolidated Balance Sheets
December 31, 2023 and 2022
2023 | 2022 | |||||||
Assets |
||||||||
Assets |
||||||||
Cash and cash equivalents |
$ | 38,417 | $ | 9,319,837 | ||||
Loans receivable, net |
111,264,256 | 92,383,159 | ||||||
Accrued interest receivable |
1,456,919 | 1,181,464 | ||||||
Goodwill |
5,663,531 | 5,663,531 | ||||||
Furniture and equipment, net |
34,642 | 35,725 | ||||||
Other assets |
105,652 | 121,706 | ||||||
|
|
|
|
|||||
Total assets |
$ | 118,563,417 | $ | 108,705,422 | ||||
|
|
|
|
|||||
Liabilities and Members Equity |
||||||||
Liabilities |
||||||||
Credit facility, net |
$ | 83,101,563 | $ | 76,639,027 | ||||
Accounts payable and accrued expenses |
4,158,427 | 2,929,111 | ||||||
Dividend payable |
1,495,058 | 529,029 | ||||||
|
|
|
|
|||||
Total liabilities |
88,755,048 | 80,097,167 | ||||||
|
|
|
|
|||||
Members equity |
||||||||
Units, $1,000 par value, issued and outstanding 35,259 and 35,264, respectively |
32,808,874 | 32,814,339 | ||||||
Accumulated deficit |
(3,000,505 | ) | (4,206,084 | ) | ||||
|
|
|
|
|||||
Total members equity |
29,808,369 | 28,608,255 | ||||||
|
|
|
|
|||||
Total liabilities and members equity |
$ | 118,563,417 | $ | 108,705,422 | ||||
|
|
|
|
See notes to consolidated financial statements
3
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Consolidated Statements of Operations
Years Ended December 31, 2023 and 2022
2023 | 2022 | |||||||
Interest income: |
||||||||
Interest income |
$ | 13,610,602 | $ | 7,919,047 | ||||
Interest expense |
6,498,804 | 3,191,098 | ||||||
|
|
|
|
|||||
Net interest income |
7,111,798 | 4,727,949 | ||||||
Provision for loan losses |
81,159 | 117,149 | ||||||
|
|
|
|
|||||
Net interest income after provision for loan losses |
7,030,639 | 4,610,800 | ||||||
Other income |
4,275,023 | 3,673,619 | ||||||
Operating expenses: |
||||||||
Compensation and benefits |
4,896,205 | 3,934,044 | ||||||
Depreciation and amortization |
21,193 | 22,248 | ||||||
General and administrative |
930,490 | 853,453 | ||||||
|
|
|
|
|||||
Total operating expenses |
5,847,888 | 4,809,745 | ||||||
Net income |
$ | 5,457,774 | $ | 3,474,674 | ||||
|
|
|
|
See notes to consolidated financial statements
4
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Consolidated Statements of Changes in Members Equity
Years Ended December 31, 2023 and 2022
Balance at December 31, 2021 |
$ | 28,856,140 | ||
Capital distributions |
(6,444 | ) | ||
Dividends declared |
(3,716,115 | ) | ||
Net income |
3,474,674 | |||
|
|
|||
Balance at December 31, 2022 |
$ | 28,608,255 | ||
Cumulative effect of adopting new accounting standard (see Note 2) |
429,211 | |||
Capital distributions |
(5,465 | ) | ||
Dividends declared |
(4,681,406 | ) | ||
Net income |
5,457,774 | |||
|
|
|||
Balance at December 31, 2023 |
$ | 29,808,369 | ||
|
|
See notes to consolidated financial statements
5
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Consolidated Statements of Cash Flows
Years Ended December 31, 2023 and 2022
2023 | 2022 | |||||||
Cash Flows from Operating Activities |
||||||||
Net income |
$ | 5,457,774 | $ | 3,474,674 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Depreciation |
21,193 | 22,248 | ||||||
Amortization of deferred origination fees and costs |
(614,190 | ) | (421,113 | ) | ||||
Amortization of debt issuance costs |
526,642 | 240,649 | ||||||
Provision for loan losses |
81,159 | 117,149 | ||||||
Changes in assets and liabilities: |
||||||||
Increase in accrued interest receivable |
(275,455 | ) | (517,337 | ) | ||||
Decrease (increase) in other assets |
16,054 | (48,752 | ) | |||||
Increase in deferred origination fees and costs |
718,061 | 721,951 | ||||||
Increase in accounts payable and accrued expenses |
1,229,316 | 437,931 | ||||||
|
|
|
|
|||||
Net cash provided by operating activities |
7,160,554 | 4,027,400 | ||||||
|
|
|
|
|||||
Cash Flows from Investing Activities |
||||||||
Increase in loans receivable |
(18,636,916 | ) | (11,197,577 | ) | ||||
Purchase of furniture and equipment |
(20,110 | ) | (43,654 | ) | ||||
|
|
|
|
|||||
Net cash used in investing activities |
(18,657,026 | ) | (11,241,231 | ) | ||||
|
|
|
|
|||||
Cash Flows from Financing Activities |
||||||||
Proceeds from credit facility |
7,700,000 | 17,000,000 | ||||||
Debt issuance costs |
(1,764,106 | ) | | |||||
Dividends |
(3,715,377 | ) | (3,716,144 | ) | ||||
Capital distributions |
(5,465 | ) | (6,444 | ) | ||||
|
|
|
|
|||||
Net cash provided by financing activities |
2,215,052 | 13,277,412 | ||||||
|
|
|
|
|||||
Net (decrease) increase in cash and cash equivalents |
(9,281,420 | ) | 6,063,581 | |||||
Cash and cash equivalents, beginning of the year |
9,319,837 | 3,256,256 | ||||||
|
|
|
|
|||||
Cash and cash equivalents, end of the year |
$ | 38,417 | $ | 9,319,837 | ||||
|
|
|
|
|||||
Supplemental Disclosure of Cash Flow Information |
||||||||
Interest paid |
$ | 5,808,623 | $ | 2,669,380 | ||||
|
|
|
|
See notes to consolidated financial statements
6
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
1. | Description of Business |
Gemino Healthcare Finance, LLC is a Delaware limited liability company formed in December 2006. In February 2021, the Company filed a d/b/a in the name of SLR Healthcare ABL (SLR Healthcare). SLR Healthcare is a commercial finance company that originates, underwrites and manages primarily secured, asset-based loans for small and mid-sized companies operating across the U.S. in the healthcare industry. SLR Healthcares loans are primarily in the form of revolving lines of credit, secured by accounts receivable of the borrowers. The accounts receivable serving as collateral are primarily third party obligations from government payers, such as Medicare or Medicaid, and commercial insurers.
In certain cases, SLR Healthcare may provide senior term loan financing, including real estate financing to qualified borrowers in addition to a revolving line of credit. Senior term loans, including real estate loans are typically secured by accounts receivable and all other assets of the borrowers, such as inventory, equipment and real estate.
Gemino Healthcare Funding, LLC (Gemino Funding) is a wholly-owned special purpose limited liability company that purchases and holds certain eligible loans and related property from SLR Healthcare (collectively, the Company).
On September 30, 2013, SLR Senior Investment Corp. formerly known as Solar Senior Capital Ltd. (SLR Senior), a Maryland corporation, acquired a controlling interest in SLR Healthcare. On April 1, 2022, SLR Senior merged with the surviving affiliated entity, SLR Investment Corp. (SLR Investment), a Maryland corporation. The remaining interest of SLR Healthcare is held by the management team of SLR Healthcare.
2. | Summary of Significant Accounting Policies |
Principles of Consolidation
The consolidated financial statements include the accounts of SLR Healthcare and Gemino Funding. All significant intercompany balances have been eliminated in consolidation.
Use of Estimates
The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and to report amounts of revenues and expenses during the reporting period. Actual results could differ materially from these estimates. The allowance for credit losses represents an estimate that is particularly susceptible to material change.
Cash and Cash Equivalents
Cash and cash equivalents include funds deposited with financial institutions and short-term, liquid investments in money market accounts with original maturities of three months or less.
7
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
2. | Summary of Significant Accounting Policies continued |
Loans Receivable
Loans receivable that management has the intent and ability to hold for the foreseeable future or until maturity or payoff are reported at their outstanding unpaid principal balances less the allowance for credit losses and any deferred fees or costs.
Commitment terms of the Companys financing agreements generally range from two to five years with interest charged on a floating rate basis. Funding under revolving loan commitments is subject to the Companys estimation of the value of the accounts receivable pledged as collateral.
Revenue Recognition
Income on loans receivable is recognized using the simple interest method. Revolving loan origination fees and costs are deferred and amortized on a straight-line basis over the terms of the related loan commitments as an adjustment to interest income on loans. Term loan origination fees and costs are deferred and amortized using either the effective interest method or the straight-line method over the life of the loan as an adjustment to interest income. The straight-line method may be used for term loan facilities when it approximates the effective interest method. Other fees, such as unused balance and collateral monitoring fees, are recognized when the services are provided. Termination fees are recognized when a loan is terminated. These other fees are included in other income.
The accrual of interest on loans is discontinued at the time the loan is 90 days delinquent unless the loan is adequately secured. Typically, loans are placed on non-accrual or charged off at an earlier date if collection of principal or interest is considered doubtful. When a loan is placed on non-accrual status, all interest previously accrued, but not collected, is reversed against current interest income and all future proceeds received will generally be applied against principal or interest, in the judgment of management. Loans are returned to accrual status when all principal and interest amounts contractually due are reasonably assured.
The Company recognizes revenue in accordance with the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers, which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. The core principle of the revenue model is for an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services.
ASC 606 is not applicable to financial instruments and, therefore, does not impact the Companys revenues. The Company has evaluated the nature of its contracts with customers and fully satisfies its performance obligations on its contracts as services are rendered and the transaction prices are typically fixed; they are charged either on a periodic basis or based on activity.
8
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
2. | Summary of Significant Accounting Policies continued |
Impaired Loans
A loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due in accordance with the contractual terms of the loan agreement. Loans are evaluated for impairment by the Company based on an ongoing analysis of each borrowers repayment capacity, the value of the collateral support and the strength of any guarantees. Loans identified as impaired are further evaluated to determine the estimated extent of impairment.
Allowance for Credit Losses
Effective January 1, 2023, the Company adopted Accounting Standards Update (ASU) 2016-13, Financial Instruments Credit Losses (Topic 326). ASU 2016-13 requires a current expected credit loss (CECL) measurement to estimate the allowance for credit losses replacing the estimate of probable credit losses inherent in the loan portfolio. The Company adopted ASU 2016-13 using the modified retrospective method. Results for 2023 are presented in accordance with ASU 2016-13 while prior period amounts continue to be reported in accordance with previously applicable accounting standards. Upon adoption, the Company recognized an overall decrease in the allowance for credit losses of approximately $429,000 as a cumulative effect adjustment from a change in accounting policies, which increased Members equity.
The allowance for credit losses reflects the Companys current estimate of potential credit losses in the loan portfolio at year end. The CECL methodology is based on relevant information about past events, including, but not limited to, historical loss experience, current portfolio composition, market conditions and reasonable and supportable forecasts that affect the collectability of the reported loan balances for the duration of each respective loan. Increases and decreases to the allowance for credit losses are recorded through the Provision for loan losses in the Consolidated Statements of Operations.
The Companys portfolio currently consists of revolving lines of credit. All loans in the Companys portfolio are individually evaluated when determining the risk rating for each loan. A lower internal risk rating represents less risk while a higher internal risk rating represents more risk. Credit risk ratings for each borrower are established based on certain qualitative and quantitative factors including an assessment of management and strategy, historical and projected repayment capacity, collateral coverage and performance, financial condition and sponsorship, strength of guarantees and any contingencies.
The allowance for credit losses on loans classified as Pass is assessed using historical loss experience, the expected weighted-average remaining maturity of the portfolio, adjusted for expected prepayments, and a qualitative economic view. The Company also reviews trends in the weighted-average risk of the portfolio to determine whether risk characteristics of the current portfolio, relative to the historical portfolio, could signal a greater risk of expected loss. In accordance with CECL, the Companys allowance for credit losses may be adjusted to reflect managements assessment of current and future economic conditions that may impact the performance of each borrower. The assessment includes, but is not limited to, unemployment rates, interest rates, expectations of inflation and/or recession, as well as various other macroeconomic factors that could impact the likelihood of potential credit losses during a loans anticipated term.
9
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
2. | Summary of Significant Accounting Policies continued |
Allowance for Credit Losses continued
Specific allowances for credit losses are generally applied to certain loans classified as Substandard. Generally, these loans are deemed to be impaired and are typically measured based on a comparison of the recorded carrying value of the loan to the present value of the loans expected cash flow using the loans effective interest rate, the loans estimated market price or the estimated fair value of the underlying collateral, if the loan is collateral-dependent combined with the strength of any guarantee arrangements. Specific allowances are recorded when the discounted cash flows, collateral value, or aggregate market price of the impaired loan is lower than the carrying value of that loan.
Loans are charged off when collection is questionable and when the Company can no longer justify maintaining the loan as an asset on the consolidated balance sheets. Loans qualify for charge off when, after thorough analysis, all possible sources of collection are determined to be insufficient to repay the loan. These include impairment of potential future cash flow, value of collateral and/or financial strength of guarantors. Recoveries of previous charge-offs are recorded when received. For the years ended December 31, 2023 and 2022, there were no recoveries of previous charge-offs.
Goodwill
Goodwill arose from the acquisition of the Company on September 30, 2013 (Note 1). Goodwill represents the excess of the purchase price over the fair value of those acquired net assets. Goodwill is not amortized, but instead is reviewed for impairment annually typically in December of each year or more frequently upon the occurrence of certain events or substantive changes in circumstances. The Company assesses goodwill for impairment by comparing the carrying value of the Company to its fair value. The Company has the option to perform a qualitative assessment to determine if an impairment is more likely than not to have occurred. If the conclusion is supported that it is more likely than not that the fair value is less than its carrying amount, then the Company would need to perform a quantitative impairment test. If the conclusion cannot be supported, or if the Company does not elect to do the qualitative assessment, then the Company will perform a quantitative assessment. If a quantitative goodwill impairment assessment is performed, the Company utilizes a combination of market and income valuation approaches. No impairment of goodwill resulted for the years ended December 31, 2023 and 2022, respectively.
Furniture and Equipment
Furniture and equipment are recorded at cost, net of accumulated depreciation, and are depreciated on a straight-line basis over their estimated useful lives ranging from three to five years.
Debt Issuance Costs
The Company reports origination and other costs related to debt issuances as a direct deduction from the carrying amount of the debt liability. These expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life as an adjustment to interest expense. The straight-line method may be used on revolving facilities when it approximates the effective interest method.
10
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
2. | Summary of Significant Accounting Policies continued |
Income Taxes
The Company is not subject to federal or state income taxes. Members of the Company have elected to report the taxable income or loss on their individual tax returns. Accordingly, no provision for income taxes has been recorded in the accompanying consolidated financial statements.
The Company applies authoritative guidance relating to the accounting for uncertain tax positions. Accordingly, a provision for uncertain tax positions and related penalties and interest is recognized when it is more-likely-than-not, based on the technical merits, that the tax position will not be realized or sustained upon examination by the appropriate taxing authority. Management determined there were no tax uncertainties that met the recognition threshold in 2023 and 2022.
The Company files both federal and state income tax returns. The Company remains subject to examination by taxing authorities for the years 2020 and after.
Accounting Standard Adopted in 2023
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (ASU 2020-04). ASU 2020-04 provided optional, temporary relief to ease the burden of accounting for reference rate reform activities that affect contractual modifications of floating rate financial instruments indexed to interbank rates. Modifications of qualifying contracts are accounted for as the continuation of an existing contract rather than as a new contract. The Company modified its outstanding loans receivable and credit facility agreements by replacing references to the London Inter-Bank Offered Rate (LIBOR) with the Secured Overnight Financing Rate (SOFR) or another alternative reference rate. There was no impact to the consolidated financial statements as a result of adopting ASU 2020-04.
11
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
3. | Loans Receivable |
The following table shows the composition of loans receivable, net as of December 31, 2023 and 2022:
2023 | 2022 | |||||||
Revolving loans receivable |
$ | 112,835,755 | $ | 94,198,839 | ||||
Less allowance for credit losses |
(605,751 | ) | (953,803 | ) | ||||
Less deferred origination fees and costs, net |
(965,748 | ) | (861,877 | ) | ||||
|
|
|
|
|||||
Loans receivable, net |
$ | 111,264,256 | $ | 92,383,159 | ||||
|
|
|
|
4. | Allowance for Credit Losses and Recorded Investment in Loans Receivables |
The following table summarizes the activity in the allowance for credit losses by revolving loans for the respective years ended December 31, 2023 and 2022:
2023 | 2022 | |||||||
Beginning balance |
$ | 953,803 | $ | 836,654 | ||||
Cumulative effect of adopting ASU 2016-13 |
(429,211 | ) | | |||||
Provision for loan losses |
81,159 | 117,149 | ||||||
|
|
|
|
|||||
Ending balance |
$ | 605,751 | $ | 953,803 | ||||
|
|
|
|
|||||
Collectively evaluated for impairment |
$ | 605,751 | $ | 952,745 | ||||
|
|
|
|
|||||
Individually evaluated for impairment |
$ | | $ | 1,058 | ||||
|
|
|
|
The following table presents revolving loans collectively and individually evaluated for impairment at December 31, 2023 and 2022:
2023 | 2022 | |||||||
Revolving loans |
$ | 112,835,755 | $ | 94,198,839 | ||||
|
|
|
|
|||||
Collectively evaluated for impairment |
$ | 112,835,755 | $ | 94,093,002 | ||||
|
|
|
|
|||||
Individually evaluated for impairment |
$ | | $ | 105,837 | ||||
|
|
|
|
The following table summarizes the non-accrual revolving loans at December 31, 2023 and 2023:
2023 | 2022 | |||||||
Recorded investment |
$ | | $ | 105,837 | ||||
|
|
|
|
|||||
Unpaid principal |
$ | | $ | 105,837 | ||||
|
|
|
|
|||||
Related allowance |
$ | | $ | 1,058 | ||||
|
|
|
|
12
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
4. | Allowance for Credit Losses and Recorded Investment in Loans Receivables continued |
Credit Quality Indicators
The following table summarizes the loan portfolio by the Companys internal credit rating (scale: 1 to 7) as of December 31, 2023 and 2022: Loans with a rating of 4 or better generally pose minimal risk to the Company as they exhibit, among other things, one or more of the following attributes: (1) secured collateral position; (2) satisfactory cash flows; and (3) history of timely payment of debt obligations. Loans credit rated below 4 are considered watchlist loans; an overall degree of risk exists with these loans that warrants managements review each quarter.
December 31, | ||||||||
2023 | 2022 | |||||||
Rated 4 or better |
$ | 107,346,528 | $ | 88,001,460 | ||||
Rated 5 |
5,489,227 | 6,091,542 | ||||||
Rated 6 |
| 105,837 | ||||||
|
|
|
|
|||||
Total revolving loans |
$ | 112,835,755 | $ | 94,198,839 | ||||
|
|
|
|
5. | Furniture and Equipment |
Furniture and equipment are comprised of the following at December 31, 2023 and 2022:
2023 | 2022 | |||||||
Computer software and equipment |
$ | 156,947 | $ | 136,837 | ||||
Furniture and fixtures |
41,032 | 41,032 | ||||||
Leasehold improvement |
21,551 | 21,551 | ||||||
|
|
|
|
|||||
Total |
219,530 | 199,420 | ||||||
Less accumulated depreciation |
(184,888 | ) | (163,695 | ) | ||||
|
|
|
|
|||||
Furniture and equipment, net |
$ | 34,642 | $ | 35,725 | ||||
|
|
|
|
Depreciation expense was $21,193 and $22,248 for the years ended December 31, 2023 and 2022, respectively.
13
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
6. | Debt |
On May 27, 2016, the Company entered into a four-year, non-recourse $125,000,000 secured revolving credit facility. Effective with an amendment dated August 24, 2023, the credit facility was increased to $150,000,000, which is expandable to $200,000,000 under its accordion feature. The maturity date of the credit facility is March 31, 2026. Under the terms of the credit facility, the Company has made certain customary representations and warranties, and is required to comply with various covenants, including financial and reporting requirements and other customary requirements for similar credit facilities. The credit facility also includes usual and customary events of default for credit facilities of this nature.
Amounts available to borrow under the credit facility are also subject to compliance with a borrowing base that applies different advance rates to different types of assets in the Companys portfolio that are pledged as collateral. As of December 31, 2023 and 2022, there were principal borrowings of $84,700,000 and $77,000,000 outstanding, respectively, under the credit facility which is collateralized by eligible loans and related securities.
Interest on the credit facility accrues at a variable rate per annum of one-month Term SOFR plus 2.85% and one-month LIBOR plus 2.25%, respectively, approximating 8.21% and 6.64% at December 31, 2023 and 2022, respectively. The Company also pays other customary loan fees for the credit facility.
The credit facility is comprised of the following at December 31, 2023 and 2022:
2023 | 2022 | |||||||
Principal borrowings |
$ | 84,700,000 | $ | 77,000,000 | ||||
Unamortized debt issuance costs |
(1,598,437 | ) | (360,973 | ) | ||||
|
|
|
|
|||||
Credit facility, net |
$ | 83,101,563 | $ | 76,639,027 | ||||
|
|
|
|
7. | Commitments and Concentrations |
At December 31, 2023 and 2022, the Company has committed facilities to its borrowers totaling approximately $255,000,000 and $242,106,000, respectively, of which approximately $142,164,000 and $147,907,000, respectively, was unused. Borrowers may borrow up to the lesser of (i) the committed facility or (ii) the underlying collateral value multiplied by the advance rate. Of the unused committed facility amount at December 31, 2023 and 2022, borrowers could borrow up to approximately $53,284,000 and $43,954,000, respectively. As of December 31, 2023 and 2022, the Company had sufficient cash available and/or availability under its credit facility to fund its commitments.
At December 31, 2023, the Company had one loan approximating 24% of the total loans receivable and at December 31, 2022, the Company had two loans approximating 16% and 12% of the total loans receivable, respectively.
14
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
8. | Employee Benefit Plans |
The Company sponsors a 401(k) savings plan, where the Company contributes a defined percentage of employees earnings up to the maximum contribution amount as determined by the Internal Revenue Service.
The Company formed a Long-Term Incentive Plan (LTIP) that provides for an annual bonus pool to employees based on the Company achieving certain performance criteria.
9. | Fair Value Disclosure |
Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. There are three levels of inputs that may be used to measure fair values:
Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date.
Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
Level 3: Significant unobservable inputs that reflect a companys own assumptions about the assumptions that market participants would use in pricing an asset or liability.
The following information should not be interpreted as an estimate of the fair value of the entire Company, since a fair value calculation is only provided for a limited portion of the Companys assets and liabilities. Assets and liabilities measured at fair value on a recurring basis are summarized in the table below at December 31, 2023 and 2022.
2023 | ||||||||
Carrying Value | Fair Value | |||||||
Financial assets: |
||||||||
Cash and cash equivalents (Level 1) |
$ | 38,417 | $ | 38,417 | ||||
Loans receivable, net (Level 3) |
111,264,256 | 112,230,004 | ||||||
Financial liabilities: |
||||||||
Credit facility, net (Level 2) |
83,101,563 | 84,700,000 | ||||||
2022 | ||||||||
Carrying Value | Fair Value | |||||||
Financial assets: |
||||||||
Cash and cash equivalents (Level 1) |
$ | 9,319,837 | $ | 9,319,837 | ||||
Loans receivable, net (Level 3) |
92,383,159 | 93,245,036 | ||||||
Financial liabilities: |
||||||||
Credit facility, net (Level 2) |
76,639,027 | 77,000,000 |
15
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2023 and 2022
10. | Related Parties |
Employees of an affiliated entity provide marketing, sales and legal services to the Company for which the Company reimburses the affiliated entity. Such reimbursements have been included in compensation and benefits expenses.
In August 2022, the Company sold a participation in a loan agreement to SLR Investment for a total commitment of $5,000,000 and the outstanding loans receivable balance at December 31, 2022 was $3,966,336. This participation was redeemed by the Company from SLR Investment during September 2023.
11. | Subsequent Events |
The Company evaluated subsequent events for recognition or disclosure through February 15, 2024, which was the date the consolidated financial statements were available to be issued.
16
Exhibit 99.5
North Mill Holdco LLC
and Subsidiaries
Consolidated Financial Report
December 31, 2023
North Mill Holdco LLC and Subsidiaries
Independent Auditors Report |
3-4 | |||
Consolidated Balance Sheets |
5 | |||
Consolidated Statements of Operations |
6 | |||
Consolidated Statements of Members Equity |
7 | |||
Consolidated Statements of Cash Flows |
8 | |||
Notes to Consolidated Financial Statements |
9 |
Independent Auditors Report
Audit Committee
North Mill Holdco LLC
Opinion
We have audited the consolidated financial statements of North Mill Holdco LLC and its subsidiaries (the Company), which comprise the consolidated balance sheets as of December 31, 2023 and 2022, the related consolidated statements of operations, members equity, and cash flows for the years then ended, and the related notes to the consolidated financial statements (collectively, the financial statements).
In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of their operations and their cash flows for the years then ended in accordance with accounting principles generally accepted in the United States of America.
Basis for Opinion
We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditors Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Emphasis of Matter
As discussed in Note 3 to the financial statements, the Company adopted Accounting Standards Update (ASU) No. 2016-13, Financial InstrumentsCredit Losses (Topic 326), using the modified retrospective transition method. Our opinion is not modified with respect to this matter.
Responsibilities of Management for the Financial Statements
Management is responsible for the preparation and fair presentation of the financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Companys ability to continue as a going concern within one year after the date that the financial statements are issued or available to be issued.
3
Auditors Responsibilities for the Audit of the Financial Statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.
In performing an audit in accordance with GAAS, we:
| Exercise professional judgment and maintain professional skepticism throughout the audit. |
| Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. |
| Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Companys internal control. Accordingly, no such opinion is expressed. |
| Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements. |
| Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Companys ability to continue as a going concern for a reasonable period of time. |
We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.
/s/ RSM US LLP
Philadelphia, Pennsylvania
February 23, 2024
North Mill Holdco LLC and Subsidiaries
Consolidated Balance Sheets
December 31, 2023 and 2022
2023 | 2022 | |||||||
Assets |
||||||||
Cash |
$ | 20,229,478 | $ | 7,396,967 | ||||
Finance receivables: |
||||||||
Loans receivable |
168,427,831 | 154,062,897 | ||||||
Less: unearned fee income |
103,286 | 284,640 | ||||||
|
|
|
|
|||||
168,324,545 | 153,778,257 | |||||||
Accounts receivable |
105,113,189 | 131,942,768 | ||||||
Less: allowance for uncollectible finance receivables |
2,328,391 | 1,834,061 | ||||||
|
|
|
|
|||||
Finance receivables, net |
271,109,343 | 283,886,964 | ||||||
Goodwill |
19,242,729 | 36,187,729 | ||||||
Accrued interest receivable |
2,158,775 | 1,735,159 | ||||||
Other assets |
335,799 | 256,914 | ||||||
Furniture and equipment, net |
604,124 | 545,337 | ||||||
Right of use asset |
1,654,855 | 2,238,007 | ||||||
|
|
|
|
|||||
Total assets |
$ | 315,335,103 | $ | 332,247,077 | ||||
|
|
|
|
|||||
Liabilities and Members Equity |
||||||||
Liabilities: |
||||||||
Credit facility payable, net of issuance costs (Note 7) |
$ | 222,061,862 | $ | 213,141,607 | ||||
Due to factoring clients |
25,073,717 | 34,200,052 | ||||||
Accounts payable and accrued expenses |
4,928,206 | 3,401,465 | ||||||
Lease liability |
1,654,855 | 2,238,007 | ||||||
|
|
|
|
|||||
Total liabilities |
253,718,640 | 252,981,131 | ||||||
Commitments (Note 8) |
||||||||
Members equity |
61,616,463 | 79,265,946 | ||||||
|
|
|
|
|||||
Total liabilities and members equity |
$ | 315,335,103 | $ | 332,247,077 | ||||
|
|
|
|
See notes to consolidated financial statements.
5
North Mill Holdco LLC and Subsidiaries
Consolidated Statements of Operations
Years Ended December 31, 2023 and 2022
Year Ended December 31, 2023 |
Year Ended December 31, 2022 |
|||||||
Interest and finance charges |
$ | 33,700,679 | $ | 26,815,365 | ||||
Less: interest expense |
15,047,895 | 8,306,061 | ||||||
|
|
|
|
|||||
Net interest income |
18,652,784 | 18,509,304 | ||||||
Service fees and other finance charges |
4,442,246 | 2,617,984 | ||||||
|
|
|
|
|||||
Net interest and other non-interest income |
23,095,030 | 21,127,288 | ||||||
Provision (credit) for uncollectible finance receivables |
(453,120 | ) | | |||||
|
|
|
|
|||||
Net interest income after provision (credit) for uncollectible finance receivables |
23,548,150 | 21,127,288 | ||||||
|
|
|
|
|||||
Expenses: |
||||||||
Personnel |
12,384,594 | 9,984,711 | ||||||
Acquisition expenses |
| 3,699,997 | ||||||
Impairment of goodwill |
16,945,000 | | ||||||
General and administrative |
3,266,764 | 3,048,501 | ||||||
Legal and professional fees |
439,601 | 453,413 | ||||||
|
|
|
|
|||||
33,035,959 | 17,186,622 | |||||||
|
|
|
|
|||||
Net (loss) income |
$ | (9,487,809 | ) | $ | 3,940,666 | |||
|
|
|
|
See notes to consolidated financial statements.
6
North Mill Holdco LLC and Subsidiaries
Consolidated Statements of Members Equity
Years Ended December 31, 2023 and 2022
Balance, January 1, 2022 |
$ | 77,103,196 | ||
Net income |
3,940,666 | |||
SLR contributions |
5,000,000 | |||
Distribution to members |
(6,777,916 | ) | ||
|
|
|||
Balance, December 31, 2022 |
79,265,946 | |||
Cumulative change in accounting principle (see note 3) |
(1,085,173 | ) | ||
Net loss |
(9,487,809 | ) | ||
Distribution to members |
(7,076,501 | ) | ||
|
|
|||
Balance, December 31, 2023 |
$ | 61,616,463 | ||
|
|
See notes to consolidated financial statements.
7
North Mill Holdco LLC and Subsidiaries
Consolidated Statements of Cash Flows
Years Ended December 31, 2023 and 2022
Year Ended December 31, 2023 |
Year Ended December 31, 2022 |
|||||||
Cash flows from operating activities: |
||||||||
Net (loss) income |
$ | (9,487,809 | ) | $ | 3,940,666 | |||
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: |
||||||||
Provision (credit) for uncollectible finance receivables |
(453,120 | ) | | |||||
Depreciation |
182,428 | 149,413 | ||||||
Amortization of deferred financing costs |
495,283 | 367,771 | ||||||
Impairment of goodwill |
16,945,000 | | ||||||
Changes in assets and liabilities: |
||||||||
(Increase) decrease in: |
||||||||
Accrued interest receivable |
(423,616 | ) | (889,598 | ) | ||||
Other assets |
(78,884 | ) | 72,915 | |||||
Increase (decrease) in: |
||||||||
Unearned fee income |
(181,354 | ) | 248,713 | |||||
Accounts payable and accrued expenses |
1,526,741 | 1,371,381 | ||||||
Due to factoring clients |
(9,126,335 | ) | 6,255,447 | |||||
|
|
|
|
|||||
Net cash (used in) provided by operating activities |
(601,666 | ) | 11,516,708 | |||||
Cash flows from investing activities: |
||||||||
Decrease (increase) in finance receivables, net |
12,326,922 | (37,353,685 | ) | |||||
Purchases of furniture and equipment |
(241,215 | ) | (412,744 | ) | ||||
|
|
|
|
|||||
Net cash provided by (used in) investing activities |
12,085,707 | (37,766,429 | ) | |||||
|
|
|
|
|||||
Cash flows from financing activities: |
||||||||
Net proceeds from credit facility payable |
8,491,955 | 31,173,335 | ||||||
SLR contributions |
| 5,000,000 | ||||||
Payment of debt issuance costs |
(66,984 | ) | (936,160 | ) | ||||
Distribution to members |
(7,076,501 | ) | (6,777,916 | ) | ||||
|
|
|
|
|||||
Net cash provided by financing activities |
1,348,470 | 28,459,259 | ||||||
|
|
|
|
|||||
Net increase in cash |
12,832,511 | 2,209,538 | ||||||
Cash: |
||||||||
Beginning |
7,396,967 | 5,187,429 | ||||||
|
|
|
|
|||||
Ending |
$ | 20,229,478 | $ | 7,396,967 | ||||
|
|
|
|
|||||
Supplemental disclosure of cash flow information: |
||||||||
Cash paid for interest |
$ | 14,027,175 | $ | 6,993,995 | ||||
|
|
|
|
|||||
Non-Cash Disclosure: |
||||||||
Cumulative change in accounting principle |
$ | (1,085,173 | ) | $ | | |||
Right of use asset and lease liability |
| 1,451,570 | ||||||
|
|
|
|
See notes to consolidated financial statements.
8
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
Note 1. Nature of the Business
The operations of North Mill Holdco LLC (Holdco) and Subsidiaries (collectively, the Company) consist primarily of those financial activities common to the commercial asset-based finance industry.
Holdco, a subsidiary of SLR Investment Corp. (SLR), was formed on May 17, 2019 in connection with the acquisition of Summit Financial Resources, LLC (Summit).
North Mill Capital LLC (NMC) was formed as a single-member Delaware limited liability company on August 18, 2010 and commenced operations on October 29, 2010. SLR acquired a controlling interest in NMC on October 20, 2017. SLR contributed its interests in NMC to Holdco on June 28, 2019. NMC is a wholly owned subsidiary of Holdco.
NMC is a specialty finance company engaged in providing asset-based commercial financing to small and medium-sized businesses. The Companys core business is providing and servicing loans ranging from $200,000 to $40,000,000 secured by accounts receivable, inventory, and equipment. Borrowers are located throughout the United States.
PrinSource Capital Companies, LLC, a wholly owned subsidiary of NMC, and their wholly owned subsidiary Partner Plus, LLC (collectively, PrinSource), were acquired by NMC on December 30, 2011. Summit was acquired by Holdco on June 28, 2019. PrinSource, Summit, and SLR Digital Finance LLC (Digital Finance) (Note 2) provide financial services through the funding and financing of working capital assets, primarily accounts receivable and inventory.
Note 2: Acquisition
In connection with NMCs acquisition of Digital Finance on June 3, 2021, an additional earn out payment of $3,699,997 was made in 2022 and was based on reaching certain loan balances for a six month period subsequent to the acquisition date. The payment has been recorded as acquisition expense in the accompanying consolidated statements of operations.
Note 3: Significant Accounting Policies
Significant accounting policies are as follows:
Principles of consolidation: The financial statements include the accounts of NMC and its subsidiaries. All material intercompany accounts and transactions have been eliminated in consolidation.
Revenue recognition: The Company recognizes interest and fee income in accordance with ASC 310, Receivables and ASC 825, Interest. Interest income is recognized as earned based on the terms of the underlying loan agreement. Fees received for the origination of loans are deferred and amortized into income over the contractual lives of the loans and annual fees received for loans are deferred and amortized into income over a twelve-month period using the straight-line method, which approximates the effective interest rate method. Unamortized amounts are recognized as income at the time that loans are paid in full. Interest income on loans receivable is recognized using the interest method. Interest and fee income are accrued based on the outstanding loan balance and charged monthly to the loan balance as earned, except in instances that a reasonable doubt exists as to the collectability of interest, in which case the accrual of income may be suspended.
9
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
The Company recognizes and measures revenue recognition on other fee income in accordance with ASC 606, Revenue from Contracts With Customers. Other fee income, which includes wire transfers, field examination charges, late reporting fees and other items charged to borrowers, is recognized as charged.
Cash: The Company maintains its cash balances at several financial institutions which at various times during the year have exceeded the threshold for insurance provided by the Federal Deposit Insurance Corporation.
Loans receivable: The Companys portfolio consists of asset based loans. The loans are further classified as either performing or non-performing. The Company provides asset-based financing primarily in the form of revolving credit facilities collateralized by the borrowers assets, including, but not limited to, accounts receivable, inventory, equipment and general intangibles. The loan term is generally two years and management has the intention and ability to hold until maturity or payoff. Provisions for credit losses for finance receivables are charged to operations in amounts sufficient to maintain the allowance for uncollectible finance receivables at an amount considered adequate to cover the estimated losses of principal and accrued interest in the existing loan portfolio. The Companys charge-off policy is based on a loan-by-loan review for all receivables. Management periodically evaluates the adequacy of the allowance for uncollectible finance receivables by reviewing credit loss experience, change in size and character of credit risks, the value of collateral and general economic conditions. Loans are charged off against the allowance when management determines that there is insufficient collateral to support the loan and believes that it is no longer probable that principal and/or interest payments will be collected. These loans can be affected by economic conditions.
Accounts receivable: Accounts receivable consist of factored receivables including factored receivables specifically for digital media companies. As of December 31, 2023 and 2022, the factored receivables portfolio is $20,258,992 and $31,087,439 and the factored receivables specifically for digital media companies portfolio balance is $84,854,197 and $100,855,329, both of which comprise the balance of accounts receivable on the consolidated balance sheets of $105,113,189 and $131,942,768, respectively. Accounts receivable are stated at cost, net of an allowance for uncollectible finance receivables. The allowance for uncollectible finance receivables is based on managements assessment of the collectability of specific customer accounts, the aging of the accounts receivable, historical experience and other currently available evidence. If there is a deterioration of a major customers credit worthiness or actual defaults are higher than the historical experience, managements estimates of the recoverability of amounts due to the Company could be adversely affected. These receivables can be affected by economic conditions.
Allowance for credit losses: On January 1, 2023, the Company adopted ASU 2016-13 Financial Instruments Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, as amended, which replaces the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (CECL) methodology. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost, including loan and accounts receivables. The method utilized by the Company to estimate expected credit losses is the weighted average maturity (WARM) methodology which contemplates expected losses at a pool-level, utilizing historic loss information.
10
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
Results for reporting periods beginning after January 1, 2023 are presented under ASC 326 while prior period amounts continue to be reported in accordance with previously applicable GAAP. There was an adjustment to retained earnings of $1,085,173 as a result of adoption ASC 326.
In accordance with CECL, the Companys allowance for loan losses may be adjusted to reflect managements assessment of current and future economic conditions that may impact the performance of the borrowers, historical charge-offs, trends in loan volumes, industry concentrations including providing working capital facilities to digital media companies, the weighted average maturity of the loan portfolio, and the likelihood of funding unfunded commitments.
The cumulative loss rate used as the basis for the estimate of credit losses for asset based loans, factored receivables, and factored receivables specifically for digital media companies is comprised of the Companys historical loss experience from 2010 to 2023. As of December 31, 2023, the Company expects that the markets in which it operates will experience stable economic conditions, low level of future charge-offs and delinquencies, low to medium level of originations, and low to medium geographic and industry concentrations over the next two years. Management adjusted the historical loss experience for these expectations. No reversion adjustments were necessary, as the starting point for the Companys estimate was a cumulative loss rate covering the expected contractual term of the portfolio.
When the Company determines there is insufficient collateral to support an outstanding loan or accounts receivable balance and believes it is no longer probable that principal and/or interest payments will be collected, the Company will place the loan on non-accrual status. Such non-accrual loans may be restored to accrual status if past due principal and interest are paid in cash, and, in managements judgment, are likely to continue.
Participation funding: The Company enters into participation funding and servicing arrangements with other lending institutions whereby the other institutions pay the Company a processing fee for servicing financing arrangements that the other institutions have entered into with their customers. Under these arrangements, the Company, as the participant, assumes the risk related to their percentage share of the arrangement. The Company pays the lending institutions a pro rata percentage of the fee income earned. The arrangements are presented in finance receivables in the accompanying consolidated balance sheet net of the amount due to the institution.
The Company enters into participation funding arrangements with third-party lending institutions, whereby those institutions participate in loans originated by the Company. These arrangements are used by the Company to manage risk associated with loans and accounts receivable that may potentially exceed funding limits. Transfers of financial assets are accounted for as sales, when control over the assets has been surrendered. Control over transferred assets is deemed to be surrendered when: the assets have been isolated from the Company put presumptively beyond the reach of the transferor and its creditors, even in bankruptcy or other receivership; the transferee obtains the right (free of conditions that constrain it from taking advantage of that right) to pledge or exchange the transferred assets; and the Company does not maintain effective control over the transferred assets through an agreement to repurchase them before their maturity or the ability to unilaterally cause the holder to return specific assets, other than through a cleanup call.
Furniture and Equipment: Property and equipment acquired in acquisitions is initially recorded at fair value. Additions are recorded at cost and stated net of accumulated depreciation. Depreciation and amortization are provided using the straight-line method over the estimated lives of the assets, which is generally three to five years for equipment and ten years for furniture and fixtures.
11
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
Debt issuance costs: Costs incurred in connection with the placement of the revolving credit facility have been capitalized and recorded as a reduction to the note payable on the balance sheets. These costs are amortized as interest expense over the life of the facility using the effective interest method or straight line method if it approximates the effective interest method.
Impairment of long-lived assets: The Company reviews long-lived assets, including furniture and equipment and intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. An impairment loss would be recognized when undiscounted future cash flows expected to result from the use of the asset and its eventual disposition is less than the carrying amount. No impairments have occurred to date.
Goodwill: Goodwill represents the excess of consideration paid for an acquired business over the fair value of the related assets acquired and liabilities assumed. Goodwill arose from the acquisition of the Company on October 20, 2017, Summit, and Digital Finance (Note 2). The Company is required to assess its goodwill for impairment annually, or more frequently if events or changes in circumstances indicate impairment may have occurred. The Company assesses goodwill for impairment by comparing the carrying value of the Company to its fair value. If the fair value were less than the carrying value, an impairment loss would be recorded for the difference between the fair value and carrying value. The Company determines the fair value of the entity using a weighting of fair values derived from the income approach and market approach valuation methodologies. The income approach uses the discounted cash flow method and the market approach uses the guideline public company method. If the Company determines the fair value of the entitys goodwill is less than its carrying value, an impairment loss is recognized and reflected in the consolidated statements of operations. For the year ended December 31, 2023, the Company performed an interim and annual impairment test resulting in an impairment charge $16,945,000 and has been recorded as impairment of goodwill in the consolidated statements of operations. The impairment charge was caused by the measurement of discounting cash flows of future earnings resulting in a value less than the Companys carrying value as the estimated growth in the loan portfolio and corresponding revenues were not sufficient to support its current carrying value. There was no impairment in 2022. Changes in the carrying amount of goodwill is as follows:
Goodwill as of January 1, 2022 |
$ | 36,187,729 | ||
Impairment loss |
| |||
|
|
|||
Goodwill as of December 31, 2022 |
36,187,729 | |||
Impairment loss |
(16,945,000 | ) | ||
|
|
|||
Goodwill as of December 31, 2023 |
$ | 19,242,729 | ||
|
|
Income taxes: No provision has been made for income taxes, if any, as these are the obligation of the members. The Company files income tax returns as a partnership in the U.S. federal jurisdiction and in various state jurisdictions.
The Company applies authoritative guidance relating to the accounting for uncertain tax positions. Accordingly, a provision for uncertain tax positions and related penalties and interest is recognized when it is more likely-than-not, based on the technical merits, that the tax position will be realized or sustained upon examination. The term more-likely-than-not means a likelihood or more than 50%. A tax position that meets the more-likely-than-not recognition threshold is initially and subsequently measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon settlement with a taxing authority that has full knowledge of all relevant information. The determination of whether or not a tax position has met the more-likely-than-not recognition threshold considers the facts, circumstances, and information available at the reporting date and is subject to managements judgment.
12
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
Interest rate risk: Inherent in the Companys principal business activities is the potential for the Company to assume interest rate risks that result from differences in the maturities and re-pricing characteristics of certain assets and liabilities.
Use of estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.
Leases: The Company recognizes and measures its leases in accordance with FASB ASC 842, Leases. The Company is a lessee in several non-cancellable operating leases for office space. The Company determines if an arrangement is a lease, or contains a lease, at inception of a contract and when the terms of an existing contract are changed. The Company recognizes a right of use (ROU) asset and a lease liability asset, initially and subsequently, based on the present value of its future lease payments. The discount rate is the implicit rate, if it is readily determinable, or otherwise the Company uses its incremental borrowing rate. The implicit rates of the Companys leases are not readily determinable and accordingly, the Company uses an incremental borrowing rate based on the information available at the commencement date for all leases. The Companys incremental borrowing rate for a lease is the rate of interest it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms and in a similar economic environment. The Company used a weighted average discount rate of 3.00% and the weighted average remaining lease terms is 3.27 years. The ROU asset is subsequently measured throughout the lease term at the amount of the remeasured lease liability (i.e., present value of the remaining lease payments), plus unamortized initial direct costs, plus (minus) any prepared (accrued) lease payments, less the unamortized balance of lease incentives received, and any impairment recognized.
Subsequent events: The Company has evaluated its subsequent events (events occurring after December 31, 2023) through February 23, 2024, which represents the date the financial statements were available to be issued, and determined that there were no material subsequent events requiring adjustment to, or disclosure in the consolidated financial statements for the year ended December 31, 2023.
Recent Accounting Pronouncement:
In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment (Topic 350), which simplifies how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal year 2023, with early adoption permitted for annual or interim tests performed on testing dates after January 1, 2017. The amendments included in this ASU are to be applied prospectively. Implementation of this new standard did not have a material impact on the Companys consolidated financial statements.
13
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
In January 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, March 2020, to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as the Secured Overnight Financing Rate. Entities can elect not to apply certain modification accounting requirements to contracts affected by what the guidance calls reference rate reform if certain criteria are met. An entity that makes this election would not have to remeasure the contracts at the modification date or reassess a previous accounting determination. Also, entities can elect various optional expedients that would allow them to continue applying hedge accounting for hedging relationships affected by reference rate reform if certain criteria are met, and can make a one-time election to sell and/or reclassify held-to-maturity debt securities that reference an interest rate affected by reference rate reform. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848), Deferral of the Sunset date of Topic 848, which defers the sunset date in Topic 848 from December 31, 2022 to December 31, 2024. The amendments in this ASU apply to all entities (subject to meeting certain criteria) that have contracts, hedging relationships, or other transactions that reference the London Interbank Offered Rate (LIBOR) or another reference rate expected to be discontinued because of reference rate reform. The Company is currently evaluating the impact the adoption of the standard will have on the Companys financial position and results of operations.
Note 4. Fair Value of Financial Instruments
FASB ASC 820, Fair Value Measurements (ASC 820), establishes a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect managements market assumptions.
These two types of inputs create the following fair value hierarchy:
Level 1 Quoted prices for identical instruments in active markets.
Level 2 Observable inputs other than quoted prices in active markets for identical assets and liabilities, such as interest rates and foreign exchange rates that are observable at commonly quoted intervals. Financial assets utilizing Level 2 inputs include currency swaps and interest rate caps.
Level 3 Unobservable inputs.
ASC 820 also requires that the Company disclose estimated fair values for its financial instruments. No quoted market exists for the Companys financial instruments. Therefore, fair market estimates are based on judgments, risk characteristics of various financial instruments and other factors. Changes in these assumptions could significantly affect the estimates.
The Company estimates the carrying amounts of cash approximated its fair value as of December 31, 2023 and 2022. Since there is no liquid secondary market for the Companys financing receivables, the Company estimated the fair value of its secured loans by comparing the average yield of the portfolio to recent issuances of similar loans. The Company has determined that the secured loans and credit facility payable are considered level three under the fair value hierarchy described above.
14
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
The carrying amount and estimated fair values of the Companys financial instruments at December 31, 2023 and 2022 were as follows:
December 31, 2023 | December 31, 2022 | |||||||||||||||
Carrying Amount | Estimated Fair Value |
Carrying Amount |
Estimated Fair Value |
|||||||||||||
Financial assets: |
||||||||||||||||
Cash |
$ | 20,229,478 | $ | 20,229,478 | $ | 7,396,967 | $ | 7,396,967 | ||||||||
Finance receivables: |
||||||||||||||||
Net of allowance |
271,109,343 | 271,109,343 | 283,886,964 | 283,886,964 | ||||||||||||
Liabilities: |
||||||||||||||||
Credit facility payable |
$ | 222,061,862 | $ | 222,061,862 | $ | 213,141,607 | $ | 213,141,607 |
Note 5. Loans and Accounts Receivable and Allowance for Uncollected Finance Receivables
Loans receivable at December 31, 2023 and 2022 consist of revolving lines of credit to commercial customers that range from one to three years and are secured by accounts receivable, inventory and equipment. There are commitments to borrowers that are dependent on the borrowing base. The commitments are generally limited to 85% of the collateral being presented.
Changes in the allowance for credit losses for loans receivable and accounts receivable are as follows:
Loans Receivable |
Accounts Receivable |
Accounts Receivable - Digital |
Total | |||||||||||||
Balance, January 1, 2022 |
$ | 1,726,973 | $ | 22,283 | $ | 84,805 | $ | 1,834,061 | ||||||||
Provision for uncollectible finance receivables |
| | | | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balance, December 31, 2022, prior to adoption of ASC 326 |
1,726,973 | 22,283 | 84,805 | 1,834,061 | ||||||||||||
Impact of adopting ASC 326 |
896,474 | 59,186 | 129,513 | 1,085,173 | ||||||||||||
Provision (credit) for uncollectible finance receivables |
(379,941 | ) | (39,177 | ) | (34,003 | ) | (453,121 | ) | ||||||||
Net charge offs |
(137,722 | ) | | | (137,722 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balance, December 31, 2023 |
$ | 2,105,784 | $ | 42,292 | $ | 180,315 | $ | 2,328,391 | ||||||||
|
|
|
|
|
|
|
|
The Company has implemented and adheres to an internal review system and credit loss allowance methodology designed to provide for the detection of problem receivables and an adequate allowance to cover credit losses. At least quarterly, a risk rating is assigned to individual balances. Management assigns a higher risk rating when they determine that their credit exposure has increased. Management assigns these risk ratings based on a number of factors including, but not limited to, the profitability, cash flow position, tangible net worth, strength of collateral performance and coverage, the probability of a loss being realized and results of internal audits and verifications related to each specific receivable.
15
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
The Companys credit risk rating system has nine grades, with each grade corresponding to a progressively greater risk of default. Risk ratings of (1) through (6) are performing categories and risk ratings of (7) through (9) are non-performing categories. Non-performing credits are: a (7) rated credit has a potential weakness which, if uncorrected, may result in a deterioration of the repayment prospects or inadequately protect the Companys credit position at some time in the future; (8) loans are credits that have a well-defined weakness or weaknesses that jeopardize the full repayment of the debt or make collection or liquidation in full highly questionable and improbable, when considering existing facts, conditions, and values. Loans rated (9) are considered uncollectible and of such little value that their continuance as assets is not warranted.
Loans receivable that are classified as performing loans are $168,427,832 and $154,062,897 as of December 31, 2023 and 2022, respectively. There were no loans receivable classified as non-performing as of December 31, 2023 and 2022.
Accounts receivables that are classified as performing are $105,113,189 and $131,942,768 as of December 31, 2023 and 2022, respectively. There were no accounts receivable classified as non-performing as of December 31, 2023 and 2022.
The Company typically classifies all loans as held to maturity.
A loan is considered non-performing when, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments in accordance with the contractual terms of the loan. Factors considered in determining non-performing loans and accounts receivable include payment status, collateral value and the probability of collecting payments when due. The significance of payment delays and/or shortfalls is determined on a case-by-case basis. All circumstances surrounding the loan are taken into account. Such factors include the length of the delinquency, the underlying reasons and the borrowers prior payment record. These factors are considered on a loan-by-loan basis.
Accrued interest receivable totaled $2,158,775 at December 31, 2023 and was reported on the consolidated balance sheets and is excluded from the estimate of credit losses. The accrual of accrued interest is in accordance with the non-accrual policy as stated in Note 3.
NMC did not have any loans or accounts receivable that are non-performing, modified, or past due 30 days or more as of December 31, 2023 and December 31, 2022.
Note 6. Furniture and Equipment
Furniture and equipment consists of the following at December 31, 2023 and 2022:
2023 | 2022 | |||||||
Furniture and fixtures |
$ | 457,122 | $ | 457,122 | ||||
Equipment |
2,379,622 | 2,138,407 | ||||||
|
|
|
|
|||||
2,836,744 | 2,595,529 | |||||||
Accumulated depreciation |
2,232,620 | 2,050,192 | ||||||
|
|
|
|
|||||
$ | 604,124 | $ | 545,337 | |||||
|
|
|
|
Depreciation expense was $182,428 for the year ended December 31, 2023 and $149,413 for the year ended December 31, 2022.
16
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
Note 7. Credit Facility Payable
The Company has entered into a $285,307,000 credit facility which expires November 13, 2025. Borrowings are secured by substantially all of the Companys assets. Interest on borrowings under the facility is payable monthly and is based on the SOFR plus an applicable margin, as defined. The interest rate was 7.69 percent as of December 31, 2023 and 6.22 percent as of December 2022. Outstanding borrowings under the credit facility are generally limited to 85 percent of eligible receivables, less any reserves established by the bank, as defined. The Company is required to maintain specified financial ratios and to comply with other covenants. The balance outstanding under this credit facility was $222,917,160 at December 31, 2023 and $214,425,205 at December 31, 2022. Credit facility payable as of December 31, 2023 and 2022 consist of the following:
2023 | 2022 | |||||||
Outstanding borrowings |
$ | 222,917,160 | $ | 214,425,205 | ||||
Less: debt issuance costs, net of accumulated amortization of $2,227,641 and $1,732,358, respectively |
855,298 | 1,283,598 | ||||||
|
|
|
|
|||||
$ | 222,061,862 | $ | 213,141,607 | |||||
|
|
|
|
Total interest expense related to credit facility payable was $14,314,816 and $7,837,581 for the years ended December 31, 2023 and 2022, respectively. Amortization of deferred costs of $495,283 and $367,771, fees on the unused commitment of $225,796 and $88,709, and loan administration fees of $12,000 and $12,000 for the years ended December 31, 2023 and 2022, respectively, are included in interest expense in the Consolidated Statements of Operations.
Note 8. Commitments
Employment agreements: The Company has entered into service agreements with certain members of management. Annual base compensation due under these agreements is included in personnel expenses in the consolidated statements of operations. The annual base compensation is subject to review and adjustment by the Company. The employees are also eligible to receive bonus compensation at the discretion of the Board of Managers. The agreements can be terminated by either the Company or the employees at any time upon written notice. Certain additional amounts may be paid to the employees, contingent upon the circumstances surrounding the termination, as defined in the service agreements.
Operating lease: The Company rents its office space under non-cancelable operating leases that expire through December 2027. Base rents due under the leases escalate throughout the term of the leases. These leases generally contain renewal options but the Company is not reasonably certain to exercise these options. The optionable periods are not included in determining the lease term and the associated payments under the renewal options are excluded from lease payments.
17
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
The total minimum rental commitment at December 31, 2023, is due as follows:
Years ending December 31:
2024 |
$ | 548,135 | ||
2025 |
512,349 | |||
2026 |
492,379 | |||
2027 |
208,377 | |||
|
|
|||
Total lease commitments |
1,761,240 | |||
Less: interest |
(106,385 | ) | ||
|
|
|||
Present value of lease liability |
$ | 1,654,855 | ||
|
|
Rent expense was $677,446 and $586,007 for the years ended December 31, 2023 and 2022, respectively.
Unfunded Commitments: Commitments under loan and finance receivable facilities aggregated $610,948,740 at December 31, 2023, of which $337,407,720 were unfunded. Advances relating to these unfunded commitments were limited to those facilities with available collateral which aggregated $78,759,635. At December 31, 2022, total commitments were $603,432,040, of which $317,426,375 were unfunded. Advances relating to these unfunded commitments were limited to those facilities with available collateral which aggregated $79,474,864.
Note 9. Related Party Transactions
NMC has sold participations in several loan agreements to SLR and its affiliates. The participations sold for a total commitment of $114.5 million and the amount outstanding at December 31, 2023 was $84.0 million. At December 31, 2022, participations sold were $68 million and the amount outstanding was $53.4 million.
18
Exhibit 99.6
Report of Independent Registered Public Accounting Firm on Supplemental Information
To the Stockholders and Board of Directors
SLR Investment Corp.:
We have audited and reported separately herein on the consolidated financial statements of SLR Investment Corp. (and subsidiaries) (the Company) as of December 31, 2023 and December 31, 2022 and for each of the years in the three-year period ended December 31, 2023.
We have also previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated statements of assets and liabilities of the Company, including the consolidated schedules of investments, as of December 31, 2021, 2020, 2019, 2018, 2017, 2016, 2015 and 2014, and the related consolidated statements of operations, changes in net assets, and cash flows for the years ended December 31, 2020, 2019, 2018, 2017, 2016, 2015 and 2014, (none of which is presented herein), and we expressed unqualified opinions on those consolidated financial statements.
The senior securities table included in Part II, Item 7 of the Annual Report on Form 10-K of the Company for the year ended December 31, 2023, under the caption Senior Securities (the Senior Securities Table) has been subjected to audit procedures performed in conjunction with the audit of the Companys respective consolidated financial statements. The Senior Securities Table is the responsibility of the Companys management. Our audit procedures included determining whether the Senior Securities Table reconciles to the respective consolidated financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the Senior Securities Table. In forming our opinion on the Senior Securities Table, we evaluated whether the Senior Securities Table, including its form and content, is presented in conformity with the instructions to Form N-2. In our opinion, the Senior Securities Table is fairly stated, in all material respects, in relation to the respective consolidated financial statements as a whole.
/s/ KPMG LLP
New York, New York
February 27, 2024